Documente Academic
Documente Profesional
Documente Cultură
Sectia FO
Data eliberarii: 12/02/2020 CHIRURGIE GENERALA
: 1109
3 Urgenta N
Perioada 07/06/2013 - Medic Dr. GRIGOREAN VALENTIN
internarii: 11/06/2013 : TITUS U
EPICRIZA
Pacient in varsta 69 de ani, acuzand stare generala alterata, paloare tegumentara, scadere
poderala, absenta tranzitului intestinal pentru materii fecale de 2 saptamani , rectoragii. Se
interneaza pentru investigatii suplimentare si atitudine chirurgicala adecvata.
Ecografie abdominal : in limite normale.
Colonoscopie –-formatiune tumorala RECTALA circumferentiala, sangeranda spontan si
la palpare, la nivel sigmoidian polip de 4 mm fara sangerare. Pana la 60 de cm - aspect normal in
rest. Se practica biopsie din formatiunea tumorala.
CT toraco-abdominal - rezultat anexat biletului de externare.
PROTOCOL OPERATOR:
RECOMANDARI/REGIM/MEDICATIE
- revine pentru rezultatul anatomo-patologic la 14 de zile de la biopsie
- dispensarizare oncologica in serviciul teritorial;
- tratament conform retetei;
- reevaluare chirurgicala la nevoie.
DATA INVESTIGATII
07/06/2013 10:03:30 ALT/GPT.:25 U/L; Amilaza:65 U/L; AST/GOT:8 U/L;
Creatinina.:1.5 mg/dL; Glucoza:103 mg/dL; Ionograma (Na:138
mmol/L, K:4.06 mmol/L, Cl:104 mmol/L); Urea:29 mg/dL; APTT:26.7
s; Fibrinogen:426 mg/dL; PT-APP-INR (PT:14.1 s, APP:94 %,
INR:1.04 ); Hemograma (WBC:7.4 x 103/uL, RBC:4.30 x 106/uL,
HGB:11.0 g/dL, HCT:31.7 %, MCV:73.8 fL, MCH:25.7 pg,
MCHC:34.8 g/dL, RDW:23.4 %, PLT:315 x 103/uL, PCT:0.278 %,
MPV:8.8 fL, PDW:17.1 , LY#:2.0 x 103/uL, MO#:0.5 x 103/uL, NE#:4.7
x 103/uL, EO#:0.2 x 103/uL, BA#:0.0 x 103/uL, LY%:27.3 %, MO%:6.4
%, NE%:64.2 %, EO%:2.1 %, BA%:0.0 %, Comentariu:3+
Anisocytosis; 3+ Microcytosis; 1+ Hypochromia; 1+ Poikilocytosis; );
VSH:28 mm/h; Medic: As.Pr. ELENA CAMELIA CALITA
EPICRIZA
Pacienta de 68 de ani, operata in urma cu aproximativ un an pentru tumora rectosigmoidiana
invadanta in vasele iliace si uter, la care s-a practica colostomie stanga terminala - se prezinta
pentru rectoragii.
La internare: stare generala buna, afebrila, abdomen suplu, mobil cu respiratia, nedureros spontan
si la palpare, fara semne de iritatie peritoneala, tranzit intestinal prezent pe colostoma.
Rectoragii.
Biologic atasat biletului de externare.
Consult ginecologic: col fara leziuni. Vagin suplu. TV - uter greu de apreciat, pare normal. ETV
= uter de 4,8/2,2 cm. Retrouterin lama de lichid de 5-6 mm.
Recto-sigmoidoscopie: hemoroizi externi. Rect normal, sigmoid pana la 20 cm de orificiul anal =
formatiune protruziva, circumferentiala, sangeranda spontan.
Sub tratament hemostatic, administrare de sange si plasma, simptomatologia se amelioreaza.
Pacienta se externeaza avand stare generala satisfacatoare, stabila hemodinamic si respirator,
abdomen fara semne de iritatie peritoneala.
PROTOCOL OPERATOR:
RECOMANDARI/REGIM/MEDICATIE
1) Dispensarizare oncologica in serviciul teritorial
2) Reevaluare la nevoie
DATA INVESTIGATII
02/04/2015 08:19:41 Hemograma (WBC:13.6 x 103/uL, RBC:3.15 x 106/uL, HGB:6.5 g/dL,
HCT:22.5 %, MCV:71.5 fL, MCH:20.6 pg, MCHC:28.8 g/dL,
RDW:22.4 %, PLT:650 x 103/uL, PCT:0.506 %, MPV:7.8 fL,
PDW:16.0 , LY#:1.4 x 103/uL, MO#:1.1 x 103/uL, NE#:10.9 x 103/uL,
EO#:0.2 x 103/uL, BA#:0.0 x 103/uL, LY%:10.0 %, MO%:8.0 %,
NE%:80.4 %, EO%:1.5 %, BA%:0.1 %, Comentariu:Leukocytosis;
Neutrophilia %; Neutrophilia #; Lymphopenia %; Monocytosis #;
Anemia; 3+ Anisocytosis; 3+ Microcytosis; 3+ Hypochromia; 3+
Poikilocytosis; Thrombocytosis; ); Medic: Dr. DOINA ILIANA
BOGDANESCU
01/04/2015 10:45:34 Hemograma (WBC:14.4 x 103/uL, RBC:3.30 x 106/uL, HGB:6.8 g/dL,
HCT:23.5 %, MCV:71.3 fL, MCH:20.7 pg, MCHC:29.0 g/dL,
RDW:23.2 %, PLT:651 x 103/uL, PCT:0.489 %, MPV:7.5 fL,
PDW:16.0 , LY#:1.2 x 103/uL, MO#:1.0 x 103/uL, NE#:11.8 x 103/uL,
EO#:0.1 x 103/uL, BA#:0.3 x 103/uL, LY%:8.2 %, MO%:7.2 %,
NE%:81.7 %, EO%:1.0 %, BA%:1.9 %, Comentariu:Leukocytosis;
Neutrophilia %; Neutrophilia #; Lymphopenia %; Lymphopenia #;
Monocytosis #; Basophilia %; Basophilia #; Anemia; 3+ Anisocytosis;
3+ Microcytosis; 3+ Hypochromia; 3+ Poikilocytosis; Thrombocytosis;
); Medic: Dr. ELENA DORINA BOTEZ
30/03/2015 11:13:45 ALT/GPT.:18 U/L; Amilaza:21 U/L; AST/GOT:15 U/L;
Creatinina.:0.5 mg/dL; Glucoza:101 mg/dL; Ionograma (Na:142
mmol/L, K:4.7 mmol/L, Cl:107 mmol/L); Urea:35 mg/dL; APTT:25.3
s; Fibrinogen:637 mg/dL; PT-APP-INR (PT:16.8 s, APP:67 %,
INR:1.25 ); Hemograma (WBC:10.4 x 103/uL, RBC:2.53 x 106/uL,
HGB:4.9 g/dL, HCT:16.8 %, MCV:66.5 fL, MCH:19.2 pg, MCHC:28.9
g/dL, RDW:16.7 %, PLT:623 x 103/uL, PCT:0.494 %, MPV:7.9 fL,
PDW:15.8 , LY#:1.4 x 103/uL, MO#:0.8 x 103/uL, NE#:8.1 x 103/uL,
EO#:0.1 x 103/uL, BA#:0.0 x 103/uL, LY%:13.6 %, MO%:7.7 %,
NE%:77.7 %, EO%:1.0 %, BA%:0.0 %, Comentariu:Neutrophilia %;
Neutrophilia #; Lymphopenia %; Anemia; 1+ Anisocytosis; 3+
Microcytosis; 3+ Hypochromia; 3+ Poikilocytosis; Thrombocytosis; );
Medic: Ch.Pr. CARMEN BAJENARU
EPICRIZA
Pacient in varsta de 79 de ani se interneaza in clinica pentru rectoragii debutate in urma
cu 2 luni, durere la nivel pelvin si anal, stare generala usor alterata, paloare tegumnetara si
scadere ponderala in ultimele luni de zile. Pacientul se interneaza in clinica pentru supraveghere
si tratament de specialitate.
Biologic la internare – anexate biletului de externare.
Rx pulmonar si rx abdominal in otrostatism – in limite normale.
Echografia abdominala- ficat de dimensiuni normale, fara cai biliare intrahepatice
destinse, colecistectomizat, Splina omogena de dimensiuni normale. Pancreas normal. Rinichi cu
microlitiaza. Prostata de dimensiuni crescute, Fara lichid in peritoneu.
Se intervine chirurgical laparoscopic. Intraoperator : la inspectia cavitatii peritoneale
nu se evidentiaza determinari secundare sau alte leziuni. Se efectueaza colectomie a la Hartmann,
limfadenectomie si drenaj peritoneal.
Evolutia postoperatorie este lent favorabila, pacientul externandu-se cu o stare generala
buna, cu recomandarile :
- regim igienodietetic ;
- dispensarizare oncologica teritoriala ;
- revine pentru rezultatul anatomopatologic peste 21 de zile (etj 2) ;
- reevaluare chirurgicala la 2 luni sau la nevoie.
PROTOCOL OPERATOR:
RECOMANDARI/REGIM/MEDICATIE
RECOMANDARI EXTERNARE
- regim igienodietetic ;
- dispensarizare oncologica teritoriala ;
- revine pentru rezultatul anatomopatologic peste 21 de zile - reevaluare
chirurgicala la 2 luni sau la nevoie.
EPICRIZA
Pacient in varsta de 58 de ani, se prezinta la spital pentru durere perianala si sindrom subocluziv.
Examen clinic - pacient in pozitie genupectorala - arie perianala de aspect normal, sfincter anal
normoton, ampula rectala cu formatiune tumorala circumferentiala partial stenozanta, sangeranda
la atingere ce nu poate fi depasita.
Irigografie efectuata in urma cu 2 saptamani - stenoza la nivelul canalului anal si ampulei rectale.
In urma examenului histopatologic se pune in evidenta - adenocarcinomde tip intra si
extracelular.
La recomandarea medicului oncolog - se practica colostoma stanga definitiva.
Postoperator, evolutia este favorabila, pacientul nu prezinta semne de sangerare de la nivelul
formatiunii tumorale, colostoma functionala, cu tranzit prezent pentru gaze si materii fecale.
PROTOCOL OPERATOR:
RECOMANDARI/REGIM/MEDICATIE
- dispensarizare oncologica in serviciul teriotrial;
- revine pentru interventia chirurgicala - dupa finalizarea tratamentului oncologic .
- reevaluare chirurgicala la nevoie.
DATA INVESTIGATII
25/07/2013 07:30:49 ALT/GPT.:31 U/L; Amilaza:47 U/L; AST/GOT:3 U/L;
Creatinina.:1.0 mg/dL; Glucoza:215 mg/dL; Ionograma (Na:146
mmol/L, K:5.49 mmol/L, Cl:105 mmol/L); Urea:42 mg/dL; APTT:23.4
s; Fibrinogen:669 mg/dL; PT-APP-INR (PT:12.8 s, APP:118 %,
INR:0.93 ); Hemograma (WBC:9.94 x 103/uL, LY#:2.07 x 103/uL,
LY:20.80 %, MO#:0.75 x 103/uL, MO:7.50 %, NE#:6.97 x 103/uL,
NE:70.10 %, EO#:0.12 x 103/uL, EO:1.20 %, BA#:0.04 x 103/uL,
BA:0.40 %, RBC:4.60 x 106/uL, HGB:13.23 g/dL, HCT:40.50 %,
MCV:88.07 fL, MCH:28.78 pg, MCHC:32.68 g/dL, RDW:12.63 %,
PLT:288 x 103/uL, MPV:8.06 fL); Medic: Ch.Pr. CARMEN STOICA
EPICRIZA
Pacient in varsta de 63 de ani se prezinta la spital pentru scadere ponderala importanta
importanta insotita de astenie si rectoragii, simptomatologie debutata in urma cu ~ 1 luna.
Examen local: abdomen suplu, mobil cu respiratia, nedureros spontan si la palpare, fara semene
de iritatie peritoneala. TR: Arie perianala cu hemoraizi necomplicati la ~ 3-4 cm de orificiul anal
formatiune tumorala stenozanta sangeranda.
Biologic atasat biletului de iesire.
Ecografie abdominala: Fara lichid in peritoneu. Ficat omogen, fara CBIH destinse. Colesct -
normal. Pancreas - normal. Splina - omogena. Rinichi - fara dilatatii pielocaliciale.
Se intervine chirurgical in data de 16.02.2016 si se practica amputatie de rect pe cale
abdominopelvina.
Evolutia post operatorie este favorabila, initial cu reluarea tranzitului pe colostoma, ulterior
evolutia este grefata de aparitia fenomenelor subocluzive si necroza partiala de colostoma.
In data de se reintervine chirurgical pentru refacerea colostomei ocazie cu care se evidentiaza un
abces intercoloenteral prin perforatie de prima ansa jejunala prin corp strain (sumburi),
practicandu-se sutura perforatiei, adezioliza si desfintare colostomiei cu recolostomizare.
A 5 zii postreinterventie pacientul dezvolta o fistula enterala cu debit scazut, care este tratata
conservator avand evolutie favorabila cu inchiderea acestea in aproximativ 7 zile, deasemenea
pacientul prezinta o evisceratie fixata.
Se indruma catre serviciul chirurgie generala a spitalului teritorial, Spitalul Oltenita aviz DR.
Soare.
Pacientul se externeaza cu stare generala buna, afebril, abdomen suplu, mobil cu respiratia,
nedureros spontan si la palpare, fara semne de iritatie peritoneala, toleranta digestiva buna,
tranzit prezent pe colostoma pentru materii fecale si gaze.
PROTOCOL OPERATOR:
RECOMANDARI/REGIM/MEDICATIE
DATA INVESTIGATII
13/03/2016 06:02:20 Hemograma (WBC:9.94 x 103/uL, LY#:2.33 x 103/uL, LY:23.50 %,
MO#:1.09 x 103/uL, MO:11.00 %, NE#:6.16 x 103/uL, NE:62.00 %,
EO#:0.25 x 103/uL, EO:2.50 %, BA#:0.10 x 103/uL, BA:1.00 %,
RBC:3.31 x 106/uL, HGB:9.80 g/dL, HCT:28.73 %, MCV:86.82 fL,
MCH:29.62 pg, MCHC:34.12 g/dL, RDW:13.17 %, PLT:675 x 103/uL,
MPV:7.94 fL); Medic: As.Pr. CRISTINA PETROVICI
11/03/2016 10:47:20 Albumina:1.5 g/dL; ALT/GPT:18 mg/dL; Amilaza:25 U/L;
AST/GOT:18 U/L; Bilirubina Directa:0.1 mg/dL; Bilirubina
indirecta:0.10 ; Bilirubina totala:0.2 mg/dL; Creatinina.:1.0 mg/dL;
Glucoza:171 mg/dL; Ionograma:LIPSA REACTIV ; Proteine
totale:5.5 g/dL; Urea:26 mg/dL; APTT.:37.500 s; Fibrinogen.:629.971
mg/dL; PT-APP-INR. (PT:19.200 s, INR:1.505 , APP:54.602 %);
VSH:66 mm/h; Medic: As.Pr. DANIELA ALEXANDRU
11/03/2016 08:53:25 Hemograma (WBC:10.3 x 103/uL, RBC:2.82 x 106/uL, HGB:7.8 g/dL,
HCT:23.2 %, MCV:82.3 fL, MCH:27.6 pg, MCHC:33.6 g/dL,
RDW:14.0 %, PLT:681 x 103/uL, PCT:0.551 %, MPV:8.1 fL,
PDW:16.6 , LY#:2.1 x 103/uL, MO#:1.2 x 103/uL, NE#:6.8 x 103/uL,
EO#:0.2 x 103/uL, BA#:0.0 x 103/uL, LY%:20.6 %, MO%:12.1 %,
NE%:65.8 %, EO%:1.5 %, BA%:0.0 %, Comentariu:Neutrophilia %;
Neutrophilia #; Monocytosis %; Monocytosis #; Anemia;
Thrombocytosis; ); Medic: Dr. DOINA ILIANA BOGDANESCU
06/03/2016 11:14:29 Acid uric:3.5 mg/dL; Albumina:2.4 g/dL; ALP:72 UI; ALT/GPT:5
U/L; Amilaza:31 UI; AST/GOT:12 U/L; Bilirubina Directa:0.09
mg/dL; Bilirubina indirecta:0.16 ; Bilirubina totala:0.25 mg/dL;
Calciu:7.6 mg/dL; Calciu Ionic:4.05 mg/dL; CK:27 UI; CK-MB:26
U/L; Colesterol:73 mg/dL; Creatinina:0.72 mg/dL; Fier:20 µg/dL;
GGT:60 U/L; Glucoza:128 mg/dL; HDL-Colesterol:11 mg/dL;
Ionograma (Na:136 mmol/L, K:3.52 mmol/L, Cl:98 mmol/L);
LDH:413 UI; LDL-Colesterol:18 ; Lipide Totale:474.25 mg/dL;
Magneziu:1.5 mg/dL; Proteine totale:4.86 g/dL; Trigliceride:220
mg/dL; Urea:37 mg/dL; APTT:27.9 s; Fibrinogen:fibrinogenul derivat
nu poate fi calculat de aparat ; PT-APP-INR (PT:15.3 s, APP:73 %,
INR:1.20 ); Hemograma (WBC:11.87 x 103/uL, LY#:1.58 x 103/uL,
LY:13.30 %, MO#:1.25 x 103/uL, MO:10.50 %, NE#:8.69 x 103/uL,
NE:73.20 %, EO#:0.25 x 103/uL, EO:2.10 %, BA#:0.11 x 103/uL,
BA:0.90 %, RBC:2.91 x 106/uL, HGB:8.84 g/dL, HCT:25.54 %,
MCV:87.78 fL, MCH:30.37 pg, MCHC:34.60 g/dL, RDW:12.89 %,
PLT:580 x 103/uL, MPV:8.06 fL); Medic: As.Pr. CRISTINA
FLIPACHE
02/03/2016 08:50:43 Albumina:1.8 g/dL; ALT/GPT:19 mg/dL; Amilaza:32 U/L;
AST/GOT:16 U/L;
Bilirubina totala:0.4 mg/dL; CK:37 U/L; CK-MB:32 U/L;
Creatinina.:1.0 mg/dL; Glucoza:100 mg/dL; Ionograma (Na:138
mmol/L, K:3.85 mmol/L, Cl:102 mmol/L); LDH:252 U/L; Proteine
totale:5.8 g/dL; Urea:58 mg/dL; APTT.:26.000 s; Fibrinogen.:756.300
mg/dL; PT-APP-INR. (PT:15.000 s, INR:1.130 , APP:82.048 %);
Hemograma (WBC:12.3 x 103/uL, RBC:3.71 x 106/uL, HGB:10.7 g/dL,
HCT:31.3 %, MCV:84.3 fL, MCH:28.8 pg, MCHC:34.1 g/dL,
RDW:13.9 %, PLT:784 x 103/uL, PCT:0.666 %, MPV:8.5 fL,
PDW:16.0 , LY#:0.8 x 103/uL, MO#:1.2 x 103/uL, NE#:10.1 x 103/uL,
EO#:0.2 x 103/uL, BA#:0.0 x 103/uL, LY%:6.9 %, MO%:9.6 %,
NE%:81.9 %, EO%:1.6 %, BA%:0.0 %, Comentariu:Leukocytosis;
Neutrophilia %; Neutrophilia #; Lymphopenia %; Lymphopenia #;
Monocytosis #; Anemia; Thrombocytosis; ); Medic: B.Pr. IRINA
CIUREL
29/02/2016 15:18:53 Acid uric:4.2 mg/dL; Albumina:1.5 g/dL; ALP:70 U/L; ALT/GPT:30
U/L; Amilaza:14 U/L; AST/GOT:42 U/L;
Bilirubina totala:0.2 mg/dL; Calciu:7.5 mg/dL;
CK:105 U/L; CK-MB:22 U/L; Colesterol:63 mg/dL; Creatinina.:0.9
mg/dL; Fier (Fier:7 µg/dL [repeta recoltarea pentru
confirmare]Comentarii:repeta recol ); Glucoza:129 mg/dL; Ionograma
(Na:138 mmol/L, K:3.9 mmol/L, Cl:103 mmol/L); Proteine totale:4.8
g/dL; Urea:55 mg/dL; APTT:25.8 s; Fibrinogen:690 mg/dL; PT-APP-
INR (PT:16.2 s, APP:65 %, INR:1.28 ); Hemograma (WBC:15.56 x
103/uL, LY#:0.86 x 103/uL, LY:5.50 %, MO#:2.80 x 103/uL, MO:18.00
%, NE#:11.64 x 103/uL, NE:74.80 %, EO#:0.16 x 103/uL, EO:1.00 %,
BA#:0.11 x 103/uL, BA:0.70 %, RBC:2.64 x 106/uL, HGB:7.95 g/dL,
HCT:23.10 %, MCV:87.38 fL, MCH:30.08 pg, MCHC:34.43 g/dL,
RDW:12.61 %, PLT:681 x 103/uL, MPV:8.19 fL); Medic: As.Pr.
SIMONA OPREA
28/02/2016 07:59:07 UROCULTURA CU ANTIBIOGRAMA:NEGATIVA ; Medic: Dr.
ELENA DORINA BOTEZ
28/02/2016 00:28:22 Acid uric:3.8 mg/dL; Albumina:1.1 g/dL; ALP:71 U/L; ALT/GPT:20
U/L; Amilaza:20 U/L; AST/GOT:42 U/L; Bilirubina Directa:0.2
mg/dL; Bilirubina indirecta:0.4 ; Bilirubina totala:0.6 mg/dL;
CK:118 U/L; CK-MB:33 U/L; Colesterol:42 mg/dL; Creatinina.:1.2
mg/dL; Fier:10 µg/dL; GGT:69 U/L; Glucoza (Glucoza:28 mg/dL,
Comentarii:REPETA. ); HDL-Colesterol:10 mg/dL; Ionograma
(Na:138 mmol/L, K:3.43 mmol/L, Cl:110 mmol/L); LDH:294 U/L;
Lipide Totale:268.5 mg/dL; Proteine totale:3.9 g/dL; Trigliceride:84
mg/dL; Urea:41 mg/dL; APTT:24.6 s; Fibrinogen:444 mg/dL; PT-
APP-INR (PT:17.3 s, APP:59 %, INR:1.37 ); Hemograma
(WBC:33.23 x 103/uL, LY#:1.23 x 103/uL, LY:3.70 %, MO#:14.09 x
103/uL, MO:42.40 %, NE#:17.18 x 103/uL, NE:51.70 %, EO#:0.27 x
103/uL, EO:0.80 %, BA#:0.47 x 103/uL, BA:1.40 %, RBC:3.21 x
106/uL, HGB:9.62 g/dL, HCT:28.59 %, MCV:88.99 fL, MCH:29.96 pg,
MCHC:33.66 g/dL, RDW:12.81 %, PLT:632 x 103/uL, MPV:8.58 fL);
Medic: As.Pr. ILEANA DOBRE
27/02/2016 20:52:00 SUMAR DE URINA (Densitate:1020 , pH:5 , Glucoza:Negativ ,
Urobilinogen:Normal , Proteine:+/-(15 mg/dl) , Bilirubina:Negativ ,
Hematii:3+(1.0 mg/dl) , Nitriti:Negativ , Corpi Cetonici:Negativ mg/dL,
COMENTARII:HEMATII COLORATE. , Epitelii plate:Relativ
frecvente , Leucocite:Frecvente , Hematii:Frecvente , Cilindrii
hialini:Relativ frecventi , Mucus:Frecvent , Altele:PREZENTA FLORA
MICROBIANA. PREZENTI PSEUDOCILINDRI LEUCOCITARI.
RAR URAT AMORF. ); Medic: B.Pr. IRINA CIUREL
27/02/2016 20:47:39 Albumina:0.7 g/dL; ALP:49 U/L; ALT/GPT:14 U/L; Amilaza:13 U/L;
AST/GOT:22 U/L; Bilirubina Directa:0.2 mg/dL; Bilirubina
indirecta:0.1 ; Bilirubina totala:0.3 mg/dL; CK:66 U/L; CK-MB:21
U/L; Colesterol:34 mg/dL; Creatinina.:1.0 mg/dL; Fier:5 µg/dL;
GGT:53 U/L; Glucoza (Glucoza:18 mg/dL, Comentarii:REPETA );
HDL-Colesterol:5 mg/dL; Ionograma (Na:144 mmol/L, K:2.48
mmol/L, Cl:119 mmol/L); LDH:139 U/L;
Lipide Totale:248.5 mg/dL; Proteine totale:2.5 g/dL; Trigliceride:82
mg/dL; Urea:28 mg/dL; APTT:25.5 s; Fibrinogen:383 mg/dL; PT-
APP-INR (PT:17.5 s, APP:57 %, INR:1.40 ); Hemograma
(WBC:36.37 x 103/uL, LY#:1.53 x 103/uL, LY:4.20 %, MO#:15.24 x
103/uL, MO:41.90 %, NE#:18.62 x 103/uL, NE:51.20 %, EO#:0.40 x
103/uL, EO:1.10 %, BA#:0.58 x 103/uL, BA:1.60 %, RBC:3.32 x
106/uL, HGB:10.01 g/dL, HCT:29.70 %, MCV:89.51 fL, MCH:30.16
pg, MCHC:33.69 g/dL, RDW:12.55 %, PLT:810 x 103/uL, MPV:8.32
fL); Medic: As.Pr. ILEANA DOBRE
27/02/2016 11:55:03 CULTURA COLECTIE PURULENTA INCHISA CU
ANTIBIOGRAMA(Aerobioza) (GERMENI:Citrobacter freundii
complex , ANTIBIOTICE INTERMEDIAR:Piperacillin / tazobactam--
Intermediar; , ANTIBIOTICE REZISTENT:Ampicillin--Rezistent;
Ampicillin- sulbactam--Rezistent; Augumentin (Amoxacillin /
Clav.acid)--Rezistent; Aztreonam--Rezistent; Cefazolin--Rezistent;
Cefepime--Rezistent; Cefotaxime--Rezistent; Cefotetan--Rezistent;
Cefoxitin--Rezistent; Ceftazidime--Rezistent; Ceftriaxone--Rezistent;
Cefuroxime--Rezistent; Chloramphenicol--Rezistent; Imipenem--
Rezistent; Meropenem--Rezistent; Piperaciliin--Rezistent; Trimethoprim
/ Sulphametoxazol--Rezistent; , ANTIBIOTICE SENSIBIL:Amikacin--
Sensibil; Ciprofloxacin--Sensibil; Gatifloxacin--Sensibil; Gentamicin--
Sensibil; Levofloxacin--Sensibil; MOXIFLOXACIN--Sensibil;
Tetracycline--Sensibil; Tobramycin--Sensibil; Trimethoprim /
Sulphametoxazol--Sensibil; ); Medic: Dr. ELENA DORINA BOTEZ
26/02/2016 16:58:38 ALT/GPT:17 U/L; Amilaza:35 UI; AST/GOT:31 U/L; Bilirubina
Directa:0.12 mg/dL; Bilirubina indirecta:0.25 ; Bilirubina totala:0.37
mg/dL; Creatinina:0.87 mg/dL; Glucoza:116 mg/dL; Ionograma
(Na:132 mmol/L, K:3.53 mmol/L, Cl:104 mmol/L); Proteine
totale:5.09 g/dL; Urea:28 mg/dL; APTT:29.1 s; Fibrinogen:697
mg/dL; PT-APP-INR (PT:14.9 s, APP:77 %, INR:1.16 ); Hemograma
(WBC:12.02 x 103/uL, LY#:1.33 x 103/uL, LY:11.10 %, MO#:3.86 x
103/uL, MO:32.10 %, NE#:6.38 x 103/uL, NE:53.10 %, EO#:0.34 x
103/uL, EO:2.80 %, BA#:0.11 x 103/uL, BA:0.90 %, RBC:3.04 x
106/uL, HGB:9.18 g/dL, HCT:26.42 %, MCV:86.78 fL, MCH:30.17 pg,
MCHC:34.76 g/dL, RDW:12.89 %, PLT:666 x 103/uL, MPV:8.45 fL);
VSH:82 mm/h; Medic: As.Pr.MARIAN BOBU
26/02/2016 16:51:45 CULTURA SECRETIE PLAGA CU ANTIBIOGRAMA
(GERMENI:Staphylococcus xylosus; , ANTIBIOTICE
INTERMEDIAR:Levofloxacin--Intermediar; Synercid--Intermediar; ,
ANTIBIOTICE REZISTENT:Ampicillin--Rezistent; Ampicillin-
sulbactam--Rezistent; Augumentin (Amoxacillin / Clav.acid)--Rezistent;
Cefazolin--Rezistent; Cefepime--Rezistent; Cefotaxime--Rezistent;
Ceftriaxone--Rezistent; Clindamycin--Rezistent; Imipenem--Rezistent;
Oxacillin--Rezistent; Penicillin--Rezistent; Tetracycline--Rezistent; ,
ANTIBIOTICE SENSIBIL:Ciprofloxacin--Sensibil; Erythromycin--
Sensibil; Gatifloxacin--Sensibil; Gentamicin--Sensibil; LINEZOLID--
Sensibil; MOXIFLOXACIN--Sensibil; Rifampicin--Sensibil;
Trimethoprim / Sulphametoxazol--Sensibil; Vancomycin--Sensibil; );
Medic: Dr. MIRELA CONSTANTIN
24/02/2016 09:18:19 RADIOGRAFIA TORACO-PULMONARA -FATA (µGray x
m2:1.56 Dozamedie/organ, Asistent:BATAIOSU GETA; Sirbu Elena
Dumitra; , REZULTAT:Hiluri accentuate , fibroase.
Cord cu dimensiuni normale.
Simfiza partiala SCD drept. ); Medic: RADU ROMULUS
ALEXANDRESCU
23/02/2016 05:52:41 Acid uric:4 mg/dL; Albumina:2.8 g/dL; ALP:101 UI; ALT/GPT:8
U/L; Amilaza:26 UI; AST/GOT:19 U/L; Bilirubina Directa:0.15
mg/dL; Bilirubina indirecta:0.4 ; Bilirubina totala:0.55 mg/dL;
Colesterol:100 mg/dL; Creatinina:0.91 mg/dL; GGT:69 U/L;
Glucoza:87 mg/dL; Ionograma (Na:140 mmol/L, K:3.25 mmol/L,
Cl:108 mmol/L); LDH:640 UI; Proteine totale:5.44 g/dL;
Trigliceride:196 mg/dL; Urea:67 mg/dL; APTT:17.1 s;
Fibrinogen:980 mg/dL; PT-APP-INR (PT:11.6 s, APP:134 %,
INR:0.87 ); Hemograma (WBC:13.61 x 103/uL, LY#:1.33 x 103/uL,
LY:9.80 %, MO#:2.99 x 103/uL, MO:22.00 %, NE#:8.90 x 103/uL,
NE:65.40 %, EO#:0.18 x 103/uL, EO:1.30 %, BA#:0.20 x 103/uL,
BA:1.50 %, RBC:3.42 x 106/uL, HGB:10.40 g/dL, HCT:31.19 %,
MCV:91.31 fL, MCH:30.44 pg, MCHC:33.34 g/dL, RDW:12.25 %,
PLT:448 x 103/uL, MPV:8.96 fL, Comentarii:PREZENTI
MICROCOAGULI, REPETA. ); VSH:110 mm/h; Medic: As.Pr.
ILEANA DOBRE
21/02/2016 09:41:34 ALT/GPT:18 U/L; Amilaza:43 U/L; AST/GOT:23 U/L; Bilirubina
Directa:0.1 mg/dL; Bilirubina indirecta:0.2 ; Bilirubina totala:0.3
mg/dL; Colesterol:111 mg/dL; Creatinina.:1.0 mg/dL; Glucoza:134
mg/dL; Ionograma (Na:141 mmol/L, K:3.22 mmol/L, Cl:107 mmol/L);
Trigliceride:86 mg/dL; Urea:87 mg/dL; APTT:31.3 s;
Fibrinogen:Fibrinogenul derivat nu poate fi calculat de aparat. ; PT-
APP-INR (PT:14.7 s, APP:87 %, Comentarii:INR=1,07 ); Hemograma
(WBC:13.12 x 103/uL, RBC:3.53 x 106/uL, HGB:10.60 g/dL,
HCT:31.51 %, MCV:89.33 fL, MCH:30.04 pg, MCHC:33.63 g/dL,
RDW:12.71 %, PLT:444 x 103/uL, MPV:8.70 fL,
Comentarii:PREZENTI MICROCOAGULI ); VSH:96 mm/h; Medic:
As.Pr. GEORGETA CORDONEANU
20/02/2016 14:49:45 Albumina:3 g/dL; ALT/GPT:10 U/L; Amilaza:89 UI; AST/GOT:11
U/L; Bilirubina Directa:0.15 mg/dL; Bilirubina indirecta:0.42 ;
Bilirubina totala:0.57 mg/dL; Creatinina:1.39 mg/dL; Glucoza:197
mg/dL; Ionograma (Na:141 mmol/L, K:4.11 mmol/L, Cl:106 mmol/L);
Urea:73 mg/dL; APTT:24.6 s; Fibrinogen:891 mg/dL; PT-APP-INR
(PT:14.6 s, APP:80 %, INR:1.13 ); Hemograma (WBC:7.28 x 103/uL,
LY#:0.35 x 103/uL, LY:4.80 %, MO#:1.17 x 103/uL, MO:16.10 %,
NE#:5.64 x 103/uL, NE:77.50 %, EO#:0.08 x 103/uL, EO:1.10 %,
BA#:0.04 x 103/uL, BA:0.50 %, RBC:3.64 x 106/uL, HGB:10.90 g/dL,
HCT:32.20 %, MCV:88.53 fL, MCH:29.97 pg, MCHC:33.85 g/dL,
RDW:12.52 %, PLT:474 x 103/uL, MPV:8.70 fL); VSH:90 mm/h;
Medic: As.Pr. ILEANA DOBRE
15/02/2016 08:51:21 Acid uric:3.3 mg/dL; Albumina:3.1 g/dL; ALP:85 U/L; ALT/GPT:19
mg/dL; Amilaza:66 U/L; AST/GOT:21 U/L; Bilirubina Directa:0.1
mg/dL; Bilirubina indirecta:0.4 ; Bilirubina totala:0.5 mg/dL;
Colesterol:164 mg/dL; Creatinina.:0.7 mg/dL; Glucoza:94 mg/dL;
Ionograma (Na:141 mmol/L, K:4.43 mmol/L, Cl:108 mmol/L);
Proteine totale:6.7 g/dL; Urea:52 mg/dL; APTT.:26.700 s;
Fibrinogen.:694.558 mg/dL; PT-APP-INR. (PT:15.500 s, INR:1.174 ,
APP:77.415 %); Hemograma (WBC:9.53 x 103/uL, LYM#:3.31 x
103/uL, LYM:34.70 %, MON#:0.70 x 103/uL, MON:7.30 %, NEU#:4.99
x 103/uL, NEU:52.40 %, EOS#:0.48 x 103/uL, EOS:5.00 %, BAS#:0.06
x 103/uL, BAS:0.60 %, RBC:3.94 x 106/uL, HGB:12.13 g/dL,
HCT:35.04 %, MCV:88.88 fL, MCH:30.76 pg, MCHC:34.61 g/dL,
RDW:11.16 %, PLT:427.20 x 103/uL, MPV:8.32 fL); VSH:72 mm/h;
Medic: As.Pr. CRISTINA PETROVICI
11/02/2016 08:22:03 ALT/GPT:21 U/L; Amilaza:58 U/L; AST/GOT:16 U/L; Bilirubina
Directa:0.1 mg/dL;
Bilirubina totala:0.3 mg/dL; Creatinina.:0.8 mg/dL; Glucoza:83
mg/dL; Ionograma (Na:144 mmol/L, K:5.17 mmol/L, Cl:107 mmol/L);
Urea:77 mg/dL; APTT.:25.500 s; Fibrinogen.:807.254 mg/dL; PT-
APP-INR. (PT:16.300 s, INR:1.244 , APP:71.001 %); Hemograma
(WBC:9.41 x 103/uL, LYM#:3.40 x 103/uL, LYM:36.10 %, MON#:0.72
x 103/uL, MON:7.70 %, NEU#:4.57 x 103/uL, NEU:48.50 %,
EOS#:0.67 x 103/uL, EOS:7.10 %, BAS#:0.06 x 103/uL, BAS:0.60 %,
RBC:4.21 x 106/uL, HGB:12.82 g/dL, HCT:36.79 %, MCV:87.39 fL,
MCH:30.46 pg, MCHC:34.86 g/dL, RDW:9.78 %, PLT:492.18 x
103/uL, MPV:8.83 fL); Medic: B.Pr. IRINA CIUREL
EPICRIZA
Pacient in varsta de 63 de ani se prezinta la spital pentru scadere ponderala importanta
importanta insotita de astenie si rectoragii, simptomatologie debutata in urma cu ~ 1 luna.
Examen local: abdomen suplu, mobil cu respiratia, nedureros spontan si la palpare, fara semene
de iritatie peritoneala. TR: Arie perianala cu hemoraizi necomplicati la ~ 3-4 cm de orificiul anal
formatiune tumorala stenozanta sangeranda.
Biologic atasat biletului de iesire.
Ecografie abdominala: Fara lichid in peritoneu. Ficat omogen, fara CBIH destinse. Colesct -
normal. Pancreas - normal. Splina - omogena. Rinichi - fara dilatatii pielocaliciale.
Se intervine chirurgical in data de 16.02.2016 si se practica amputatie de rect pe cale
abdominopelvina.
Evolutia post operatorie este favorabila, initial cu reluarea tranzitului pe colostoma, ulterior
evolutia este grefata de aparitia fenomenelor subocluzive si necroza partiala de colostoma.
In data de se reintervine chirurgical pentru refacerea colostomei ocazie cu care se evidentiaza un
abces intercoloenteral prin perforatie de prima ansa jejunala prin corp strain (sumburi),
practicandu-se sutura perforatiei, adezioliza si desfintare colostomiei cu recolostomizare.
A 5 zii postreinterventie pacientul dezvolta o fistula enterala cu debit scazut, care este tratata
conservator avand evolutie favorabila cu inchiderea acestea in aproximativ 7 zile, deasemenea
pacientul prezinta o evisceratie fixata.
Se indruma catre serviciul chirurgie generala a spitalului teritorial, Spitalul Oltenita aviz DR.
Soare.
Pacientul se externeaza cu stare generala buna, afebril, abdomen suplu, mobil cu respiratia,
nedureros spontan si la palpare, fara semne de iritatie peritoneala, toleranta digestiva buna,
tranzit prezent pe colostoma pentru materii fecale si gaze.
DATA INVESTIGATII
13/03/2016 06:02:20 Hemograma (WBC:9.94 x 103/uL, LY#:2.33 x 103/uL, LY:23.50 %,
MO#:1.09 x 103/uL, MO:11.00 %, NE#:6.16 x 103/uL, NE:62.00 %,
EO#:0.25 x 103/uL, EO:2.50 %, BA#:0.10 x 103/uL, BA:1.00 %,
RBC:3.31 x 106/uL, HGB:9.80 g/dL, HCT:28.73 %, MCV:86.82 fL,
MCH:29.62 pg, MCHC:34.12 g/dL, RDW:13.17 %, PLT:675 x 103/uL,
MPV:7.94 fL); Medic: As.Pr. CRISTINA PETROVICI
11/03/2016 10:47:20 Albumina:1.5 g/dL; ALT/GPT:18 mg/dL; Amilaza:25 U/L;
AST/GOT:18 U/L; Bilirubina Directa:0.1 mg/dL; Bilirubina
indirecta:0.10 ; Bilirubina totala:0.2 mg/dL; Creatinina.:1.0 mg/dL;
Glucoza:171 mg/dL; Ionograma:LIPSA REACTIV ; Proteine
totale:5.5 g/dL; Urea:26 mg/dL; APTT.:37.500 s; Fibrinogen.:629.971
mg/dL; PT-APP-INR. (PT:19.200 s, INR:1.505 , APP:54.602 %);
VSH:66 mm/h; Medic: As.Pr. DANIELA ALEXANDRU
11/03/2016 08:53:25 Hemograma (WBC:10.3 x 103/uL, RBC:2.82 x 106/uL, HGB:7.8 g/dL,
HCT:23.2 %, MCV:82.3 fL, MCH:27.6 pg, MCHC:33.6 g/dL,
RDW:14.0 %, PLT:681 x 103/uL, PCT:0.551 %, MPV:8.1 fL,
PDW:16.6 , LY#:2.1 x 103/uL, MO#:1.2 x 103/uL, NE#:6.8 x 103/uL,
EO#:0.2 x 103/uL, BA#:0.0 x 103/uL, LY%:20.6 %, MO%:12.1 %,
NE%:65.8 %, EO%:1.5 %, BA%:0.0 %, Comentariu:Neutrophilia %;
Neutrophilia #; Monocytosis %; Monocytosis #; Anemia;
Thrombocytosis; ); Medic: Dr. DOINA ILIANA BOGDANESCU
06/03/2016 11:14:29 Acid uric:3.5 mg/dL; Albumina:2.4 g/dL; ALP:72 UI; ALT/GPT:5
U/L; Amilaza:31 UI; AST/GOT:12 U/L; Bilirubina Directa:0.09
mg/dL; Bilirubina indirecta:0.16 ; Bilirubina totala:0.25 mg/dL;
Calciu:7.6 mg/dL; Calciu Ionic:4.05 mg/dL; CK:27 UI; CK-MB:26
U/L; Colesterol:73 mg/dL; Creatinina:0.72 mg/dL; Fier:20 µg/dL;
GGT:60 U/L; Glucoza:128 mg/dL; HDL-Colesterol:11 mg/dL;
Ionograma (Na:136 mmol/L, K:3.52 mmol/L, Cl:98 mmol/L);
LDH:413 UI; LDL-Colesterol:18 ; Lipide Totale:474.25 mg/dL;
Magneziu:1.5 mg/dL; Proteine totale:4.86 g/dL; Trigliceride:220
mg/dL; Urea:37 mg/dL; APTT:27.9 s; Fibrinogen:fibrinogenul derivat
nu poate fi calculat de aparat ; PT-APP-INR (PT:15.3 s, APP:73 %,
INR:1.20 ); Hemograma (WBC:11.87 x 103/uL, LY#:1.58 x 103/uL,
LY:13.30 %, MO#:1.25 x 103/uL, MO:10.50 %, NE#:8.69 x 103/uL,
NE:73.20 %, EO#:0.25 x 103/uL, EO:2.10 %, BA#:0.11 x 103/uL,
BA:0.90 %, RBC:2.91 x 106/uL, HGB:8.84 g/dL, HCT:25.54 %,
MCV:87.78 fL, MCH:30.37 pg, MCHC:34.60 g/dL, RDW:12.89 %,
PLT:580 x 103/uL, MPV:8.06 fL); Medic: As.Pr. CRISTINA
FLIPACHE
02/03/2016 08:50:43 Albumina:1.8 g/dL; ALT/GPT:19 mg/dL; Amilaza:32 U/L;
AST/GOT:16 U/L;
Bilirubina totala:0.4 mg/dL; CK:37 U/L; CK-MB:32 U/L;
Creatinina.:1.0 mg/dL; Glucoza:100 mg/dL; Ionograma (Na:138
mmol/L, K:3.85 mmol/L, Cl:102 mmol/L); LDH:252 U/L; Proteine
totale:5.8 g/dL; Urea:58 mg/dL; APTT.:26.000 s; Fibrinogen.:756.300
mg/dL; PT-APP-INR. (PT:15.000 s, INR:1.130 , APP:82.048 %);
Hemograma (WBC:12.3 x 103/uL, RBC:3.71 x 106/uL, HGB:10.7 g/dL,
HCT:31.3 %, MCV:84.3 fL, MCH:28.8 pg, MCHC:34.1 g/dL,
RDW:13.9 %, PLT:784 x 103/uL, PCT:0.666 %, MPV:8.5 fL,
PDW:16.0 , LY#:0.8 x 103/uL, MO#:1.2 x 103/uL, NE#:10.1 x 103/uL,
EO#:0.2 x 103/uL, BA#:0.0 x 103/uL, LY%:6.9 %, MO%:9.6 %,
NE%:81.9 %, EO%:1.6 %, BA%:0.0 %, Comentariu:Leukocytosis;
Neutrophilia %; Neutrophilia #; Lymphopenia %; Lymphopenia #;
Monocytosis #; Anemia; Thrombocytosis; ); Medic: B.Pr. IRINA
CIUREL
29/02/2016 15:18:53 Acid uric:4.2 mg/dL; Albumina:1.5 g/dL; ALP:70 U/L; ALT/GPT:30
U/L; Amilaza:14 U/L; AST/GOT:42 U/L;
Bilirubina totala:0.2 mg/dL; Calciu:7.5 mg/dL;
CK:105 U/L; CK-MB:22 U/L; Colesterol:63 mg/dL; Creatinina.:0.9
mg/dL; Fier (Fier:7 µg/dL [repeta recoltarea pentru
confirmare]Comentarii:repeta recol ); Glucoza:129 mg/dL; Ionograma
(Na:138 mmol/L, K:3.9 mmol/L, Cl:103 mmol/L); Proteine totale:4.8
g/dL; Urea:55 mg/dL; APTT:25.8 s; Fibrinogen:690 mg/dL; PT-APP-
INR (PT:16.2 s, APP:65 %, INR:1.28 ); Hemograma (WBC:15.56 x
103/uL, LY#:0.86 x 103/uL, LY:5.50 %, MO#:2.80 x 103/uL, MO:18.00
%, NE#:11.64 x 103/uL, NE:74.80 %, EO#:0.16 x 103/uL, EO:1.00 %,
BA#:0.11 x 103/uL, BA:0.70 %, RBC:2.64 x 106/uL, HGB:7.95 g/dL,
HCT:23.10 %, MCV:87.38 fL, MCH:30.08 pg, MCHC:34.43 g/dL,
RDW:12.61 %, PLT:681 x 103/uL, MPV:8.19 fL); Medic: As.Pr.
SIMONA OPREA
28/02/2016 07:59:07 UROCULTURA CU ANTIBIOGRAMA:NEGATIVA ; Medic: Dr.
ELENA DORINA BOTEZ
28/02/2016 00:28:22 Acid uric:3.8 mg/dL; Albumina:1.1 g/dL; ALP:71 U/L; ALT/GPT:20
U/L; Amilaza:20 U/L; AST/GOT:42 U/L; Bilirubina Directa:0.2
mg/dL; Bilirubina indirecta:0.4 ; Bilirubina totala:0.6 mg/dL;
CK:118 U/L; CK-MB:33 U/L; Colesterol:42 mg/dL; Creatinina.:1.2
mg/dL; Fier:10 µg/dL; GGT:69 U/L; Glucoza (Glucoza:28 mg/dL,
Comentarii:REPETA. ); HDL-Colesterol:10 mg/dL; Ionograma
(Na:138 mmol/L, K:3.43 mmol/L, Cl:110 mmol/L); LDH:294 U/L;
Lipide Totale:268.5 mg/dL; Proteine totale:3.9 g/dL; Trigliceride:84
mg/dL; Urea:41 mg/dL; APTT:24.6 s; Fibrinogen:444 mg/dL; PT-
APP-INR (PT:17.3 s, APP:59 %, INR:1.37 ); Hemograma
(WBC:33.23 x 103/uL, LY#:1.23 x 103/uL, LY:3.70 %, MO#:14.09 x
103/uL, MO:42.40 %, NE#:17.18 x 103/uL, NE:51.70 %, EO#:0.27 x
103/uL, EO:0.80 %, BA#:0.47 x 103/uL, BA:1.40 %, RBC:3.21 x
106/uL, HGB:9.62 g/dL, HCT:28.59 %, MCV:88.99 fL, MCH:29.96 pg,
MCHC:33.66 g/dL, RDW:12.81 %, PLT:632 x 103/uL, MPV:8.58 fL);
Medic: As.Pr. ILEANA DOBRE
27/02/2016 20:52:00 SUMAR DE URINA (Densitate:1020 , pH:5 , Glucoza:Negativ ,
Urobilinogen:Normal , Proteine:+/-(15 mg/dl) , Bilirubina:Negativ ,
Hematii:3+(1.0 mg/dl) , Nitriti:Negativ , Corpi Cetonici:Negativ mg/dL,
COMENTARII:HEMATII COLORATE. , Epitelii plate:Relativ
frecvente , Leucocite:Frecvente , Hematii:Frecvente , Cilindrii
hialini:Relativ frecventi , Mucus:Frecvent , Altele:PREZENTA FLORA
MICROBIANA. PREZENTI PSEUDOCILINDRI LEUCOCITARI.
RAR URAT AMORF. ); Medic: B.Pr. IRINA CIUREL
27/02/2016 20:47:39 Albumina:0.7 g/dL; ALP:49 U/L; ALT/GPT:14 U/L; Amilaza:13 U/L;
AST/GOT:22 U/L; Bilirubina Directa:0.2 mg/dL; Bilirubina
indirecta:0.1 ; Bilirubina totala:0.3 mg/dL; CK:66 U/L; CK-MB:21
U/L; Colesterol:34 mg/dL; Creatinina.:1.0 mg/dL; Fier:5 µg/dL;
GGT:53 U/L; Glucoza (Glucoza:18 mg/dL, Comentarii:REPETA );
HDL-Colesterol:5 mg/dL; Ionograma (Na:144 mmol/L, K:2.48
mmol/L, Cl:119 mmol/L); LDH:139 U/L;
Lipide Totale:248.5 mg/dL; Proteine totale:2.5 g/dL; Trigliceride:82
mg/dL; Urea:28 mg/dL; APTT:25.5 s; Fibrinogen:383 mg/dL; PT-
APP-INR (PT:17.5 s, APP:57 %, INR:1.40 ); Hemograma
(WBC:36.37 x 103/uL, LY#:1.53 x 103/uL, LY:4.20 %, MO#:15.24 x
103/uL, MO:41.90 %, NE#:18.62 x 103/uL, NE:51.20 %, EO#:0.40 x
103/uL, EO:1.10 %, BA#:0.58 x 103/uL, BA:1.60 %, RBC:3.32 x
106/uL, HGB:10.01 g/dL, HCT:29.70 %, MCV:89.51 fL, MCH:30.16
pg, MCHC:33.69 g/dL, RDW:12.55 %, PLT:810 x 103/uL, MPV:8.32
fL); Medic: As.Pr. ILEANA DOBRE
27/02/2016 11:55:03 CULTURA COLECTIE PURULENTA INCHISA CU
ANTIBIOGRAMA(Aerobioza) (GERMENI:Citrobacter freundii
complex , ANTIBIOTICE INTERMEDIAR:Piperacillin / tazobactam--
Intermediar; , ANTIBIOTICE REZISTENT:Ampicillin--Rezistent;
Ampicillin- sulbactam--Rezistent; Augumentin (Amoxacillin /
Clav.acid)--Rezistent; Aztreonam--Rezistent; Cefazolin--Rezistent;
Cefepime--Rezistent; Cefotaxime--Rezistent; Cefotetan--Rezistent;
Cefoxitin--Rezistent; Ceftazidime--Rezistent; Ceftriaxone--Rezistent;
Cefuroxime--Rezistent; Chloramphenicol--Rezistent; Imipenem--
Rezistent; Meropenem--Rezistent; Piperaciliin--Rezistent; Trimethoprim
/ Sulphametoxazol--Rezistent; , ANTIBIOTICE SENSIBIL:Amikacin--
Sensibil; Ciprofloxacin--Sensibil; Gatifloxacin--Sensibil; Gentamicin--
Sensibil; Levofloxacin--Sensibil; MOXIFLOXACIN--Sensibil;
Tetracycline--Sensibil; Tobramycin--Sensibil; Trimethoprim /
Sulphametoxazol--Sensibil; ); Medic: Dr. ELENA DORINA BOTEZ
26/02/2016 16:58:38 ALT/GPT:17 U/L; Amilaza:35 UI; AST/GOT:31 U/L; Bilirubina
Directa:0.12 mg/dL; Bilirubina indirecta:0.25 ; Bilirubina totala:0.37
mg/dL; Creatinina:0.87 mg/dL; Glucoza:116 mg/dL; Ionograma
(Na:132 mmol/L, K:3.53 mmol/L, Cl:104 mmol/L); Proteine
totale:5.09 g/dL; Urea:28 mg/dL; APTT:29.1 s; Fibrinogen:697
mg/dL; PT-APP-INR (PT:14.9 s, APP:77 %, INR:1.16 ); Hemograma
(WBC:12.02 x 103/uL, LY#:1.33 x 103/uL, LY:11.10 %, MO#:3.86 x
103/uL, MO:32.10 %, NE#:6.38 x 103/uL, NE:53.10 %, EO#:0.34 x
103/uL, EO:2.80 %, BA#:0.11 x 103/uL, BA:0.90 %, RBC:3.04 x
106/uL, HGB:9.18 g/dL, HCT:26.42 %, MCV:86.78 fL, MCH:30.17 pg,
MCHC:34.76 g/dL, RDW:12.89 %, PLT:666 x 103/uL, MPV:8.45 fL);
VSH:82 mm/h; Medic: As.Pr.MARIAN BOBU
26/02/2016 16:51:45 CULTURA SECRETIE PLAGA CU ANTIBIOGRAMA
(GERMENI:Staphylococcus xylosus; , ANTIBIOTICE
INTERMEDIAR:Levofloxacin--Intermediar; Synercid--Intermediar; ,
ANTIBIOTICE REZISTENT:Ampicillin--Rezistent; Ampicillin-
sulbactam--Rezistent; Augumentin (Amoxacillin / Clav.acid)--Rezistent;
Cefazolin--Rezistent; Cefepime--Rezistent; Cefotaxime--Rezistent;
Ceftriaxone--Rezistent; Clindamycin--Rezistent; Imipenem--Rezistent;
Oxacillin--Rezistent; Penicillin--Rezistent; Tetracycline--Rezistent; ,
ANTIBIOTICE SENSIBIL:Ciprofloxacin--Sensibil; Erythromycin--
Sensibil; Gatifloxacin--Sensibil; Gentamicin--Sensibil; LINEZOLID--
Sensibil; MOXIFLOXACIN--Sensibil; Rifampicin--Sensibil;
Trimethoprim / Sulphametoxazol--Sensibil; Vancomycin--Sensibil; );
Medic: Dr. MIRELA CONSTANTIN
24/02/2016 09:18:19 RADIOGRAFIA TORACO-PULMONARA -FATA (µGray x
m2:1.56 Dozamedie/organ, Asistent:BATAIOSU GETA; Sirbu Elena
Dumitra; , REZULTAT:Hiluri accentuate , fibroase.
Cord cu dimensiuni normale.
Simfiza partiala SCD drept. ); Medic: RADU ROMULUS
ALEXANDRESCU
23/02/2016 05:52:41 Acid uric:4 mg/dL; Albumina:2.8 g/dL; ALP:101 UI; ALT/GPT:8
U/L; Amilaza:26 UI; AST/GOT:19 U/L; Bilirubina Directa:0.15
mg/dL; Bilirubina indirecta:0.4 ; Bilirubina totala:0.55 mg/dL;
Colesterol:100 mg/dL; Creatinina:0.91 mg/dL; GGT:69 U/L;
Glucoza:87 mg/dL; Ionograma (Na:140 mmol/L, K:3.25 mmol/L,
Cl:108 mmol/L); LDH:640 UI; Proteine totale:5.44 g/dL;
Trigliceride:196 mg/dL; Urea:67 mg/dL; APTT:17.1 s;
Fibrinogen:980 mg/dL; PT-APP-INR (PT:11.6 s, APP:134 %,
INR:0.87 ); Hemograma (WBC:13.61 x 103/uL, LY#:1.33 x 103/uL,
LY:9.80 %, MO#:2.99 x 103/uL, MO:22.00 %, NE#:8.90 x 103/uL,
NE:65.40 %, EO#:0.18 x 103/uL, EO:1.30 %, BA#:0.20 x 103/uL,
BA:1.50 %, RBC:3.42 x 106/uL, HGB:10.40 g/dL, HCT:31.19 %,
MCV:91.31 fL, MCH:30.44 pg, MCHC:33.34 g/dL, RDW:12.25 %,
PLT:448 x 103/uL, MPV:8.96 fL, Comentarii:PREZENTI
MICROCOAGULI, REPETA. ); VSH:110 mm/h; Medic: As.Pr.
ILEANA DOBRE
21/02/2016 09:41:34 ALT/GPT:18 U/L; Amilaza:43 U/L; AST/GOT:23 U/L; Bilirubina
Directa:0.1 mg/dL; Bilirubina indirecta:0.2 ; Bilirubina totala:0.3
mg/dL; Colesterol:111 mg/dL; Creatinina.:1.0 mg/dL; Glucoza:134
mg/dL; Ionograma (Na:141 mmol/L, K:3.22 mmol/L, Cl:107 mmol/L);
Trigliceride:86 mg/dL; Urea:87 mg/dL; APTT:31.3 s;
Fibrinogen:Fibrinogenul derivat nu poate fi calculat de aparat. ; PT-
APP-INR (PT:14.7 s, APP:87 %, Comentarii:INR=1,07 ); Hemograma
(WBC:13.12 x 103/uL, RBC:3.53 x 106/uL, HGB:10.60 g/dL,
HCT:31.51 %, MCV:89.33 fL, MCH:30.04 pg, MCHC:33.63 g/dL,
RDW:12.71 %, PLT:444 x 103/uL, MPV:8.70 fL,
Comentarii:PREZENTI MICROCOAGULI ); VSH:96 mm/h; Medic:
As.Pr. GEORGETA CORDONEANU
20/02/2016 14:49:45 Albumina:3 g/dL; ALT/GPT:10 U/L; Amilaza:89 UI; AST/GOT:11
U/L; Bilirubina Directa:0.15 mg/dL; Bilirubina indirecta:0.42 ;
Bilirubina totala:0.57 mg/dL; Creatinina:1.39 mg/dL; Glucoza:197
mg/dL; Ionograma (Na:141 mmol/L, K:4.11 mmol/L, Cl:106 mmol/L);
Urea:73 mg/dL; APTT:24.6 s; Fibrinogen:891 mg/dL; PT-APP-INR
(PT:14.6 s, APP:80 %, INR:1.13 ); Hemograma (WBC:7.28 x 103/uL,
LY#:0.35 x 103/uL, LY:4.80 %, MO#:1.17 x 103/uL, MO:16.10 %,
NE#:5.64 x 103/uL, NE:77.50 %, EO#:0.08 x 103/uL, EO:1.10 %,
BA#:0.04 x 103/uL, BA:0.50 %, RBC:3.64 x 106/uL, HGB:10.90 g/dL,
HCT:32.20 %, MCV:88.53 fL, MCH:29.97 pg, MCHC:33.85 g/dL,
RDW:12.52 %, PLT:474 x 103/uL, MPV:8.70 fL); VSH:90 mm/h;
Medic: As.Pr. ILEANA DOBRE
15/02/2016 08:51:21 Acid uric:3.3 mg/dL; Albumina:3.1 g/dL; ALP:85 U/L; ALT/GPT:19
mg/dL; Amilaza:66 U/L; AST/GOT:21 U/L; Bilirubina Directa:0.1
mg/dL; Bilirubina indirecta:0.4 ; Bilirubina totala:0.5 mg/dL;
Colesterol:164 mg/dL; Creatinina.:0.7 mg/dL; Glucoza:94 mg/dL;
Ionograma (Na:141 mmol/L, K:4.43 mmol/L, Cl:108 mmol/L);
Proteine totale:6.7 g/dL; Urea:52 mg/dL; APTT.:26.700 s;
Fibrinogen.:694.558 mg/dL; PT-APP-INR. (PT:15.500 s, INR:1.174 ,
APP:77.415 %); Hemograma (WBC:9.53 x 103/uL, LYM#:3.31 x
103/uL, LYM:34.70 %, MON#:0.70 x 103/uL, MON:7.30 %, NEU#:4.99
x 103/uL, NEU:52.40 %, EOS#:0.48 x 103/uL, EOS:5.00 %, BAS#:0.06
x 103/uL, BAS:0.60 %, RBC:3.94 x 106/uL, HGB:12.13 g/dL,
HCT:35.04 %, MCV:88.88 fL, MCH:30.76 pg, MCHC:34.61 g/dL,
RDW:11.16 %, PLT:427.20 x 103/uL, MPV:8.32 fL); VSH:72 mm/h;
Medic: As.Pr. CRISTINA PETROVICI
11/02/2016 08:22:03 ALT/GPT:21 U/L; Amilaza:58 U/L; AST/GOT:16 U/L; Bilirubina
Directa:0.1 mg/dL;
Bilirubina totala:0.3 mg/dL; Creatinina.:0.8 mg/dL; Glucoza:83
mg/dL; Ionograma (Na:144 mmol/L, K:5.17 mmol/L, Cl:107 mmol/L);
Urea:77 mg/dL; APTT.:25.500 s; Fibrinogen.:807.254 mg/dL; PT-
APP-INR. (PT:16.300 s, INR:1.244 , APP:71.001 %); Hemograma
(WBC:9.41 x 103/uL, LYM#:3.40 x 103/uL, LYM:36.10 %, MON#:0.72
x 103/uL, MON:7.70 %, NEU#:4.57 x 103/uL, NEU:48.50 %,
EOS#:0.67 x 103/uL, EOS:7.10 %, BAS#:0.06 x 103/uL, BAS:0.60 %,
RBC:4.21 x 106/uL, HGB:12.82 g/dL, HCT:36.79 %, MCV:87.39 fL,
MCH:30.46 pg, MCHC:34.86 g/dL, RDW:9.78 %, PLT:492.18 x
103/uL, MPV:8.83 fL); Medic: B.Pr. IRINA CIUREL
EPICRIZA
Pacient in varsta de 46 de ani, se interneaza in clinica cu durere la nivelul fosei iliace drepte si
flancului drept, cu tulburari de tranzit intestinal de 3-4 zile, si scadere ponderala. Se interneaza
pentru investigatii suplimentare si tratament de specialitate.
Biologic - anexate biletului de externare.
Ecografia abdominala - ficat omogen, vena splenica normala, pancreas normal, colecist fara
calculi, CBP normala, VPo normala, RD si RS fara hidronefroza. Splina normala. Vezica urinara
normala. In pelvis, imagine hipoecogena, neomogena, sugestiv pentru tub digestiv. Se sugereaza
efectuarea unei rectosigmoidoscopii.
Rectosigmoidoscopie - la 15 cm de OA formatiune sangeranda usor la atingere, ce se intinde pe
apox 6 cm, partial stenozanta, pe peretele posterior, ilcerata. Aspect normal pana la 40 cm de
OA, limita ce nu poate fi depasita datorita existentei de materii fecale.
CT cerebral, toraco-abdomino-pelvin (nativ contrast) - atasat biletului de externare.
Se instituie tratament antialgic, antispastic, de reeechilibrare hemohidroelectrolitica si
acidobazica cu evolutie favorabila.
Se externeaza la cerere in data de 9.01.2015 cu stare generala buna, afebril, echilibrat
hemodinamic si respirator, abdomen suplu, mobil cu respiratia, fara semne de iritatie peritoneala,
tranzit intestinal prezent pentru gaze si materii fecale, toleranta digestiva buna.
PROTOCOL OPERATOR:
RECOMANDARI/REGIM/MEDICATIE
DATA INVESTIGATII
09/01/2015 10:50:51 ALT/GPT.:55 U/L; Amilaza:76 U/L; AST/GOT:23 U/L; Bilirubina
Directa:0.2 mg/dL;
Bilirubina totala:1.0 mg/dL; Creatinina.:0.6 mg/dL; Fosfataza
alcalina.:57 U/L; Glucoza:99 mg/dL; Ionograma (Na:142 mmol/L,
K:3.85 mmol/L, Cl:101 mmol/L); Urea:40 mg/dL; APTT:31.4 s;
Fibrinogen:343 mg/dL; PT-APP-INR (PT:13.4 s, APP:95 %, INR:1.03
); Hemograma (WBC:10.19 x 103/uL, LY#:3.44 x 103/uL, LY:33.70 %,
MO#:1.04 x 103/uL, MO:10.20 %, NE#:5.32 x 103/uL, NE:52.20 %,
EO#:0.33 x 103/uL, EO:3.20 %, BA#:0.07 x 103/uL, BA:0.70 %,
RBC:5.59 x 106/uL, HGB:11.08 g/dL, HCT:34.22 %, MCV:61.20 fL,
MCH:19.82 pg, MCHC:32.38 g/dL, RDW:14.69 %, PLT:266 x 103/uL,
MPV:8.19 fL); VSH:10 mm/h; Medic: As.Pr. ADRIANA NEDELCU
06/01/2015 08:13:49 ALT/GPT.:36 U/L; Amilaza:25 U/L; AST/GOT:14 U/L;
Creatinina.:1.0 mg/dL; Glucoza:99 mg/dL; Ionograma (Na:142
mmol/L, K:4.05 mmol/L, Cl:100 mmol/L); Urea:26 mg/dL; APTT:32.1
s; Fibrinogen:592 mg/dL; PT-APP-INR (PT:13.4 s, APP:101 %,
INR:1.00 ); Hemograma (WBC:9.0 x 103/uL, RBC:4.66 x 106/uL,
HGB:13.3 g/dL, HCT:41.7 %, MCV:89.5 fL, MCH:28.6 pg,
MCHC:31.9 g/dL, RDW:12.3 %, PLT:459 x 103/uL, PCT:0.338 %,
MPV:7.4 fL, PDW:16.0 , LY#:1.7 x 103/uL, MO#:0.8 x 103/uL, NE#:6.3
x 103/uL, EO#:0.2 x 103/uL, BA#:0.0 x 103/uL, LY%:18.4 %, MO%:9.3
%, NE%:69.7 %, EO%:2.4 %, BA%:0.2 %, Comentariu:Neutrophilia %;
Neutrophilia #; Lymphopenia %; Thrombocytosis; ); Medic: B.Pr.
IRINA CIUREL
EPICRIZA
PROTOCOL OPERATOR:
RECOMANDARI/REGIM/MEDICATIE
DATA INVESTIGATII
07/02/2020 08:15:50 Albumina:0.9 g/dL; ALP:63 U/L; ALT/GPT:53 mg/dL;
Amilaza:LIPSA REACTIV ; AST/GOT:163 U/L; Bilirubina Directa
(Comenatrii:LIPSA REACTIV , Bilirubina Directa : mg/dL);
Bilirubina totala (Comentarii:LIPSA REACTIV , Bilirubina totala:
mg/dL); CK:718 U/L; CK-MB:55 U/L; Creatinina:2.43 mg/dL;
Fier:14 µg/dL; GGT:38 U/L; Glucoza:56 mg/dL; Ionograma (Na:134
mmol/L, K:4.0 mmol/L, Cl:106 mmol/L);
Proteine totale:2.9 g/dL; Urea:73 mg/dL; APTT:39.300 s;
Fibrinogen:396.654 mg/dL; PT-APP-INR (PT:31.600 s, INR:2.705 ,
APP:29.198 %); Hemograma (WBC:31.7 x 103/uL, UWBC:31.7 x
103/uL, RBC:3.78 x 106/uL, HGB:10.0 g/dL, HCT:31.1 %, MCV:82.3
fL, MCH:26.6 pg, MCHC:32.3 g/dL, RDW:16.6 %, RDW-SD:48.1 ,
PLT:133 x 103/uL, MPV:7.4 fL, PCT:0.098 %, PDW:16.5 , NE%:95.2
%, LY%:1.9 %, MO%:2.6 %, EO%:0.2 %, BA%:0.1 %, NE#:30.1 x
103/uL, LY#:0.6 x 103/uL, MO#:0.8 x 103/uL, EO#:0.1 x 103/uL,
BA#:0.0 x 103/uL, NRBC:0.1 ); Medic: B.Pr. IRINA CIUREL
06/02/2020 10:56:46 RADIOGRAFIA TORACO-PULMONARA -FATA (Asistent:Sorici
Cristian; Tacu Mariana; Bucur Marius , REZULTAT:Clinostatism.
Pacienta rotata la stanga.
CVC jugular drept cu capatul intern orientat spre stanga (trunchi
brahiocefalic stang?)
Tub endotraheal cu capatul intern la nivelul carinei. ); Medic: FLORIN
PETCU
06/02/2020 09:00:22 Acid uric:7.7 mg/dL; Albumina:1.0 g/dL; ALT/GPT:14 mg/dL;
Amilaza: U/L; AST/GOT:41 U/L; Bilirubina Directa: mg/dL;
Bilirubina totala: mg/dL; CK:176 U/L; CK-MB:75 U/L;
Creatinina:2.06 mg/dL; GGT:41 U/L; Glucoza:175 mg/dL;
Ionograma (Na:134 mmol/L, K:5.45 mmol/L, Cl:109 mmol/L);
LDH:274 U/L; Proteine totale:3.1 g/dL; Urea:67 mg/dL;
APTT:46.300 s; Fibrinogen:472.557 mg/dL; PT-APP-INR (PT:26.000
s, INR:2.153 , APP:38.011 %); Hemograma (WBC:15.6 x 103/uL,
UWBC:15.6 x 103/uL, RBC:4.00 x 106/uL, HGB:10.4 g/dL, HCT:33.6
%, MCV:83.9 fL, MCH:26.0 pg, MCHC:31.0 g/dL, RDW:17.5 %,
RDW-SD:52.1 , PLT:473 x 103/uL, MPV:7.1 fL, PCT:0.336 %,
PDW:16.7 , NE%:86.8 %, LY%:8.1 %, MO%:3.9 %, EO%:1.0 %,
BA%:0.2 %, NE#:13.5 x 103/uL, LY#:1.3 x 103/uL, MO#:0.6 x 103/uL,
EO#:0.2 x 103/uL, BA#:0.0 x 103/uL, NRBC:0.1 ); Medic: B.Pr. IRINA
CIUREL
06/02/2020 08:33:21 ANTIBIOGRAMA (Germen 1:Serratia species , Antibiograma
1:Amikacin : S ; Ampicillin : R ; Amox/K Clav : R ; Ceftazidime : S ;
Ceftazidime/K Clavulanate : ; Cefotaxime : R ; Cefotaxime/K
Clavulanate : ; Cefoxitin : R ; Cefazolin : R ; Colistin : ; Ciprofloxacin :
S ; Cefepime : S ; Cefuroxime : R ; Ertapenem : R ; Nitrofurantoin : ;
Fosfomycin : S ; Gentamicin : S ; Imipenem : N/R ; Levofloxacin : S ;
Meropenem : S ; Moxifloxacin : S ; Mezlocillin : R ; Norfloxacin : ;
Pip/Tazo : S ; Piperacillin : R ; Trimethoprim : ; Trimeth/Sulfa : R ;
Tetracycline : R ; Tigecycline : R ; Tobramycin : S ); CULTURA
AEROBA LICHID PUNCTIE CU ANTIBIOGRAMA
(GERMENI:Serratia sp. , COMENTARII:LICHID PERITONEAL );
CULTURA ANAEROBA LICHID PUNCTIE CU
ANTIBIOGRAMA:07.02.2020.Nu s-au dezvoltat germeni anaerobi
dupa 24 ore de incubare ; Medic: Dr. ELENA DORINA BOTEZ
06/02/2020 05:55:47 UROCULTURA CU ANTIBIOGRAMA:07.02.2020.Absenti germeni
cu risc epidemiologic dupa 24 ore de incubare-T1 ; Medic: Dr. ELENA
DORINA BOTEZ
06/02/2020 05:54:34 CULTURA EXUDAT NAZAL CU
ANTIBIOGRAMA:07.02.2020.Absenti germeni cu risc epidemiologic
dupa 24 ore de incubare-T1 ; Medic: Dr. ELENA DORINA BOTEZ
06/02/2020 05:53:32 CULTURA ASPIRAT BRONSIC CU
ANTIBIOGRAMA:07.02.2020.Absenti germeni cu risc epidemiologic
dupa 24 ore de incubare-T1 ; Medic: Dr. ELENA DORINA BOTEZ
05/02/2020 21:57:39 RADIOGRAFIA TORACO-PULMONARA -FATA:2.1
Dozamedie/organ; RADIOGRAFIA ABDOMENULUI:29 µGym2;
Medic: DANIELA IONELA PARVULESCU
05/02/2020 21:57:09 ALT/GPT:13 U/L; Amilaza:lipsa reactiv ; AST/GOT:20 U/L;
Bilirubina Directa:lipsa reactiv ;
Creatinina:1.87 mg/dL; Glucoza:86 mg/dL; Ionograma (Na:127
mmol/L, K:4.4 mmol/L, Cl:101 mmol/L); Urea:81 mg/dL; APTT:not
coag. s; Fibrinogen: mg/dL; PT-APP-INR (PT:22.0 s, APP:51 %,
INR:1.66 ); Hemograma (WBC:27.08 x 103/uL, LYM#:2.79 x 103/uL,
LYM:10.30 %, MON#:4.01 x 103/uL, MON:14.80 %, NEU#:19.42 x
103/uL, NEU:71.70 %, EOS#:0.51 x 103/uL, EOS:1.90 %, BAS#:0.35 x
103/uL, BAS:1.30 %, RBC:4.21 x 106/uL, HGB:10.61 g/dL, HCT:33.38
%, MCV:79.34 fL, MCH:25.22 pg, MCHC:31.79 g/dL, RDW:12.96 %,
PLT:810.72 x 103/uL, MPV:6.91 fL);
EPICRIZA
Pacient de 71 ani fara APP semnificative acuza tenesme rectale si incetinirea tranzitului
intestinal asociate cu dureri epigastrice, simptomatologie cu debut insiduos de aproximativ 2
luni.
Biologic pe parcursul internarii atasat.
Ex clinic local evidentiaza abdomen suplu mobil cu respiratia, dureros spontan si la palpare in
epigastru unde se palpeaza o formatiune tumorala de 15/10 cm de consistenta dura fixa la
planurile posterioare, fara semne de iritatie peritoneala, tranzit intestinal prezent. Tuseul rectal
evidentiaza o formatiune tumorala ulcero-vegetativa la aproximativ 4 cm de orificiul anal
nestenozanta cu singerare la atingere.
Ecografia abdominala evidentiaza ficat cu multiple determinari secundare in ambii lobi, fara
lichid in peritoneu.
Radiografia pulmonara evidentiaza opacitati nodulare cu contur difuz intensitate medie situate in
cimpul pulmonar mijlociu sting. Mediastin largit, hil pulmonar drept marit, cord cu arc inferio
sting marit.
Consultul oncologic recomanda: efectuarea biopsiei tumorale, examene CT torace, abdomen si
pelvis si inceperea chimioterapiei.
Se intervine chirurgical si se preleveaza o biopsie tumorala cu evolutie locala favorabila; rezultat
anatomopatologic in lucru.
PROTOCOL OPERATOR:
RECOMANDARI/REGIM/MEDICATIE
1)
DATA INVESTIGATII
06/05/2014 10:34:25 Hemograma (WBC:4.4 x 103/uL, RBC:4.48 x 106/uL, HGB:11.1 g/dL,
HCT:36.9 %, MCV:82.5 fL, MCH:24.8 pg, MCHC:30.0 g/dL,
RDW:16.6 %, PLT:314 x 103/uL, PCT:0.199 %, MPV:6.3 fL,
PDW:16.8 , LY#:2.3 x 103/uL, MO#:0.1 x 103/uL, NE#:1.9 x 103/uL,
EO#:0.1 x 103/uL, BA#:0.0 x 103/uL, LY%:51.1 %, MO%:1.8 %,
NE%:43.7 %, EO%:3.4 %, BA%:0.0 %, Comentariu:Leukopenia;
Neutropenia #; Lymphocytosis %; Eosinophilia %; 1+ Anisocytosis; 2+
Hypochromia; 2+ Poikilocytosis; Small Platelets; ); Medic: Dr. ELENA
DORINA BOTEZ
29/04/2014 12:05:27 ALP:306 UI; ALT/GPT.:65 U/L; Amilaza:49 U/L; AST/GOT:100
U/L; Bilirubina Directa:0.39 mg/dL;
Creatinina.:1.0 mg/dL; GGT:179 U/L; Glucoza:97 mg/dL; Ionograma
(Na:144 mmol/L, K:4.30 mmol/L, Cl:105 mmol/L); Trigliceride:71
mg/dL; Urea:29 mg/dL; APTT:25.0 s; Fibrinogen:634 mg/dL; PT-
APP-INR (PT:15.9 s, APP:78 %, INR:1.15 ); Hemograma (WBC:4.14
x 103/uL, LY#:1.46 x 103/uL, LY:35.20 %, MO#:0.10 x 103/uL,
MO:2.30 %, NE#:2.38 x 103/uL, NE:57.50 %, EO#:0.19 x 103/uL,
EO:4.70 %, BA#:0.01 x 103/uL, BA:0.30 %, RBC:4.71 x 106/uL,
HGB:12.63 g/dL, HCT:37.64 %, MCV:79.94 fL, MCH:26.81 pg,
MCHC:33.54 g/dL, RDW:15.12 %, PLT:244 x 103/uL, MPV:7.17 fL);
Medic: As.Pr. NICOLETA PREDA
RECOMANDARI/REGIM/MEDICATIE
DATA INVESTIGATII
25/02/2015 12:18:13 ALT/GPT.:34 U/L; Amilaza:65 U/L; AST/GOT:10 U/L; Bilirubina
totala:0.3 mg/dL; Creatinina.:11.9 mg/dL; Glucoza:159 mg/dL;
Ionograma (Na:137 mmol/L, K:5.39 mmol/L, Cl:101 mmol/L);
Proteine totale:6.6 g/dL; Urea:548 mg/dL; APTT:63.3 s;
Fibrinogen:829 mg/dL; PT-APP-INR (PT:29.7 s, APP:27 %, INR:2.52
); Hemograma (WBC:9.53 x 103/uL, LY#:1.23 x 103/uL, LY:12.90 %,
MO#:0.64 x 103/uL, MO:6.70 %, NE#:7.47 x 103/uL, NE:78.40 %,
EO#:0.16 x 103/uL, EO:1.70 %, BA#:0.03 x 103/uL, BA:0.30 %,
RBC:2.70 x 106/uL, HGB:8.28 g/dL, HCT:24.06 %, MCV:89.27 fL,
MCH:30.73 pg, MCHC:34.43 g/dL, RDW:11.72 %, PLT:519 x 103/uL,
MPV:7.55 fL); VSH:78 mm/h; Medic: As.Pr. GEORGETA
CORDONEANU
EPICRIZA
PROTOCOL OPERATOR:
RECOMANDARI/REGIM/MEDICATIE
DATA INVESTIGATII
12/06/2017 10:39:39 RADIOGRAFIA TORACO-PULMONARA -FATA
(REZULTAT:Aer la nivelul esofagului. Aerogastric.
Torace rotat spre dreapta.
Opcitati mixte alveolare si interstitiale in 1/3 medie, arie pulmonara
dreapta.
Accentuarea desenului interstitial bazal stanga.
Opacitate in banda, intensitate calcara proiectata pleural latero-toracic
dreapta. , Asistent:Balan Mariana; Voicu Oana; ); Medic: DANIEL
SIMA
12/06/2017 09:34:55 Albumina:1.3 g/dL; ALT/GPT:20 U/L; Amilaza:22 U/L;
AST/GOT:35 U/L; Bilirubina Directa:0.7 mg/dL; Bilirubina
indirecta:0.4 ; Bilirubina totala:1.1 mg/dL; CK:115 U/L; CK-MB:17
U/L; Creatinina:1.50 mg/dL; GGT:27 U/L; Glucoza (Glucoza:32
mg/dL, Comentarii:LUCRAT DE DOUA ORI ); Ionograma:APARAT
DEFECT ; LDH:234 U/L; Proteine totale:4.5 g/dL; Urea:93 mg/dL;
APTT.:39.600 s; Fibrinogen.:418.952 mg/dL; PT-APP-INR.
(PT:18.900 s, INR:1.472 , APP:56.900 %); Hemograma:proba
coagulata ; Medic: As.Pr. NICOLETA PREDA
11/06/2017 11:00:23 Creatinina:1.10 mg/dL; Urea:76 mg/dL; Medic: As.Pr.MARIAN
BOBU
09/06/2017 06:08:40 ALT/GPT:7 U/L; Amilaza:127 U/L; AST/GOT:21 U/L; Bilirubina
totala:0.4 mg/dL; Calciu:6.2 mg/dL; CK:385 U/L; CK-MB:LIPSA
REACTIV ; Colesterol:25 mg/dL; Creatinina:1.55 mg/dL; Fier:4
µg/dL; Glucoza:103 mg/dL; Ionograma:APARAT DEFECT ;
Magneziu:1.0 mg/dL; Trigliceride:36 mg/dL; Urea:32 mg/dL;
APTT:36.6 s; Fibrinogen:244 mg/dL; PT-APP-INR (PT:21.9 s,
APP:44 %, INR:1.76 ); Hemograma (WBC:5.67 x 103/uL, LY#:0.48 x
103/uL, LY:8.40 %, MO#:1.45 x 103/uL, MO:25.60 %, NE#:3.65 x
103/uL, NE:64.30 %, EO#:0.05 x 103/uL, EO:0.80 %, BA#:0.05 x
103/uL, BA:0.90 %, RBC:2.10 x 106/uL, HGB:5.98 g/dL, HCT:17.28 %,
MCV:82.40 fL, MCH:28.53 pg, MCHC:34.63 g/dL, RDW:16.21 %,
PLT:126 x 103/uL, MPV:7.30 fL); Medic: As.Pr. GEORGETA
CORDONEANU
08/06/2017 14:07:52 UROCULTURA CU ANTIBIOGRAMA:NEGATIVA ; CULTURA
EXUDAT FARINGIAN CU ANTIBIOGRAMA:Absent streptococ
beta hemolitic si stafilococ auriu ; CULTURA EXUDAT NAZAL CU
ANTIBIOGRAMA:Flora fara semnificatie patogena ; Medic: Dr.
ELENA DORINA BOTEZ
31/05/2017 21:35:06 Albumina:2.7 g/dL; ALT/GPT:18 U/L; AST/GOT:13 U/L; Bilirubina
Directa:0.1 mg/dL; Bilirubina indirecta:0.20 mg/dL; Bilirubina
totala:0.3 mg/dL; Creatinina:0.74 mg/dL; Glucoza:108 mg/dL;
Ionograma:APARAT DEFECT ; Proteine totale:6.3 g/dL; Urea:28
mg/dL; APTT:26.9 s; Fibrinogen:487 mg/dL; PT-APP-INR (PT:14.9
s, APP:82 %, INR:1.12 ); Hemograma (WBC:6.61 x 103/uL, LY#:1.59
x 103/uL, LY:24.10 %, MO#:0.45 x 103/uL, MO:6.80 %, NE#:4.29 x
103/uL, NE:64.90 %, EO#:0.24 x 103/uL, EO:3.70 %, BA#:0.03 x
103/uL, BA:0.50 %, RBC:3.76 x 106/uL, HGB:10.06 g/dL, HCT:29.43
%, MCV:78.34 fL, MCH:26.78 pg, MCHC:34.18 g/dL, RDW:14.30 %,
PLT:174 x 103/uL, MPV:6.53 fL); Medic: As.Pr. GEORGETA
CORDONEANU
31/05/2017 18:58:11 RADIOGRAFIA TORACO-PULMONARA -FATA:19.3
Dozamedie/organ; RADIOGRAFIA ABDOMENULUI:105.2 µGym2;
Medic: MARIA CRISTINA TOLBARU
EPICRIZA
Pacienta in varsta de 44 de ani, se prezinta la spital cu rectoragii debutate de ~ 4 zile, cu dureri
perianale. Examen clinic - pacient in pozitie genupectorala - arie perianala de aspect normal,
sfincter anal normoton, ampula rectala cu formatiune tumorala formatiune tumorala rectala
inferioara sangeranda situata la ~ 6 cm de orificiul anal, nesangeranda, ulcerovegetanta, partial
stennozanta.
Biologic anexat biletului de externare.
Ecografie abdominala -in abdomenul inferior, posterior de uter, formatiune imprecis delimitata,
neomogena, hipoecogena. .
Consult ginecologic- UM noi, N-2, A-7, vagin cu pereti suplii, cu perete posterior impins de o
formatiune cu consistenta ferma, nu poate fi evaluat colul cu valvele. TV col cu consistenta
normala. Nu pierde sange pe cale vaginala. Ecografie transvaginala nu se poate efectua. Eco abd
inf uter ascensionat de 7.5/ 3.8cm, endometru 7mm. Posterior si inferior de uter o formatiune cu
ecogenitate mixta, care impinge si vezica urinara. Se recomanda CT pelvis, consult urologic.
CT toracic si abdomino-pelvin atasat biletului de externare.
Se decide si se intervine chirurgical sub rahianestezie; se practica biopsia tumorala a formatiunii
situate la ~ 6 cm de OA.
Evolutie postoperatorie favorabila, pacienta externandu-se la cerere cu stare generala buna,
afebrila, echilibrata hemodinamic si respirator, abdomen suplu, mobil cu respiratia, fara semne
de iritatie peritoneala, TI prezent pentru gaze si materii fecale de aspect normal; fara sangerare
rectala.
PROTOCOL OPERATOR:
RECOMANDARI/REGIM/MEDICATIE
DATA INVESTIGATII
10/12/2015 14:25:04 TOMOGRAFIA COMPUTERIZATA A TORACELUI,
ABDOMENULUI SI PELVISULUI CU SUBSTANTA DE
CONTRAST INTRAVENOASA (REZULTAT:
CT abdomen + pelvis (N+K)
Formatiune tumorala rectala inferioara , endorectala, dezvoltata
parietalcircumferential cu un diametrru de aproximativ 6 cm ,
intinzandu-se pe aproximativ 4-5 cm. Formatiunea vegetanta este
intens neomogena dupa administrarea substantei de contrast si determina
stenoza neuniforma .Tumora infiltreaza peretele posterior al vaginului.
Lpsa planului de demarcatie fata de peretele posterior al vezicii
urinare (posibil efect compresiv).
Micropoliodenopatii in grasimea perirectala si adenopatii in grasimea
mezenterica.
Uter dimensiuni normale, structura omogena.
Ficat : steatozic, fara procese inlocuitoare de spatiu.
Colecist: cudat cu calcificari parietale .
Splina :,glande suprarenale , pancreas, rinichi cu aspect CT normal.
Ambele uretre sunt permeabile ,nedilatate .
Fara lichid in cavitatea periteneala.
Fara leziuni sugestive pentru determinari secundare la nivelul
structurilor osoase examinate.
Concluzii:
Tumora rectala inferioara invadanta in vagin.
Adenopatii perirectale si mezenterice.
, ASISTENT:Tutulus Mihaela; ); Medic: GHEORGHE
BRATILOVEANU
08/12/2015 11:34:15 ALT/GPT:24 U/L; Amilaza:33 U/L; AST/GOT:15 U/L;
Creatinina.:0.7 mg/dL; Glucoza:79 mg/dL; Ionograma (Na:131
mmol/L, K:4.12 mmol/L, Cl:105 mmol/L); Urea:21 mg/dL; APTT:27.8
s; Fibrinogen:764 mg/dL; PT-APP-INR (PT:14.4 s, APP:82 %,
INR:1.12 ); Hemograma (WBC:19.5 x 103/uL, RBC:4.02 x 106/uL,
HGB:11.8 g/dL, HCT:35.4 %, MCV:88.0 fL, MCH:29.4 pg,
MCHC:33.4 g/dL, RDW:12.8 %, PLT:345 x 103/uL, PCT:0.299 %,
MPV:8.7 fL, PDW:16.1 , LY#:1.7 x 103/uL, MO#:1.1 x 103/uL,
NE#:16.5 x 103/uL, EO#:0.1 x 103/uL, BA#:0.1 x 103/uL, LY%:8.8 %,
MO%:5.6 %, NE%:84.5 %, EO%:0.5 %, BA%:0.6 %,
Comentariu:Leukocytosis; Neutrophilia %; Neutrophilia #;
Lymphopenia %; Monocytosis #; Anemia; ); Medic: As.Pr.MARIAN
BOBU
EPICRIZA
Pacient in varsta de 60 ani, se prezinta pentru rectoragii, absenta tranzitului intestinal si scadere
ponderala.
Clinic prezinta abdomen suplu, mobil cu respiratia, dureros difuz la palpare, fara semne de
iritatie peritoneala, tuseu rectal: la aproximativ 4 cm de orificiul anal formatiune tumorala
neregulata, sangeranda, de mari dimensiuni.
Rx pulmonar evidentiaza opacitate macronodulara in treimea medie a campului pulmonar stang,
calcificate, contur regulat.Nu se evidentiaza radiologic pneumoperitoneu sau nivele hidroaerice.
Se decide si se intervine chirurgical; intraoperator se evidentiaza formatiune tumorala la nivelul
sigmoidului, la aproximativ 20 cm de anus; se practica rezectie segmentara sigmoidiana, cu
ridicarea in bloc a formatiunii tumorale, cu colostomie stanga maturata primar; la nivel rectal
formatiune tumorala restanta.
Evolutia postoperatorie este favorabila; se externeaza cu stare generala buna, afebril, abdomen
suplu, mobil cu respiratia, nedureros spontan si la palpare, fara semne de iritatie peritoneala,
tranzit intestinal prezent pe colostoma.
Se recomanda internarea pentru supraveghere chirurgicala in serviciul teritorial.
Se transfera la Spitalul Municipal Oltenita, jud. Calarasi, cu aviz Dr. Soare.
PROTOCOL OPERATOR:
RECOMANDARI/REGIM/MEDICATIE
DATA INVESTIGATII
02/09/2015 14:46:40 CULTURA AEROBA LICHID PUNCTIE CU ANTIBIOGRAMA
(COMENTARII:LICHID PERITONEAL 4.09.2015 Nu s-au dezvoltat
germeni dupa 48 ore de incubare;cultura in curs de observatie pana in
7.09.2015 , GERMENI:7.09.2015 Nu s-au dezvoltat germeni dupa 5 zile
de incubare ); EXAMEN MICROSCOPIC COLORAT PENTRU
CITOLOGIE(GIEMSA):Nu se evidentiaza elemente celulare in frotiul
direct ; Medic: Dr. ELENA DORINA BOTEZ
27/08/2015 14:49:23 ALT/GPT:32 U/L; Amilaza:50 U/L; AST/GOT:28 U/L;
Creatinina.:0.4 mg/dL; Glucoza:74 mg/dL; Ionograma (Na:137
mmol/L, K:3.51 mmol/L, Cl:92 mmol/L); Urea:17 mg/dL; APTT:38.5
s; Fibrinogen:FIBRINOGENUL DERIVAT NU POATE FI
CALCULAT DE APARAT ; PT-APP-INR (PT:14.4 s, APP:91 %,
Comentarii:INR=1,05 ); Hemograma (WBC:24.64 x 103/uL, LY#:4.58
x 103/uL, LY:18.60 %, MO#:3.15 x 103/uL, MO:12.80 %, NE#:16.41 x
103/uL, NE:66.60 %, EO#:0.25 x 103/uL, EO:1.00 %, BA#:0.25 x
103/uL, BA:1.00 %, RBC:3.87 x 106/uL, HGB:9.00 g/dL, HCT:29.77 %,
MCV:76.88 fL, MCH:23.24 pg, MCHC:30.23 g/dL, RDW:18.57 %,
PLT:709 x 103/uL, MPV:6.91 fL); VSH:COAGUL PREZENT ; Medic:
As.Pr. CRISTINA PETROVICI
PROTOCOL OPERATOR:
RECOMANDARI/REGIM/MEDICATIE
DATA INVESTIGATII
13/07/2012 08:56:44 Albumina:2.4 g/dL; ALP:74 UI; ALT/GPT.:26 U/L; Amilaza:43 U/L;
AST/GOT:15 U/L;
Bilirubina totala:0.3 mg/dL; Calciu:8.3 mg/dL;
Colesterol:122 mg/dL; Creatinina.:0.7 mg/dL; Fier:60 µg/dL; GGT:27
U/L; Glucoza:192 mg/dL;
Ionograma (Na:145 mmol/L, K:3.85 mmol/L, Cl:107 mmol/L);
LDH:209 U/L;
Lipide Totale:428.5 mg/dL; Magneziu:1.9 mg/dL; Proteine totale:5.21
g/dL; Trigliceride:64 mg/dL; Urea:25 mg/dL; APTT:24.1 s;
Fibrinogen:604 mg/dL; PT-APP-INR (PT:10.1 s, APP:183 %,
INR:0.75 ); Hemograma (WBC:9.5 x 103/uL, RBC:3.98 x 106/uL,
HGB:11.3 g/dL, HCT:33.1 %, MCV:83.1 fL, MCH:28.5 pg,
MCHC:34.3 g/dL, RDW:17.1 %, PLT:164 x 103/uL, PCT:0.161 %,
MPV:9.8 fL, PDW:16.1 ); VSH:50 mm/h; Medic: As.Pr. SILVIA
CONSTANTIN
12/07/2012 08:39:34 Hemograma (WBC:12.3 x 103/uL, RBC:3.55 x 106/uL, HGB:9.6 g/dL,
HCT:29.0 %, MCV:81.8 fL, MCH:27.2 pg, MCHC:33.2 g/dL,
RDW:17.8 %, PLT:201 x 103/uL, PCT:0.180 %, MPV:9.0 fL,
PDW:16.1 ); Medic: Dr. DOINA ILIANA BOGDANESCU
11/07/2012 10:30:59 ALT/GPT.:29 U/L; Amilaza:70 U/L; AST/GOT:27 U/L;
Bilirubina totala:0.5 mg/dL; Creatinina.:0.8 mg/dL; GGT:28 U/L;
Glucoza:108 mg/dL; Ionograma (Na:145 mmol/L, K:3.62 mmol/L,
Cl:107 mmol/L); Proteine totale:4.93 g/dL; Urea:24 mg/dL;
APTT:24.9 s; Fibrinogen:425 mg/dL; PT-APP-INR (PT:14.6 s,
APP:69 %, INR:1.27 ); Hemograma (WBC:9.1 x 103/uL, RBC:3.54 x
106/uL, HGB:9.9 g/dL, HCT:27.4 %, MCV:77.5 fL, MCH:28.1 pg,
MCHC:36.2 g/dL, RDW:17.0 %, PLT:175 x 103/uL, PCT:0.148 %,
MPV:8.5 fL, PDW:16.1 ); VSH:32 mm/h; Medic: As.Pr. GEORGETA
CORDONEANU
10/07/2012 20:54:05 CULTURA AEROBA LICHID PUNCTIE CU ANTIBIOGRAMA
(COMENTARII:12.07.2012.Nu s-au dezvoltat germeni dupa 48 ore de
incubare;cultura in curs de observatie pana in data de 15.07.2012 ,
GERMENI:LICHID PERITONEAL 16.07.2012 Nu s-au dezvoltat
germeni dupa 5 zile de incubare ); Medic: Dr. ELENA DORINA
BOTEZ
09/07/2012 04:49:13 Albumina:3.3 g/dL; ALT/GPT:15 U/L; Amilaza:58 UI; AST/GOT:15
U/L; Bilirubina Directa:0.16 mg/dL; Bilirubina indirecta:0.22 ;
Bilirubina totala:0.38 mg/dL; Colesterol:185 mg/dL; Creatinina:0.83
mg/dL; Glucoza:70 mg/dL; Ionograma (Na:147 mmol/L, K:4.70
mmol/L, Cl:105 mmol/L); Urea:20 mg/dL;
EPICRIZA
Pacienta de 59 ani se prezinta pentru dureri la nivelul etajului abdominal inferior, insotite de
constipatie, anorexie, scadere ponderala.
Biologic: analize atasate la biletul de externare.
Rg. torace - fara modificari patologice vizibile radiologic.
Ecografia abdominala- deceleaza imagine hiperecogena 3 cm, sugestiva de hemangiom, fara
CBIH destinse. Colecist fara calculi, splina omogena, pancreasul nu se vizualizeaza, rinichii fara
hidronefroza, vezica urinara normala. Fara lichid liber in peritoneu.
Consult Cardiologie- stabileste diagnosticele: tahicardie sinusala, anemie feripriva.
Pe data de 09.02.2015 se intervine chirurgical (VCONr. 239) si se practica amputatie de rect,
colpectomie posterioara. Evolutie postoperstorie favorabila.
Pacienta se externeaza cu starea generala buna, afebrila. Abdomen suplu, mobil cu respiratia,
nedureros spontan si ls palpare, fara semne de iritatie peritoneala.Plaga supla, curata. Colostoma
functionala. Diureza prezenta.
PROTOCOL OPERATOR:
RECOMANDARI/REGIM/MEDICATIE
DATA INVESTIGATII
08/02/2015 17:26:59 APTT:29.5 s; Fibrinogen:448 mg/dL; PT-APP-INR (PT:15.1 s,
APP:75 %, INR:1.18 ); Medic: Dr. MIRELA CONSTANTIN
08/02/2015 10:03:23 APTT:30.0 s; Fibrinogen:573 mg/dL; PT-APP-INR (PT:15.3 s,
APP:74 %, INR:1.19 ); Hemograma (WBC:4.63 x 103/uL, LY#:0.86 x
103/uL, LY:18.60 %, MO#:0.55 x 103/uL, MO:11.90 %, NE#:3.14 x
103/uL, NE:67.70 %, EO#:0.07 x 103/uL, EO:1.60 %, BA#:0.01 x
103/uL, BA:0.20 %, RBC:3.57 x 106/uL, HGB:8.36 g/dL, HCT:26.06 %,
MCV:72.97 fL, MCH:23.40 pg, MCHC:32.07 g/dL, RDW:16.60 %,
PLT:380 x 103/uL, MPV:7.04 fL); Medic: As.Pr.MARIAN BOBU
04/02/2015 09:45:44 ALT/GPT (ALT/GPT: U/L, ALT/GPT:9 U/L); Amilaza:61 UI;
AST/GOT:16 U/L; Creatinina.:0.4 mg/dL; Glucoza:100 mg/dL;
Ionograma:lipsa reactiv ; Urea:21 mg/dL; APTT:25.2 s;
Fibrinogen:504 mg/dL; PT-APP-INR (PT:13.3 s, APP:96 %, INR:1.02
); Hemograma (WBC:7.8 x 103/uL, RBC:4.19 x 106/uL, HGB:9.7 g/dL,
HCT:32.3 %, MCV:77.1 fL, MCH:23.1 pg, MCHC:30.0 g/dL,
RDW:17.7 %, PLT:488 x 103/uL, PCT:0.313 %, MPV:6.4 fL,
PDW:15.9 , LY#:0.8 x 103/uL, MO#:0.4 x 103/uL, NE#:6.4 x 103/uL,
EO#:0.2 x 103/uL, BA#:0.0 x 103/uL, LY%:10.7 %, MO%:5.5 %,
NE%:81.8 %, EO%:2.0 %, BA%:0.0 %, Comentariu:Neutrophilia %;
Neutrophilia #; Lymphopenia %; Lymphopenia #; Anemia; 1+
Anisocytosis; 1+ Microcytosis; 2+ Hypochromia; 2+ Poikilocytosis;
Thrombocytosis; Small Platelets; ); Medic: Ch.Pr. CARMEN
BAJENARU
EPICRIZA
PROTOCOL OPERATOR:
RECOMANDARI/REGIM/MEDICATIE
DATA INVESTIGATII
25/01/2016 10:09:30 ALT/GPT:18 mg/dL; Amilaza:39 U/L; AST/GOT:24 U/L; Bilirubina
Directa:0.1 mg/dL; Bilirubina indirecta:0.2 ; Bilirubina totala:0.3
mg/dL; Creatinina.:0.8 mg/dL; Glucoza:80 mg/dL; Ionograma
(Na:140 mmol/L, K:4.03 mmol/L, Cl:99 mmol/L); Urea:26 mg/dL;
APTT.:23.900 s; Fibrinogen.:1080.120 mg/dL; PT-APP-INR.
(PT:14.300 s, INR:1.069 , APP:89.550 %); Hemograma (WBC:8.93 x
103/uL, LYM#:0.58 x 103/uL, LYM:6.50 %, MON#:0.54 x 103/uL,
MON:6.00 %, NEU#:7.45 x 103/uL, NEU:83.40 %, EOS#:0.36 x
103/uL, EOS:4.00 %, BAS#:0.01 x 103/uL, BAS:0.10 %, RBC:2.94 x
106/uL, HGB:8.45 g/dL, HCT:24.93 %, MCV:84.92 fL, MCH:28.78 pg,
MCHC:33.89 g/dL, RDW:11.65 %, PLT:565.91 x 103/uL, MPV:6.91
fL); VSH:100 mm/h; Medic: As.Pr.MARIAN BOBU
19/01/2016 08:51:42 ALT/GPT:11 mg/dL; Amilaza:29 U/L; AST/GOT:21 U/L; Bilirubina
Directa:0.1 mg/dL; Bilirubina indirecta:0.2 ; Bilirubina totala:0.3
mg/dL; Creatinina.:1.2 mg/dL; Glucoza:179 mg/dL; Ionograma
(Na:135 mmol/L, K:4.1 mmol/L, Cl:101 mmol/L); Urea:34 mg/dL;
APTT.:26.600 s; Fibrinogen.:842.736 mg/dL; PT-APP-INR.
(PT:16.500 s, INR:1.262 , APP:76.151 %); Hemograma (WBC:15.2 x
103/uL, RBC:3.71 x 106/uL, HGB:10.6 g/dL, HCT:32.6 %, MCV:87.9
fL, MCH:28.5 pg, MCHC:32.5 g/dL, RDW:15.9 %, PLT:439 x 103/uL,
PCT:0.327 %, MPV:7.4 fL, PDW:16.3 , LY#:0.4 x 103/uL, MO#:0.5 x
103/uL, NE#:14.3 x 103/uL, EO#:0.0 x 103/uL, BA#:0.0 x 103/uL,
LY%:2.8 %, MO%:3.0 %, NE%:94.1 %, EO%:0.1 %, BA%:0.0 %,
Comentariu:Leukocytosis; Neutrophilia %; Neutrophilia #;
Lymphopenia %; Lymphopenia #; Anemia; 1+ Anisocytosis;
Thrombocytosis; ); VSH:90 mm/h; Medic: As.Pr. CRISTINA
PETROVICI
18/01/2016 07:47:34 ALT/GPT:14 mg/dL; Amilaza:63 U/L; AST/GOT:21 U/L; Bilirubina
Directa:0.1 mg/dL; Bilirubina indirecta:0.3 ; Bilirubina totala:0.4
mg/dL; Creatinina.:1.1 mg/dL; Glucoza:92 mg/dL; Ionograma
(Na:138 mmol/L, K:4.6 mmol/L, Cl:104 mmol/L); Urea:34 mg/dL;
APTT.:25.000 s; Fibrinogen:884 mg/dL; PT-APP-INR. (PT:13.800 s,
INR:1.026 , APP:105.407 %); Hemograma (WBC:7.9 x 103/uL,
RBC:3.85 x 106/uL, HGB:11.2 g/dL, HCT:33.6 %, MCV:87.2 fL,
MCH:29.0 pg, MCHC:33.3 g/dL, RDW:16.1 %, PLT:428 x 103/uL,
PCT:0.304 %, MPV:7.1 fL, PDW:16.3 , LY#:0.7 x 103/uL, MO#:0.7 x
103/uL, NE#:6.3 x 103/uL, EO#:0.2 x 103/uL, BA#:0.0 x 103/uL,
LY%:8.5 %, MO%:9.1 %, NE%:80.0 %, EO%:2.3 %, BA%:0.1 %,
Comentariu:Neutrophilia %; Neutrophilia #; Lymphopenia %;
Lymphopenia #; Anemia; 1+ Anisocytosis; Thrombocytosis; Small
Platelets; ); VSH:90 mm/h; Medic: As.Pr. CRISTINA PETROVICI
13/01/2016 14:37:01 TOMOGRAFIA COMPUTERIZATA A ABDOMENULUI SI
PELVISULUI, CU SUBSTANTA DE CONTRAST
INTRAVENOASA (REZULTAT:
Ficat omogen nativ si in timpul portal.In faza arteriala se evidentiaza o
mica zona hiperdensa neomogena segm VII(dispare in faza portala-
aspect de hemangiom).Pancreas,splina,gl suprarenale,rinichi fara
determinari secundare.Colecist alitiazic.
Adenopatie 12 mm in spatiul recto-vezical stang
Colostoma iliaca stanga
Perete ingrosat ano-rectal.
Fara colectii peritoneale
, CTDI (doza medie efectiva):567 mGy x CM, ASISTENT:Tane Adela;
); Medic: DANIEL SIMA
11/01/2016 11:03:35 ALT/GPT:15 mg/dL; Amilaza:72 U/L; AST/GOT:22 U/L; Bilirubina
Directa:0.1 mg/dL; Creatinina.:0.9 mg/dL; Glucoza:86 mg/dL;
Ionograma (Na:143 mmol/L, K:4.4 mmol/L, Cl:102 mmol/L); Urea:31
mg/dL; APTT.:21.900 s; Fibrinogen:958 mg/dL; PT-APP-INR.
(PT:12.500 s, INR:0.915 , APP:129.330 %); Hemograma (WBC:4.5 x
103/uL, RBC:3.98 x 106/uL, HGB:11.6 g/dL, HCT:34.8 %, MCV:87.4
fL, MCH:29.2 pg, MCHC:33.4 g/dL, RDW:18.1 %, PLT:354 x 103/uL,
PCT:0.259 %, MPV:7.3 fL, PDW:16.2 , LY#:1.0 x 103/uL, MO#:0.7 x
103/uL, NE#:2.7 x 103/uL, EO#:0.1 x 103/uL, BA#:0.0 x 103/uL,
LY%:23.2 %, MO%:14.5 %, NE%:59.0 %, EO%:3.3 %, BA%:0.0 %,
Comentariu:Leukopenia; Lymphopenia #; Monocytosis %; Eosinophilia
%; Anemia; 1+ Anisocytosis; Small Platelets; ); VSH:84 mm/h; Medic:
As.Pr. CRISTINA PETROVICI
EPICRIZA
Pacienta in varsta de 77 ani, cunoscuta cu HTA, se prezinta pentru durere localizata la nivelul
hipogastrului, durere si disconfort in timpul defecatiei, materii fecale amestecate cu sange si
mucus, metroragiei, pierdere ponderala, in evolutie de aproximativ 1 luna.
TV: arie vulvo-vaginala de aspect normal, vagin cu perete posterior infiltratat tumoral,
sangeranda la atingere.Col uterin fara formatiuni tumorala palpabile. FSV suple. Anexe
nepalpabile.
TR: la aproximativ 2 cm de O.A se palpeaza formatiune tumorala nestenozanta ulcero-vegetanta,
sangeranda la atingere.
Biologic la internare: vezi anexat.
Radiografie cardio-pulmonara: vezi anexat.
Se intervine chirurgical VCO 1035/ 08.06.2016 si se practica: - Biopsie tumorala rectala. Biopsie
invazie tumorala perete vaginal posterior.
Postoperator evolutie favorabila, pacienta se externeaza cu recomandarile:
PROTOCOL OPERATOR:
RECOMANDARI/REGIM/MEDICATIE
DATA INVESTIGATII
07/06/2016 12:00:42 ALT/GPT:14 U/L; Amilaza:95 UI; AST/GOT:31 U/L;
Creatinina:0.86 mg/dL; Glucoza:101 mg/dL; Ionograma (Na:138.4
mmol/L, K:3.94 mmol/L, Cl:97 mmol/L); Urea:56 mg/dL; APTT:23.1
s; Fibrinogen:523 mg/dL; PT-APP-INR (PT:14.3 s, APP:83 %,
INR:1.10 ); Hemograma (WBC:9.87 x 103/uL, LY#:1.41 x 103/uL,
LY:14.30 %, MO#:1.14 x 103/uL, MO:11.50 %, NE#:6.97 x 103/uL,
NE:70.60 %, EO#:0.28 x 103/uL, EO:2.80 %, BA#:0.08 x 103/uL,
BA:0.80 %, RBC:3.77 x 106/uL, HGB:11.56 g/dL, HCT:34.64 %,
MCV:91.95 fL, MCH:30.70 pg, MCHC:33.38 g/dL, RDW:12.52 %,
PLT:310 x 103/uL, MPV:8.58 fL); Medic: As.Pr. GEORGETA
CORDONEANU
07/06/2016 11:59:57 RADIOGRAFIA TORACO-PULMONARA -FATA (µGray x
m2:1.20 Dozamedie/organ, Asistent:Sirbu Elena Dumitra; ,
REZULTAT:
Fara leziuni acute sau evolutive pleuropulmonare vizibile radiologic.
Fara lichid pleural bilateral.
EPICRIZA
Pacient de 86 de ani, se prezinta pentru tulburari de tranzit intestinal, tenesme rectale, scadere
ponderala importanta, simptomatologie debutata de cateva luni. Se interneaza pentru investigatii
suplimentare si tratament de specialitate.
La internare: stare general mediocra, stabil hemodinamic si respirator, abdomen suplu, mobil cu
respiratia, nedureros spontan si la palpare, fara semne de iritatie peritoneala. TR - la aproximativ
6 cm de orificiul anal formatiune tumorala vegetanta cvasistenozanta.
Biologic atasat biletului de externare.
Ecografie abdominala: ficat neomogen difuz cu multiple imagini sugestive pentru determinari
secundare. Colecist fara calculi. Chist renal stang. Prostata cu dimensiuni crescute. Fara lichid in
peritoneu.
Consult cardiologic: FiA cu AV medie, cu debut incerct. Arimie extrasistolica ventriculara clasa
II A. Neaga durere toracica, dispnee, palpitatii in ultima perioada. Prezinta tuse rara cu
expectoratii seromucoase. Obiectiv: Mv prezent bilateral, SaO2= 95% spontan, zgomote cardiace
neregulate, TA = 120/75 mmHg, fara edeme gambiere, fara sufluri, tolereaza decubit dorsal,
stabil hemodinamic. ECG: FiA, fara modificari de faza terminala. Recomanda: tratament cu
Clexane 0,6 1 f la 12 ore, Metoprolol 50 mg 1/2 x 2/zi. Reevaluare la nevoie.
CT abdominal: ingrosare parietala circumferentiala, stenozanta, iodofila cu diametrul cranio-
caudal de 87 mm, la nivel rectal, parand a se mentine fina lama grasoasa, de delimitare ntre rect
si prostata si veziculele seminale. Procese inlocuitoare de spatiu la nivel hepatic diseminate in
toti lbii, hipodense nativ cu iodofilie inferioara parenchimului adiacet, cea mai mare de 43 de
mm in plan axial la nivelul lobului caudat. Splina omogena pre si postcontrast. Rinichi stang cu
chiste corticale multiple. Multiplii calculi radiodensi infundibulari.
Se intervine chirurgical laparoscopic si se practica colostime stanga terminala si ulterior biopsie
tumorala transanala - rezultat anatomopatologic atasat biletului de externare. Evolutie
postoperatorie favorabila, pacientul se externeaza cu stare generala satisfacatoare, stabil
hemodinamic si respirator, abdomen suplu, mobil cu respiratia, nedureros spontan si la palpare,
fara semne de iritiatie peritoneala. Tranzit intestinal prezent pentru gaze si materii fecale pe
colostoma.
PROTOCOL OPERATOR:
RECOMANDARI/REGIM/MEDICATIE
INVESTIGATII PARACLINICE IN CURSUL INTERNARII
DATA INVESTIGATII
24/06/2014 08:36:44 APTT:35.1 s; Fibrinogen:584 mg/dL; PT-APP-INR (PT:26.3 s,
APP:33 %, INR:2.02 ); Medic: Ch.Pr. CARMEN BAJENARU
21/06/2014 12:06:23 APTT:33.8 s; Fibrinogen:625 mg/dL; PT-APP-INR (PT:16.0 s,
APP:76 %, INR:1.16 ); Hemograma (WBC:6.32 x 103/uL, LY#:1.57 x
103/uL, LY:24.90 %, MO#:0.71 x 103/uL, MO:11.20 %, NE#:3.88 x
103/uL, NE:61.40 %, EO#:0.13 x 103/uL, EO:2.00 %, BA#:0.03 x
103/uL, BA:0.50 %, RBC:3.29 x 106/uL, HGB:9.98 g/dL, HCT:28.94 %,
MCV:88.00 fL, MCH:30.35 pg, MCHC:34.49 g/dL, RDW:14.32 %,
PLT:246 x 103/uL, MPV:8.06 fL); Medic: As.Pr. DANIELA
ALEXANDRU
09/06/2014 13:28:15 ALT/GPT.:28 U/L; Amilaza:53 UI; AST/GOT:45 U/L; Bilirubina
Directa:0.2 mg/dL; Bilirubina indirecta:0.5 ; Bilirubina totala:0.7
mg/dL; Creatinina.:1.1 mg/dL; Fosfataza alcalina.:112 U/L;
Glucoza:87 mg/dL; Ionograma:LIPSA REACTIV ; Urea:48 mg/dL;
APTT:25.5 s; Fibrinogen:859 mg/dL; PT-APP-INR (PT:14.8 s,
APP:89 %, INR:1.06 ); Hemograma (WBC:5.53 x 103/uL, LY#:1.08 x
103/uL, LY:19.60 %, MO#:0.51 x 103/uL, MO:9.30 %, NE#:3.85 x
103/uL, NE:69.60 %, EO#:0.07 x 103/uL, EO:1.20 %, BA#:0.02 x
103/uL, BA:0.30 %, RBC:4.37 x 106/uL, HGB:13.62 g/dL, HCT:39.64
%, MCV:90.78 fL, MCH:31.18 pg, MCHC:34.35 g/dL, RDW:14.50 %,
PLT:251 x 103/uL, MPV:6.91 fL); VSH:>140 mm/h; Medic: As.Pr.
CRISTINA PETROVICI
EPICRIZA
Pacienta in varsta de 73 de ani diagnosticata in alt serviciu medical cu tumora rectosigmoidiana
se interenaza in clinica pentru dureri abdominale difuze, cu caracter colicativ, insotite de scadere
ponderala marcata aporx 30 kg in 2 luni si inapetenta neselectiva.
Consult cardiologic: CICD, Tahiaritmie, Insuficienta mitrala degenerativa, ICC cls II NYHA.
Tratament cu Betaloc zok 50 mg cp 1, Indapamid cp1, Aspirina tamponata 1/4 cp /zi.
EX ginecologic: nu pierde sange pe cale vaginala, nu poate fi examinta pe masa ginecologica,
ETV: uter 5,3/2,5 cm omogen, ovarele nu se vizualizeaza, fara lichid in peritoneu.
Consult urologic: UHN dreapta grd I si UHN stg gr III, vezica urinara fara modificari, se
monteaza sonde JJ bilateral 6Ch.
Se intervine chirurgical in data de 08.03.2012 practicandu-se enteroenteroanastomoza
laterolaterala, colostomie terminala pretumorala sigmoidiana, biopsie ganglionara.
Postoperator prezinta evolutie lent favorabila local, prezentand evisceratie fixata in ziua 4
postoperator; se practica toaleta si pansament zilnic, se practica sutura secundara. De asemenea
prezinta fistula enterocutanata exteriorizata prin bresa parietala de la nivelul fostului tub de dren
al spatiului Douglas.
Se externeaza cu stare generala buna, afebrila, abdomen suplu, nedureros, toleranta digestiva
buna, tranzit intestinal reluat.
PROTOCOL OPERATOR:
RECOMANDARI/REGIM/MEDICATIE
DATA INVESTIGATII
21/03/2012 08:30:47 Albumina:1.9 g/dL; ALP:300 UI; ALT/GPT.:38 U/L; Amilaza:62
U/L; AST/GOT:57 U/L; Bilirubina Directa.:0.38 mg/dL; Bilirubina
indirecta:0.21 mg/dL; Bilirubina totala.:0.59 mg/dL; Creatinina.:1.0
mg/dL; GGT:70 U/L; Glucoza:119 mg/dL; Ionograma (Na:128
mmol/L, K:3.24 mmol/L, Cl:91 mmol/L, Comentarii:LUCRAT DE
DOUA ORI );
Proteine totale:7.08 g/dL; Trigliceride:69 mg/dL; Urea:39 mg/dL;
APTT:26.4 s; Fibrinogen:791 mg/dL; PT-APP-INR (PT:13.2 s,
APP:85 %, INR:1.10 ); Hemograma (WBC:14.99 x 103/uL, LY#:1.68 x
103/uL, LY:11.20 %, MO#:1.18 x 103/uL, MO:7.90 %, NE#:11.90 x
103/uL, NE:79.40 %, EO#:0.16 x 103/uL, EO:1.10 %, BA#:0.06 x
103/uL, BA:0.40 %, RBC:4.00 x 106/uL, HGB:10.27 g/dL, HCT:32.40
%, MCV:80.99 fL, MCH:25.67 pg, MCHC:31.70 g/dL, RDW:18.56 %,
PLT:605 x 103/uL, MPV:7.94 fL); VSH:60 mm/h; Medic: As.Pr.
ILEANA DOBRE
12/03/2012 08:24:15 Hemograma (WBC:11.0 x 103/uL, RBC:3.99 x 106/uL, HGB:10.9 g/dL,
HCT:31.9 %, MCV:79.9 fL, MCH:27.3 pg, MCHC:34.2 g/dL,
RDW:19.4 %, PLT:186 x 103/uL, PCT:0.146 %, MPV:7.9 fL,
PDW:18.8 , LY#:2.3 x 103/uL, MO#:0.2 x 103/uL, NE#:8.3 x 103/uL,
EO#:0.2 x 103/uL, BA#:0.0 x 103/uL, LY%:21.1 %, MO%:1.8 %,
NE%:75.5 %, EO%:1.6 %, BA%:0.0 %, Comentariu:Leukocytosis;
Neutrophilia %; Neutrophilia #; Anemia; 2+ Anisocytosis; 1+
Microcytosis; ); Medic: Dr. DOINA ILIANA BOGDANESCU
05/03/2012 20:04:04 Hemograma (WBC:8.48 x 103/uL, RBC:4.01 x 106/uL, HGB:9.76 g/dL,
HCT:31.68 %, MCV:79.07 fL, MCH:24.35 pg, MCHC:30.80 g/dL,
RDW:18.14 %, PLT:469 x 103/uL, MPV:7.94 fL); Medic: As.Pr.
ADRIANA NEDELCU
05/03/2012 14:37:00 Acid uric:2.8 mg/dL; Albumina:2.4 g/dL; ALP:APARAT DEFECT ;
ALT/GPT.:22 U/L; Amilaza:39 U/L; AST/GOT:22 U/L; Bilirubina
Directa.:0.10 mg/dL; Bilirubina indirecta:0.00 mg/dL; Bilirubina
totala.:0.10 mg/dL; Colesterol:121 mg/dL; Creatinina.:1.0 mg/dL;
GGT:14 U/L; Glucoza:85 mg/dL; HDL-Colesterol:44 mg/dL;
Ionograma (Na:140 mmol/L, K:3.51 mmol/L, Cl:98.4 mmol/L);
LDH:240 U/L; LDL-Colesterol:60.6 mg/dL; Lipide Totale:444.25
mg/dL; Proteine totale:APARAT DEFECT ; RISK:2.8 ;
Trigliceride:82 mg/dL; Urea:36 mg/dL; APTT:30.8 s; Fibrinogen:452
mg/dL; PT-APP-INR (PT:13.0 s, APP:92 %, INR:1.04 );
Hemograma:COAGULATA.REPETA RECOLTAREA! ; VSH:78
mm/h; Medic: As.Pr. CRISTINA FLIPACHE
EPICRIZA
Pacient in varsta de 74 de ani, se prezinta la spital pentru dureri abdominale difuze,
predominant in etajul abdominal inferior. Se interneaza pentru investigatii suplimentare si
tratament de specialitate. Pacient diagnosticat in urma cu 2 ani cu adenocarcinom rectal,
radiotratat, pentru care s-a practicat in urma cu 2 luni colostomie in continuitate in alt serviciu
medical si ulterior in 22.06.2015 cistostomie. Pacient cu infarct miocardic anterior sechelar,
BRS, dublu by-pass venos aorto-coronarian (2006), cunoscut cu fibroza pulmonara si HTP
severa.
Examen clinic - pacient subponderal, tegument si mucoase palide, deshidratate,
TA=130/80mmHg, SaO2=98% spontan, abdomen suplu, mobil cu respiratia, dureros difuz
spontan si la palpare, fara semne de iritatie peritoneala. TR- arie perianala de aspect normal,
sfincter anal normoton, ampula rectala cu o formatiune tumorala la ~8cm de orificiul anal.
Biologic - anexat biletului de externare.
Se intervine chirurgical in data de 26.06.2015. La nivelul pelvisului, vezica urinara si rect de
aspct normal. Se diseca si se patrunde in spatiul pelvisubperitoneal de unde se evacueaza ~300ml
puroi galben cremos din care se recolteaza si se trimite la examen bacteriologic. Dublu drenaj al
cavitatii abcesului. La nivelul ficatului, 2 determinari secundare segment II, IV.
Evolutie postoperatorie initial favorabila, abdomen suplu, mobil cu respiratia, nedureros spontan
si la palpare, fara semne de iritatie peritoneala, tranzit intestinal prezent pentru gaze si materii
fecale pe colostoma; cistostoma functionala; drenaj peritoneal - aspect tulbure, diminua
progresiv.
CT abdominopelvin – atasat biletului de externare.
Se instituie tratament antisecretor, antibiotic, antialgic si medicatiei cardiovasculare de fond a
pacientului.
Se externeaza cu stare generala buna, afebril, abdomen suplu, mobil cu respiratia, fara semne de
iritatie peritoneala, supuratie in 1/3 inf a plagii postoperatorii, tranzit intestinal prezent pe
colostoma, toleranta digestiva buna, cistostoma functionala.
PROTOCOL OPERATOR:
RECOMANDARI/REGIM/MEDICATIE
DATA INVESTIGATII
09/07/2015 05:44:08 ALT/GPT:32 U/L; Amilaza:15 UI; AST/GOT:25 U/L; Bilirubina
Directa:0.43 mg/dL; Bilirubina indirecta:0.67 ; Bilirubina totala:1.1
mg/dL; Creatinina.:0.6 mg/dL; Glucoza:97 mg/dL; Ionograma
(Na:128.7 mmol/L, K:4.55 mmol/L, Cl:94.7 mmol/L); Proteine
totale:4.87 g/dL; Urea:30 mg/dL; APTT:33.8 s;
Fibrinogen:Fibrinogenul derivat nu poate fi calculat de aparat. ; PT-
APP-INR (PT:17.1 s, APP:65 %, Comentarii:INR=1,27 ); Hemograma
(WBC:6.65 x 103/uL, LY#:1.16 x 103/uL, LY:17.50 %, MO#:0.60 x
103/uL, MO:9.00 %, NE#:4.73 x 103/uL, NE:71.10 %, EO#:0.13 x
103/uL, EO:1.90 %, BA#:0.03 x 103/uL, BA:0.50 %, RBC:3.60 x
106/uL, HGB:10.38 g/dL, HCT:32.12 %, MCV:89.27 fL, MCH:28.85
pg, MCHC:32.32 g/dL, RDW:15.54 %, PLT:275 x 103/uL, MPV:7.17
fL); VSH:96 mm/h; Medic: As.Pr. SILVIA CONSTANTIN
08/07/2015 21:38:38 TOMOGRAFIA COMPUTERIZATA A ABDOMENULUI SI
PELVISULUI, CU SUBSTANTA DE CONTRAST
INTRAVENOASA (REZULTAT:
CT ABDOMINO-PELVIN nativ, contrast i.v.
Ex. CT evidentiaza:
- multiple leziuni hepatice, difuz diseminate in ambii lobi (aprox. 10), cu
diametrul de la cativa mm. la 2,5 cm., hipodense nativ, hipocaptante,
imprecis delimitate (det. sec. hepatice)
- leziune chistica, la nivelul polului inferior splenic, cu densitate fluida,
septata, cu dimensiuni de 18/24 mm., neiodofila
- ingrosare parietala la nivelul peretelui postero-lateral dr. al vezicii
urinare, cu grosimea max. de aproximativ 1 cm., pe o distanta de
aproximativ 3 cm., net delimitate, usor polilobata (se va urmari
imagistic); adenom de prostata cu amprentarea vezicii urinare;
- usoara ingrosare parietala rectala; fara modificari infiltrative in
grasimea pelvina
- adenom suprarenalian stg. (14/18 mm.)
- pleurezie postero-bazala bilaterala (2,5-3 cm.)
- doi calculi veziculari (infundibulari) cu diametrul de 7-8 mm.
- acumulare fluida subtegumentara, pe linia alba, cu dimensiuni de 13/23
mm.
EPICRIZA
Pacient in varsta de 74 de ani, internat initial in clinica pe data de 25.06.2015 pentru dureri
abdominale difuze, predominant in etajul abdominal inferior. . Pacient diagnosticat in urma cu 2
ani cu adenocarcinom rectal, radiotratat, pentru care s-a practicat in urma cu 2 luni colostomie in
continuitate in alt serviciu medical si ulterior in 22.06.2015 cistostomie. Pacient cu infarct
miocardic anterior sechelar, BRS, dublu by-pass venos aorto-coronarian (2006), cunoscut cu
fibroza pulmonara si HTP severa.
Se intervine chirurgical in data de 26.06.2015. La nivelul pelvisului, vezica urinara si rect de
aspct normal. Se diseca si se patrunde in spatiul pelvisubperitoneal de unde se evacueaza ~300ml
puroi galben cremos din care se recolteaza si se trimite la examen bacteriologic. Dublu drenaj al
cavitatii abcesului. La nivelul ficatului, 2 determinari secundare segment II, IV.
Se prezinta cu supuratie la nivelul plagii postoperatorii.
Examen clinic - pacient subponderal, tegument si mucoase palide, deshidratate,
TA=130/80mmHg, SaO2=98% spontan, abdomen suplu, mobil cu respiratia, dureros difuz
spontan si la palpare, fara semne de iritatie peritoneala, supuratie 1/3 inf plaga postoperatorie.
TR- arie perianala de aspect normal, sfincter anal normoton, ampula rectala cu o formatiune
tumorala la ~8cm de orificiul anal.
Biologic - anexat biletului de externare.
Se practica toaleta, pansament.
Pe parcursul internarii pacientul acuza dureri epigastrice.
Se efectueaza EDS – resturi alimentare si secretii in esofag, esofag normal, stomac normal, bulb
ulcer de 7mm pe fata anterioara, baza necrotica, edem in jur. DII normal.
Se instituie tratament antisecretor asociat tratamentului antibiotic, antialgic si medicatiei
cardiovasculare de fond a pacientului.
Ulterior, in pofida tratamentului complex de reechilibrare hemohidroelectrolitica si acidobazica,
evolutie lent nefavorabila, cu alterarea progresiva a starii generale.
Pacientul solicita externarea la cerere, contrar avizului medical, cu asumarea intregii
responsabilitati, inclusiv a riscului de deces, sub semnatura in FOCG. Se externeaza cu stare
generala alterata, hipotensiv, dispneic, tegumente si mucoase paalide, deshidratate, afebril,
abdomen suplu, mobil cu respiratia, fara semne de iritatie peritoneala, supuratie in 1/3 inf a plagii
postoperatorii, tranzit intestinal prezent pe colostoma, toleranta digestiva buna; cistostoma
nefunctionala.
PROTOCOL OPERATOR:
RECOMANDARI/REGIM/MEDICATIE
DATA INVESTIGATII
22/07/2015 08:41:28 ALT/GPT:75 U/L; Amilaza:14 U/L; AST/GOT:61 U/L; Bilirubina
Directa:0.6 mg/dL; Bilirubina indirecta:0.3 ; Bilirubina totala:0.9
mg/dL; Creatinina.:0.9 mg/dL; Glucoza:142 mg/dL; Ionograma
(Na:134 mmol/L, K:4.21 mmol/L, Cl:102 mmol/L); Urea:59 mg/dL;
APTT:35.3 s; Fibrinogen:701 mg/dL; PT-APP-INR (PT:18.3 s,
APP:53 %, INR:1.46 ); Hemograma (WBC:12.3 x 103/uL, RBC:3.65 x
106/uL, HGB:10.9 g/dL, HCT:33.9 %, MCV:92.8 fL, MCH:29.9 pg,
MCHC:32.2 g/dL, RDW:18.9 %, PLT:153 x 103/uL, PCT:0.125 %,
MPV:8.1 fL, PDW:17.6 , LY#:1.6 x 103/uL, MO#:0.4 x 103/uL,
NE#:10.3 x 103/uL, EO#:0.0 x 103/uL, BA#:0.0 x 103/uL, LY%:12.7 %,
MO%:3.5 %, NE%:83.6 %, EO%:0.2 %, BA%:0.0 %,
Comentariu:Leukocytosis; Neutrophilia %; Neutrophilia #;
Lymphopenia %; Anemia; 2+ Anisocytosis; ); VSH:40 mm/h; Medic:
As.Pr.MARIAN BOBU
20/07/2015 09:13:59 RADIOGRAFIA TORACO-PULMONARA -FATA
(REZULTAT:Interstitiul pulmonary moderat accentuat perihilar
bilateral.
Cord operat marit in diametrul transversal. , Asistent:Negria Floarea
Argentina; ); Medic: RADU ROMULUS ALEXANDRESCU
19/07/2015 05:44:44 ALT/GPT:100 U/L;
Amilaza:11 UI; AST/GOT:196 U/L; Bilirubina Directa:1.36 mg/dL;
Bilirubina indirecta:0.95 ; Bilirubina totala:2.31 mg/dL;
Creatinina:0.85 mg/dL; Glucoza:113 mg/dL; Ionograma (Na:129
mmol/L, K:4.09 mmol/L, Cl:101.8 mmol/L); Urea:85 mg/dL;
APTT:34.4 s; Fibrinogen:688 mg/dL; PT-APP-INR (PT:23.4 s,
APP:39 %, INR:1.81 ); Hemograma (WBC:16.65 x 103/uL, LY#:0.83 x
103/uL, LY:5.00 %, MO#:0.67 x 103/uL, MO:4.00 %, NE#:14.89 x
103/uL, NE:89.40 %, EO#:0.18 x 103/uL, EO:1.10 %, BA#:0.08 x
103/uL, BA:0.50 %, RBC:3.40 x 106/uL, HGB:9.89 g/dL, HCT:30.94 %,
MCV:91.04 fL, MCH:29.10 pg, MCHC:31.96 g/dL, RDW:16.22 %,
PLT:154 x 103/uL, MPV:7.94 fL); VSH:28 mm/h; Medic: As.Pr.
SILVIA CONSTANTIN
18/07/2015 13:03:47 Ionograma (Na:127 mmol/L, K:4.69 mmol/L, Cl:98 mmol/L);
APTT:36.1 s; Fibrinogen:636 mg/dL; PT-APP-INR (PT:26.3 s,
APP:33 %, INR:2.06 ); Hemograma (WBC:21.72 x 103/uL, LY#:1.13 x
103/uL, LY:5.20 %, MO#:0.96 x 103/uL, MO:4.40 %, NE#:19.24 x
103/uL, NE:88.60 %, EO#:0.28 x 103/uL, EO:1.30 %, BA#:0.11 x
103/uL, BA:0.50 %, RBC:3.29 x 106/uL, HGB:9.28 g/dL, HCT:29.51 %,
MCV:89.61 fL, MCH:28.19 pg, MCHC:31.46 g/dL, RDW:16.59 %,
PLT:216 x 103/uL, MPV:7.94 fL); Medic: As.Pr. DANIELA
ALEXANDRU
17/07/2015 10:39:39 ALT/GPT:39 U/L; Amilaza:13 U/L; AST/GOT:75 U/L; Bilirubina
Directa:0.3 mg/dL;
Bilirubina totala:1.3 mg/dL; Creatinina.:0.5 mg/dL; Glucoza:124
mg/dL; Ionograma (Na:125 mmol/L, K:5.93 mmol/L, Cl:95 mmol/L);
Urea:57 mg/dL; APTT:28.4 s; Fibrinogen:712 mg/dL; PT-APP-INR
(PT:18.1 s, APP:54 %, INR:1.45 ); Hemograma (WBC:22.5 x 103/uL,
RBC:3.53 x 106/uL, HGB:10.5 g/dL, HCT:32.7 %, MCV:92.7 fL,
MCH:29.7 pg, MCHC:32.0 g/dL, RDW:17.5 %, PLT:260 x 103/uL,
PCT:0.189 %, MPV:7.3 fL, PDW:17.6 , LY#:1.2 x 103/uL, MO#:0.9 x
103/uL, NE#:20.4 x 103/uL, EO#:0.0 x 103/uL, BA#:0.0 x 103/uL,
LY%:5.2 %, MO%:4.2 %, NE%:90.5 %, EO%:0.1 %, BA%:0.0 %,
Comentariu:Leukocytosis; Neutrophilia %; Neutrophilia #;
Lymphopenia %; Lymphopenia #; Monocytosis #; Anemia; 1+
Anisocytosis; Small Platelets; );
Medic: B.Pr. IRINA CIUREL
EPICRIZA
PROTOCOL OPERATOR:
RECOMANDARI/REGIM/MEDICATIE
DATA INVESTIGATII
27/08/2012 11:39:05 ALT/GPT.:26 U/L; Amilaza:66 U/L; AST/GOT:12 U/L;
Creatinina.:0.6 mg/dL; Glucoza:95 mg/dL; Ionograma (Na:142
mmol/L, K:4.51 mmol/L, Cl:100 mmol/L); Urea:23 mg/dL; APTT:27.8
s; Fibrinogen:660 mg/dL; PT-APP-INR (PT:12.4 s, APP:105 %,
INR:0.97 ); Hemograma (WBC:6.70 x 103/uL, RBC:4.06 x 106/uL,
HGB:10.20 g/dL, HCT:30.87 %, MCV:76.10 fL, MCH:25.16 pg,
MCHC:33.06 g/dL, RDW:21.58 %, PLT:427 x 103/uL, MPV:7.68 fL);
VSH:120 mm/h; Medic: B.Pr. IRINA CIUREL
EPICRIZA
Pacient in varsta de 64 de ani, se prezinta pentru disurie, dificultati la urinat, polakiurie, edeme la
nivelul membrelor inferioare, dureri abdoinale in etajul abdominal inferior, debutate in urma cu 3
saptamani.
La internare paceint stabil, afebril, abdomen suplu, mobil cu respiratia, dureros spontan si la
palpare in etajul abdominal inferior, fara semne de iritatie peritoneala, membre inferioare marite
de volum, edematiate, edem penoscrotal, eliminare de urina pe cale anala. Bioumoral: atasat.
Ecografia abdominala: ficat de dimensiuni crescute, ecogenitate crescuta, fara procese expansive.
Minima dilatatie pielocaliceala la nivelul rinichiului stang. Ascita. In rest in limite normale.
Examenul CT: vezi atasat.
Colonoscopia deceleaza: Formatiune rectala la jonctiunea recto-sigmoidiana ulcero-vegetanta,
circumferentiala, stenozanta, sangeranda din care se practica biopsie.
In data de 10.02.2016 se intervine chirurgical, interaoprator fiind decelata ascita, formatiune
tumorala rectala superioara ulcerovegetanta, stenozanta, sangeranda, invadanta in vezica urinara,
prostata si vasele iliace pentru care se practica colostomie terminala la nivelul sigmoidului,
evacuarea lichidului de ascita. Drenaj peritoneal.
Evolutie postoperatorie favorabila cu regresia edemului pensoscrotal si al memebrelor inferioare.
Rezultatul biopsiei deceleaza adenocarcinom moderat diferentiat. Rezultat histopatologic atasat.
Pacientul se externeaza cu stare generala buna, abdoemn suplu, mobil cu respiratia, nedureros
spontan si la palpare, fara semne de iritatie peritoneala, colostoma functionala.
PROTOCOL OPERATOR:
RECOMANDARI/REGIM/MEDICATIE
DATA INVESTIGATII
10/02/2017 10:06:51 CULTURA AEROBA LICHID PUNCTIE CU ANTIBIOGRAMA
(COMENTARII:LICHID PERITONEAL-13.02.2017 Nu s-au dezvoltat
germeni dupa 72 ore de incubare;cultura in curs de observatie pana in
15.02.2017 , GERMENI:15.02.2017.Nu s-au dezvoltat germeni dupa 5
zile de incubare ); Medic: Dr. MIRELA CONSTANTIN
07/02/2017 15:01:16 RADIOGRAFIA TORACO-PULMONARA -FATA:48.1
Dozamedie/organ; RADIOGRAFIA ABDOMENULUI:69.2 µGym2;
07/02/2017 13:59:02 Creatinina:0.77 mg/dL; Glucoza:118 mg/dL; Ionograma (Na:138
mmol/L, K:4.08 mmol/L, Cl:107 mmol/L); Urea:34 mg/dL; APTT:21.5
s; Fibrinogen:452 mg/dL; PT-APP-INR (PT:15.0 s, APP:81 %,
INR:1.14 ); Hemograma (WBC:6.77 x 103/uL, LY#:1.50 x 103/uL,
LY:22.20 %, MO#:0.75 x 103/uL, MO:11.10 %, NE#:4.35 x 103/uL,
NE:64.20 %, EO#:0.14 x 103/uL, EO:2.10 %, BA#:0.03 x 103/uL,
BA:0.40 %, RBC:3.50 x 106/uL, HGB:9.95 g/dL, HCT:29.35 %,
MCV:83.90 fL, MCH:28.45 pg, MCHC:33.91 g/dL, RDW:13.76 %,
PLT:273 x 103/uL, MPV:7.17 fL); VSH:40 mm/h; Medic: As.Pr.
CRISTINA PETROVICI
EPICRIZA
Pacienta de 65 ani fara antecedente chirurgicale se prezinta pentru aparitia in urma cu
aproximativ 6 luni a unei formatiuni tumorale in 1/3 inferioara a vaginului si regiunea perianala
cu fistula recto-vaginala singerinda spontan si la palpare. Se interneaza pentru completarea
investigatiilor si tratament.
Biologic pe parcursul internarii atasat.
Examenul CT evidentiaza ingrosare parietala la nivelul ampulei rectale cu fistula recto-vaginala;
adenom suprarenalian drept de 1,5 cm ; restul examinarii in limite normale.
Se decide si se practica biopsie tumorala care se trimite la examen anatomo-patologic care
evidentiaza caractere de adenocarcimnom moderat diferentiat ce asociaza zone de necroza; si
care are origine rectala.
Se practica colostoma stinga maturata primar si se indruma catre serviciul de oncologie in
vederea efectuarii radioterapiei.
PROTOCOL OPERATOR:
RECOMANDARI/REGIM/MEDICATIE
DATA INVESTIGATII
01/05/2012 09:52:28 Hemograma (WBC:10.3 x 103/uL, RBC:3.54 x 106/uL, HGB:8.1 g/dL,
HCT:24.7 %, MCV:69.8 fL, MCH:22.8 pg, MCHC:32.7 g/dL,
RDW:20.5 %, PLT:344 x 103/uL, PCT:0.297 %, MPV:8.7 fL,
PDW:16.0 , LY#:2.0 x 103/uL, MO#:0.2 x 103/uL, NE#:7.9 x 103/uL,
EO#:0.2 x 103/uL, BA#:0.0 x 103/uL, LY%:19.0 %, MO%:2.4 %,
NE%:76.8 %, EO%:1.8 %, BA%:0.0 %, Comentariu:Neutrophilia %;
Neutrophilia #; Lymphopenia %; Anemia; 2+ Anisocytosis; 3+
Microcytosis; 3+ Hypochromia; 3+ Poikilocytosis; ); Medic: Ch.Pr.
CARMEN BAJENARU
26/04/2012 11:27:36 ALT/GPT.:29 U/L; Amilaza:41 U/L; AST/GOT:15 U/L; Bilirubina
Directa.:0.15 mg/dL; Bilirubina indirecta:0.20 mg/dL; Bilirubina
totala.:0.35 mg/dL; Creatinina.:0.9 mg/dL; GGT:21 U/L; Glucoza:98
mg/dL; Ionograma (Na:139 mmol/L, K:5.09 mmol/L, Cl:101 mmol/L);
Urea:28 mg/dL; APTT:22.8 s; Fibrinogen:594 mg/dL; PT-APP-INR
(PT:11.5 s, APP:134 %, INR:0.88 ); Hemograma (WBC:9.8 x 103/uL,
RBC:3.61 x 106/uL, HGB:7.6 g/dL, HCT:23.9 %, MCV:66.2 fL,
MCH:21.1 pg, MCHC:31.8 g/dL, RDW:16.7 %, PLT:483 x 103/uL,
PCT:0.417 %, MPV:8.6 fL, PDW:16.3 , LY#:3.0 x 103/uL, MO#:0.4 x
103/uL, NE#:6.4 x 103/uL, EO#:0.0 x 103/uL, BA#:0.0 x 103/uL,
LY%:30.2 %, MO%:4.3 %, NE%:65.0 %, EO%:0.5 %, BA%:0.0 %,
Comentariu:Neutrophilia #; Lymphocytosis #; Anemia; 1+
Anisocytosis; 3+ Microcytosis; 3+ Hypochromia; 3+ Poikilocytosis;
Thrombocytosis; ); Medic: As.Pr. ANISOARA FURTUNA
PROTOCOL OPERATOR:
RECOMANDARI/REGIM/MEDICATIE
DATA INVESTIGATII
13/08/2012 13:18:01 ALT/GPT:8 U/L; AST/GOT:19 U/L; Creatinina:1.01 mg/dL; Fier:12
µg/dL; Glucoza:306 mg/dL; Ionograma (Na:136 mmol/L, K:2.56
mmol/L, Cl:100 mmol/L); Urea:23 mg/dL; APTT:23.9 s;
Fibrinogen:464 mg/dL; PT-APP-INR (PT:11.4 s, APP:123 %,
INR:0.89 ); Hemograma (WBC:7.44 x 103/uL, RBC:2.80 x 106/uL,
HGB:7.98 g/dL, HCT:23.89 %, MCV:85.24 fL, MCH:28.49 pg,
MCHC:33.42 g/dL, RDW:14.71 %, PLT:141 x 103/uL, MPV:8.83 fL);
VSH:60 mm/h; Medic: As.Pr. DANIELA ALEXANDRU
10/08/2012 23:24:53 ALP:56 UI; ALT/GPT:12 U/L; Amilaza:29 UI; AST/GOT:19 U/L;
Bilirubina totala:1.86 mg/dL; CK:109 UI; Creatinina:0.73 mg/dL;
GGT:20 U/L; Glucoza:266 mg/dL; Ionograma (Na:146 mmol/L,
K:3.04 mmol/L, Cl:107 mmol/L); Proteine totale:5.77 g/dL; Urea:28
mg/dL; APTT:27.0 s; Fibrinogen:248 mg/dL; PT-APP-INR (PT:11.4
s, APP:123 %, INR:0.89 ); Hemograma (WBC:5.97 x 103/uL,
RBC:2.58 x 106/uL, HGB:7.22 g/dL, HCT:21.60 %, MCV:83.84 fL,
MCH:28.00 pg, MCHC:33.40 g/dL, RDW:14.80 %, PLT:139 x 103/uL,
MPV:8.06 fL); Medic: As.Pr. DANIELA ALEXANDRU
02/08/2012 11:49:57 ALT/GPT.:30 U/L; Amilaza:39 U/L; AST/GOT:20 U/L;
Bilirubina totala:0.3 mg/dL; Creatinina.:0.8 mg/dL; GGT:33 U/L;
Glucoza:107 mg/dL; Ionograma (Na:143 mmol/L, K:5.17 mmol/L,
Cl:103 mmol/L); Proteine totale:8.13 g/dL; Trigliceride:89 mg/dL;
Urea:20 mg/dL; APTT:19.5 s; Fibrinogen:531 mg/dL; PT-APP-INR
(PT:11.6 s, APP:118 %, INR:0.91 ); Hemograma (WBC:7.04 x 103/uL,
RBC:4.15 x 106/uL, HGB:10.55 g/dL, HCT:32.93 %, MCV:79.28 fL,
MCH:25.40 pg, MCHC:32.03 g/dL, RDW:15.63 %, PLT:364 x 103/uL,
MPV:7.30 fL); Medic: B.Pr. IRIN
CNP 2570713400502
EPICRIZA
PROTOCOL OPERATOR:
RECOMANDARI/REGIM/MEDICATIE
DATA INVESTIGATII
21/09/2013 09:11:35 Albumina:3.4 g/dL; ALT/GPT:23 U/L; Amilaza:46 UI; AST/GOT:16
U/L; Bilirubina Directa:0.19 mg/dL; Bilirubina indirecta:0.7 ;
Bilirubina totala:0.89 mg/dL; Creatinina:0.76 mg/dL; GGT:188 U/L;
Glucoza:104 mg/dL; Ionograma (Na:140.5 mmol/L, K:3.84 mmol/L,
Cl:105.5 mmol/L); Proteine totale:6.28 g/dL; Urea:15 mg/dL;
APTT:24.3 s; Fibrinogen:788 mg/dL; PT-APP-INR (PT:14.1 s,
APP:99 %, INR:1.01 ); Hemograma (WBC:6.48 x 103/uL, LY#:1.96 x
103/uL, LY:30.20 %, MO#:0.87 x 103/uL, MO:13.50 %, NE#:3.48 x
103/uL, NE:53.70 %, EO#:0.14 x 103/uL, EO:2.10 %, BA#:0.03 x
103/uL, BA:0.50 %, RBC:4.49 x 106/uL, HGB:12.45 g/dL, HCT:39.61
%, MCV:88.31 fL, MCH:27.76 pg, MCHC:31.44 g/dL, RDW:15.03 %,
PLT:368 x 103/uL, MPV:9.73 fL); VSH:115 mm/h; Medic: As.Pr.
SILVIA CONSTANTIN
15/09/2013 08:07:19 Albumina:2.4 g/dL; ALT/GPT.:40 U/L; AST/GOT:34 U/L;
Bilirubina Directa:1.0 mg/dL;
Bilirubina totala:0.3 mg/dL; Creatinina.:0.7 mg/dL; Glucoza:106
mg/dL; Ionograma (Na:139 mmol/L, K:4.21 mmol/L, Cl:103 mmol/L);
Proteine totale:6.1 g/dL; Urea:18 mg/dL; APTT:24.6 s;
Fibrinogen:709 mg/dL; PT-APP-INR (PT:14.8 s, APP:87 %, INR:1.07
); Hemograma (WBC:7.76 x 103/uL, LY#:1.92 x 103/uL, LY:24.80 %,
MO#:0.98 x 103/uL, MO:12.60 %, NE#:4.66 x 103/uL, NE:60.00 %,
EO#:0.17 x 103/uL, EO:2.20 %, BA#:0.03 x 103/uL, BA:0.40 %,
RBC:4.28 x 106/uL, HGB:12.02 g/dL, HCT:38.00 %, MCV:88.71 fL,
MCH:28.06 pg, MCHC:31.63 g/dL, RDW:16.18 %, PLT:289 x 103/uL,
MPV:10.11 fL); Medic: As.Pr. CRISTINA PETROVICI
12/09/2013 10:16:49 UROCULTURA CU ANTIBIOGRAMA:NEGATIVA ; SUMAR DE
URINA (Densitate:1010 , pH:7 , Glucoza:Negativ ,
Urobilinogen:Normal , Proteine:Negativ , Bilirubina:Negativ ,
Hematii:3+(1.0 mg/dl) , Nitriti:Negativ , Leucocite:Negativ , Corpi
Cetonici:Negativ mg/dL, COMENTARII:PREDOMINA HEMATIILE
DECOLORATE , Epitelii plate:Foarte rare , Leucocite:Foarte rare ,
Hematii:Frecvente , Mucus:Rar , Altele:FOARTE RARA FLORA
MICROBIANA ); Medic: Ch.Pr. CARMEN STOICA
09/09/2013 04:02:39 Albumina:2.2 g/dL; ALT/GPT.:38 U/L; AST/GOT:43 U/L;
Bilirubina Directa:0.2 mg/dL; Bilirubina indirecta:0.30 mg/dL;
Bilirubina totala:0.5 mg/dL; Creatinina.:0.6 mg/dL; Glucoza:205
mg/dL; Ionograma (Na:138.7 mmol/L, K:3.64 mmol/L, Cl:97.4
mmol/L); Proteine totale:5.5 g/dL; Urea:12 mg/dL; APTT:25.0 s;
Fibrinogen:714 mg/dL; PT-APP-INR (PT:14.7 s, APP:89 %, INR:1.05
); Hemograma (WBC:8.58 x 103/uL, LY#:1.94 x 103/uL, LY:22.60 %,
MO#:1.04 x 103/uL, MO:12.10 %, NE#:5.39 x 103/uL, NE:62.80 %,
EO#:0.15 x 103/uL, EO:1.80 %, BA#:0.06 x 103/uL, BA:0.70 %,
RBC:4.14 x 106/uL, HGB:11.81 g/dL, HCT:36.54 %, MCV:88.25 fL,
MCH:28.54 pg, MCHC:32.34 g/dL, RDW:16.07 %, PLT:364 x 103/uL,
MPV:9.34 fL); VSH:55 mm/h; Medic: As.Pr. SILVIA CONSTANTIN
06/09/2013 18:04:28 Albumina:2.4 g/dL; ALT/GPT:10 U/L; Amilaza:20 UI; AST/GOT:9
U/L; Bilirubina Directa:0.12 mg/dL; Bilirubina indirecta:0.21 ;
Bilirubina totala:0.33 mg/dL; Calciu:8.7 mg/dL; CK:100 UI; CK-
MB:18 U/L; Creatinina:0.65 mg/dL; Glucoza:95 mg/dL; Ionograma
(Na:145 mmol/L, K:2.93 mmol/L, Cl:105 mmol/L); LDH:392 UI;
Proteine totale:4.6 g/dL; Urea:39 mg/dL; APTT:25.9 s;
Fibrinogen:934 mg/dL; PT-APP-INR (PT:17.1 s, APP:64 %, INR:1.25
); Hemograma (WBC:7.30 x 103/uL, LY#:1.49 x 103/uL, LY:20.40 %,
MO#:0.84 x 103/uL, MO:11.50 %, NE#:4.86 x 103/uL, NE:66.50 %,
EO#:0.09 x 103/uL, EO:1.30 %, BA#:0.02 x 103/uL, BA:0.30 %,
RBC:3.53 x 106/uL, HGB:9.91 g/dL, HCT:30.57 %, MCV:86.53 fL,
MCH:28.04 pg, MCHC:32.41 g/dL, RDW:15.68 %, PLT:430 x 103/uL,
MPV:9.60 fL); Medic: As.Pr. CRISTINA PETROVICI
05/09/2013 05:00:24 Albumina:2.8 g/dL; ALT/GPT:18 U/L; Amilaza:23 UI; AST/GOT:22
U/L; Bilirubina Directa:0.16 mg/dL; Bilirubina indirecta:0.62 ;
Bilirubina totala:0.78 mg/dL; CK:154 UI; CK-MB:54 U/L;
Creatinina:0.93 mg/dL; Glucoza:147 mg/dL; Ionograma (Na:144
mmol/L, K:3.69 mmol/L, Cl:108 mmol/L); Urea:19 mg/dL; APTT:24.4
s; Fibrinogen:890 mg/dL; PT-APP-INR (PT:19.5 s, APP:50 %,
INR:1.45 ); Hemograma (WBC:8.27 x 103/uL, LY#:1.22 x 103/uL,
LY:14.70 %, MO#:1.85 x 103/uL, MO:22.40 %, NE#:5.09 x 103/uL,
NE:61.50 %, EO#:0.07 x 103/uL, EO:0.80 %, BA#:0.05 x 103/uL,
BA:0.60 %, RBC:4.70 x 106/uL, HGB:13.22 g/dL, HCT:41.71 %,
PLT:462 x 103/uL, MPV:9.47 fL, MCV:88.82 fL, MCH:28.14 pg,
MCHC:31.68 g/dL, RDW:17.09 %); Medic: As.Pr. ILEANA DOBRE
03/09/2013 06:01:45 Acid uric:4.7 mg/dL; Albumina:2.3 g/dL; ALT/GPT.:43 U/L;
Amilaza:37 U/L; AST/GOT:16 U/L; Bilirubina Directa:0.1 mg/dL;
Bilirubina indirecta:0.00 mg/dL; Bilirubina totala:0.1 mg/dL;
Calciu:8.9 mg/dL; Colesterol:138 mg/dL; Creatinina.:0.7 mg/dL;
Fier:17 µg/dL; Fosfataza alcalina.:85 U/L; GGT:61 U/L; Glucoza:122
mg/dL; Ionograma (Na:143 mmol/L, K:3.36 mmol/L, Cl:102 mmol/L);
LDH:164 U/L; Lipide Totale:500 mg/dL; Magneziu:2.0 mg/dL;
Proteine totale:5.6 g/dL; Trigliceride:106 mg/dL; Urea:18 mg/dL;
APTT:25.8 s; Fibrinogen:FIBRINOGENUL DERIVAT NU POATE FI
CALCULAT DE APARAT. ; PT-APP-INR (PT:16.6 s, APP:68 %,
Comentarii:INR=1,21 ); Hemograma (WBC:11.51 x 103/uL, LY#:1.74
x 103/uL, LY:15.10 %, MO#:1.22 x 103/uL, MO:10.60 %, NE#:8.34 x
103/uL, NE:72.50 %, EO#:0.15 x 103/uL, EO:1.30 %, BA#:0.06 x
103/uL, BA:0.50 %, RBC:3.66 x 106/uL, HGB:10.34 g/dL, HCT:32.56
%, MCV:89.08 fL, MCH:28.28 pg, MCHC:31.75 g/dL, RDW:18.40 %,
PLT:518 x 103/uL, MPV:9.86 fL); VSH:110 mm/h; Medic: As.Pr.
ADRIANA NEDELCU
28/08/2013 07:19:31 Albumina:2.3 g/dL; ALT/GPT.:31 U/L; Amilaza:22 U/L;
AST/GOT:23 U/L; Bilirubina Directa: mg/dL;
Bilirubina totala:0.2 mg/dL; Creatinina.:0.5 mg/dL; Ionograma
(Na:146 mmol/L, K:3.63 mmol/L, Cl:105 mmol/L); Proteine totale:5.5
g/dL; Urea:12 mg/dL; APTT:25.5 s; Fibrinogen:731 mg/dL; PT-APP-
INR (PT:14.6 s, APP:87 %, INR:1.07 ); Hemograma (WBC:7.48 x
103/uL, LY#:1.77 x 103/uL, LY:23.70 %, MO#:0.86 x 103/uL, MO:11.50
%, NE#:4.65 x 103/uL, NE:62.20 %, EO#:0.16 x 103/uL, EO:2.20 %,
BA#:0.03 x 103/uL, BA:0.40 %, RBC:3.35 x 106/uL, HGB:9.38 g/dL,
HCT:29.57 %, MCV:88.16 fL, MCH:27.97 pg, MCHC:31.73 g/dL,
RDW:19.12 %, PLT:276 x 103/uL, MPV:9.47 fL); Medic: Ch.Pr.
CARMEN BAJENARU
24/08/2013 10:24:21 Acid uric:4.66 mg/dL; ALT/GPT:20 U/L; Amilaza:30 UI;
AST/GOT:18 U/L; Bilirubina Directa:0.25 mg/dL; Bilirubina
indirecta:0.54 ; Bilirubina totala:0.79 mg/dL; CK:492 UI; CK-MB:19
U/L; Colesterol:105 mg/dL; Creatinina:0.92 mg/dL; Glucoza:127
mg/dL; Ionograma (Na:147.5 mmol/L, K:3.22 mmol/L, Cl:112
mmol/L); Proteine totale:4.58 g/dL; Urea:29 mg/dL; APTT:30.4 s;
Fibrinogen:523 mg/dL; PT-APP-INR (PT:18.3 s, APP:57 %, INR:1.37
); Hemograma (WBC:9.05 x 103/uL, LY#:1.19 x 103/uL, LY:13.10 %,
MO#:0.68 x 103/uL, MO:7.50 %, NE#:7.10 x 103/uL, NE:78.40 %,
EO#:0.07 x 103/uL, EO:0.80 %, BA#:0.02 x 103/uL, BA:0.20 %,
RBC:3.88 x 106/uL, HGB:11.00 g/dL, HCT:34.37 %, MCV:88.46 fL,
MCH:28.32 pg, MCHC:32.01 g/dL, RDW:18.71 %, PLT:209 x 103/uL,
MPV:10.11 fL); Medic: As.Pr. GEORGETA CORDONEANU
24/08/2013 06:54:41 Acid uric:4.42 mg/dL; Albumina:2.8 g/dL; ALT/GPT:19 U/L;
AST/GOT:21 U/L; Bilirubina Directa:0.3 mg/dL; Bilirubina
indirecta:0.4 ; Bilirubina totala:0.7 mg/dL; CK:556 UI; CK-MB:22
U/L; Creatinina:0.98 mg/dL; GGT:61 U/L; Ionograma (Na:150
mmol/L, K:3.11 mmol/L, Cl:110 mmol/L); Urea:31 mg/dL; APTT:29.9
s; Fibrinogen:472 mg/dL; PT-APP-INR (PT:17.4 s, APP:63 %,
INR:1.29 ); Hemograma (WBC:8.52 x 103/uL, LY#:1.09 x 103/uL,
LY:12.80 %, MO#:0.65 x 103/uL, MO:7.60 %, NE#:6.69 x 103/uL,
NE:78.50 %, EO#:0.07 x 103/uL, EO:0.80 %, BA#:0.03 x 103/uL,
BA:0.30 %, RBC:4.03 x 106/uL, HGB:11.34 g/dL, HCT:35.71 %,
MCV:88.58 fL, MCH:28.12 pg, MCHC:31.74 g/dL, RDW:18.46 %,
PLT:206 x 103/uL, MPV:10.11 fL); Medic: As.Pr. DANIELA
ALEXANDRU
23/08/2013 07:21:08 Hemograma (WBC:6.92 x 103/uL, LY#:3.07 x 103/uL, LY:44.40 %,
MO#:0.85 x 103/uL, MO:12.30 %, NE#:2.78 x 103/uL, NE:40.10 %,
EO#:0.17 x 103/uL, EO:2.40 %, BA#:0.06 x 103/uL, BA:0.80 %,
RBC:4.17 x 106/uL, HGB:11.42 g/dL, HCT:37.98 %, MCV:90.99 fL,
MCH:27.37 pg, MCHC:30.08 g/dL, RDW:19.27 %, PLT:300 x 103/uL,
MPV:9.98 fL); Medic: Dr. DOINA ILIANA BOGDANESCU
21/08/2013 12:45:38 ALT/GPT.:44 U/L; Amilaza:53 U/L; AST/GOT:18 U/L;
Creatinina.:0.6 mg/dL; Glucoza:88 mg/dL; Ionograma (Na:147
mmol/L, K:4.74 mmol/L, Cl:105 mmol/L); Urea:42 mg/dL; APTT:27.9
s; Fibrinogen:405 mg/dL; PT-APP-INR (PT:13.3 s, APP:110 %,
INR:0.96 ); Hemograma (WBC:6.54 x 103/uL, LY#:2.25 x 103/uL,
LY:34.40 %, MO#:0.58 x 103/uL, MO:8.80 %, NE#:3.55 x 103/uL,
NE:54.20 %, EO#:0.14 x 103/uL, EO:2.20 %, BA#:0.03 x 103/uL,
BA:0.40 %, RBC:4.15 x 106/uL, HGB:11.92 g/dL, HCT:37.36 %,
MCV:89.95 fL, MCH:28.69 pg, MCHC:31.89 g/dL, RDW:18.14 %,
PLT:301 x 103/uL, MPV:10.37 fL); Medic: As.Pr. DANIELA
ALEXANDRU
EPICRIZA
Pacient in varsta de 62 de ani, cunoscut cu metastaze osoase cu punct de plecare renal (carcinom
cu celule clare) din septembrie 2016, se transfera de la Spitalul "Sfantul Luca" pentru o
fromatiune anorectala cu invazie locoregionala in vederea prelevarii de material bioptic.
Clinic la internare: Abdomen destins de volum, mobil cu respiratia, nedureros spontan si la
palpare, fara semne de iritatie peritoneala. TR: arie perianala infliltrata tumoral, ulcerata,
sangeranda,, sfincter anal modificat tumoral cu incontinenta pentru materii fecale, canal anal
greu de explorat in care se patrunde cu dificultate datorita infiltrarii tumorale; tumora perianala,
fuzata catre perineu.
Biologic anexat.
Rx toracic anexat.
Rx abdominal anexat.
Ecografie abdominala: ficat de dimensiuni usor crescute, steatozic, aparent omogen; colecist,
pancreas, splina, RD - normal ecografic; RS dimensiuni si contur modificate, prezinta o
formatiune hiperecogena de 30/45 mm dezvoltata postero-superior; fara lichid liber
intraperitoneal.
Se intervine in data de 30.03.2017 si se preleveaza material tisular de la nivelul formatiunii ano-
perineale, ce se trimite la examenul AP.
evolutie postoperatorie favorabla, fara sangerare de la nivelul formatiunii.
Se transfera la Spitalul "Sfantul Luca" in vederea continuarii tratamentului oncologic.
PROTOCOL OPERATOR:
RECOMANDARI/REGIM/MEDICATIE
DATA INVESTIGATII
29/03/2017 12:48:13 ALT/GPT:22 U/L; Amilaza:107 UI; AST/GOT:23 U/L; Bilirubina
Directa:0.1 mg/dL; Bilirubina indirecta:0.10 mg/dL; Bilirubina
totala:0.2 mg/dL; Creatinina:1.06 mg/dL; Glucoza:126 mg/dL;
Ionograma (Na:136 mmol/L, K:4.17 mmol/L, Cl:95 mmol/L); Proteine
totale:6.0 g/dL; Urea:25 mg/dL; APTT:32.4 s; Fibrinogen:967 mg/dL;
PT-APP-INR (PT:15.4 s, APP:79 %, INR:1.14 ); Medic: As.Pr.
CRISTINA PETROVICI
29/03/2017 10:07:36 Creatinina:0.98 mg/dL; Glucoza (Glucoza:192 mg/dL,
Comentarii:SER INTENS HEMOLIZAT, REPETA BIOCHIMIA. );
Ionograma:SER INTENS HEMOLIZAT ; Urea:25 mg/dL;
PT-APP-INR.:COAGULOGRAMA=COAGULATA.REPETA
RECOLTAREA. AUTOMATIC; Hemograma (WBC:5.80 x 103/uL,
LYM#:1.02 x 103/uL, LYM:17.50 %, MON#:0.26 x 103/uL, MON:4.50
%, NEU#:4.39 x 103/uL, NEU:75.70 %, EOS#:0.12 x 103/uL, EOS:2.00
%, BAS#:0.02 x 103/uL, BAS:0.30 %, RBC:3.26 x 106/uL, HGB:8.24
g/dL, HCT:25.13 %, MCV:77.01 fL, MCH:25.26 pg, MCHC:32.80
g/dL, RDW:17.39 %, PLT:420.02 x 103/uL, MPV:8.83 fL); Medic:
B.Pr. IRINA CIUREL
29/03/2017 10:00:40 RADIOGRAFIA TORACO-PULMONARA -FATA:24.4
Dozamedie/organ; RADIOGRAFIA ABDOMENULUI:238.1 µGym2;
Medic: MARIA CRISTINA TOLBARU
EPICRIZA
Pacient in varsta 88 de ani, se interneaza in clinica pentru oprirea tranzitului intestinal
pentru gaze si materii fecale de 4-5 zile.
Examen local – abdomen meteorizat, destins de volum, dureros intens la palpare, fara
semne de iritatie peritoneala. arie perianala de aspect normal, sfincter anal normoton, ampula
rectala goala.
Biologic - anexat biletului de externare.
Ecografie abdominal : ficat omogen, fara cai biliare intrahepatice destinse, pancreas de
dimensiuni normale, omogen, colecist fara calculi, rinichi bilateral de aspect normal. Fara lichid
in peritoneu.
Consult cardiologic - hipertensiune arteriala grad II, fibrilatie atriala, Insuficienta
cardiaca clasa II Nyha. Recomandari - tratament cu Digoxin 1/2 tb /zi cu pauza joi si duminica.
Dupa o minima reevaluare clinico-biologica se decide interventia chirurgicala in urgenta.
Intraoperator- la nivelul anselor intestinale subtiri si organelor parenchimatoase nu se deceleaza
macroscopic leziuni patologice. La nivelul rectului superior formatiune tumorala rectala
superioara invadanta in vezica urinara de 10/12 cm ; stenozanta, circumferentiala, dura la
palpare. Se decide si se practica colostoma , lavaj si drenaj peritoneal.
Postoperator evolutia pacientului este favorabila. Toleranta digestiva buna, tranzit
prezent pentru gaze si materii fecale pe colostoma.
Colonoscopie la 3 saptamani postoperator - se practica biopsie din formatiunea tumorala
rectala superioara.
PROTOCOL OPERATOR:
RECOMANDARI/REGIM/MEDICATIE
-
EPICRIZA
Pacient in varsta de 59 de ani, cunoscut u neoplasm de colon operat pe 14 octombrie
2013(colostoma) se prezinta pentru dureri abdominale difuze, cu debut de ~1 luna.
Clinic la internare: stare generala satisfacatoare, echilibrat respirator si cardiovascular, abdomen
usor meteorizat, dureros difuz spontan si la palpare, fara semne de iritatie peritoneala, TR zona
perianala de aspect normal, sfincter anal hipoton, canal anal cu pereti elastici, ampula rectala
neinfiltrata, materii fecale organizate aspect normal.
Biologic atasat biletului.
Ecografie abdominala - ficat neomogen, fara PLIH, fara CBIH destinse. Fara lichid in peritoneu.
Se administreaza tratament antialgic, antispastic, sange izogrup, izoRh , ulei de parafina - starea
generala a pacientului se amelioreaza.
Se externeaza cu stare generala buna, echilibrata respirator si cardiovascular, abdomen suplu,
mobil cu respiratia, nedureros spontan si la palpare, fara semne de iritatie peritoneala, tranzit
intestinal prezent pentru gaze si materii fecale.
PROTOCOL OPERATOR:
RECOMANDARI/REGIM/MEDICATIE
INVESTIGATII PARACLINICE IN CURSUL INTERNARII
DATA INVESTIGATII
19/02/2014 10:08:38 Albumina:2.5 g/dL; ALP:60 UI; ALT/GPT.:21 U/L; AST/GOT:15
U/L;
Bilirubina totala:0.1 mg/dL; Creatinina.:0.8 mg/dL; Glucoza:159
mg/dL; Ionograma (Na:141 mmol/L, K:4.98 mmol/L, Cl:101 mmol/L);
Proteine totale:6.3 g/dL; Urea:21 mg/dL; APTT:26.0 s;
Fibrinogen:744 mg/dL; PT-APP-INR (PT:15.1 s, APP:83 %, INR:1.10
); Hemograma (WBC:5.0 x 103/uL, RBC:3.78 x 106/uL, HGB:10.4
g/dL, HCT:33.6 %, MCV:88.9 fL, MCH:27.5 pg, MCHC:31.0 g/dL,
RDW:17.6 %, PLT:288 x 103/uL, PCT:0.189 %, MPV:6.6 fL,
PDW:16.1 , LY#:0.8 x 103/uL, MO#:0.4 x 103/uL, NE#:3.7 x 103/uL,
EO#:0.1 x 103/uL, BA#:0.0 x 103/uL, LY%:16.6 %, MO%:8.8 %,
NE%:73.4 %, EO%:1.2 %, BA%:0.0 %, Comentariu:Neutrophilia %;
Lymphopenia %; Lymphopenia #; Anemia; 1+ Anisocytosis; Small
Platelets; ); VSH:120 mm/h; Medic: As.Pr. ELENA CAMELIA
CALITA
18/02/2014 16:01:49 ALT/GPT:9 U/L; Amilaza:34 UI; AST/GOT:11 U/L; Bilirubina
Directa:0.16 mg/dL;
Creatinina:1.01 mg/dL; Glucoza:266 mg/dL; Ionograma (Na:141
mmol/L, K:5.48 mmol/L, Cl:101 mmol/L); Urea:32 mg/dL; APTT:24.6
s; Fibrinogen:868 mg/dL; PT-APP-INR (PT:14.5 s, APP:93 %,
INR:1.04 ); Hemograma (WBC:8.63 x 103/uL, LY#:1.50 x 103/uL,
LY:17.40 %, MO#:0.63 x 103/uL, MO:7.30 %, NE#:6.36 x 103/uL,
NE:73.70 %, EO#:0.09 x 103/uL, EO:1.10 %, BA#:0.04 x 103/uL,
BA:0.50 %, RBC:4.68 x 106/uL, HGB:12.84 g/dL, HCT:39.22 %,
MCV:83.82 fL, MCH:27.44 pg, MCHC:32.74 g/dL, RDW:17.42 %,
PLT:459 x 103/uL, MPV:7.17 fL); VSH:140 mm/h; Medic: As.Pr.
DANIELA ALEXANDRU
EPICRIZA
PROTOCOL OPERATOR:
RECOMANDARI/REGIM/MEDICATIE
EPICRIZA
PROTOCOL OPERATOR:
RECOMANDARI/REGIM/MEDICATIE
PROTOCOL OPERATOR:
RECOMANDARI/REGIM/MEDICATIE
EPICRIZA
Pacient in varsta de 77 de ani, se prezinta la spital pentru durere abdominala importanta cu
scadere ponderala si oprirea tranzitului intestinal pentru gaze si materii fecale debut de ~10 zile.
Examen clinic - pacient supraponderal, tegument si mucoase palide, TA=105/75mmHg,
SaO2=98% spontan, abdomen meteorizat, dureros difuz spontan si la palpare, cu semne de
iritatie peritoneala; TR- arie perianala de aspect normal, sfincter anal normoton, ampula rectala
cu materii fecale de aspect normal.
Ecografie abdominala - meteorism abdominal intens, nu permite vizualizarea prin abord
abdominal. Intercostal drept: ficat omogen, RS fara dilatatii, fara lichid in sp Morrison.
Intercostal stang splina si RS greu vizualizabil.
Biologic anexat biletului de externare
Consult cardiologic - Dg: BCI. FiA. Tratament cu: Digoxin 1/2f/zi; Carvedilol 6.25g (1+1/2)/zi;
Aspenter 75mg 2cp/zi; Sortis 1/zi.
Se decide si se intervine chirurgical de urgenta. Intraperitoneal - anse intestinale destinse, cadru
colic dilatat; lichid serocitrin minim in cavitatea peritoneala din care se recolteaza pentru examen
bacteriologic. La nivelul rectului superior, formatiune tumorala rectala stenozanta, invadanta in
vezica urinara si vasele iliace bilateral. Se practica rezectie rectosigmoidiana, inchiderea
capatului distal cu fire separate si exteriorizarea capatului proximal in colostoma in flancul stang.
Ficat de aspect normal. Nu se evidentiaza macroscopic determinari secundare. Lavaj si drenaj
peritoneal.
Evolutie postoperatorie lent favorabila, cu reluarea tranzitului intestinal pe colostoma, plaga
postoperatorie supla, in curs de vindecare.
Pacientul se externeaza ameliorat din punct de vedere chirurgical, cu abdomen suplu, nedureros,
tranzit intestinal prezent pe colostoma si toleranta digestiva buna.
PROTOCOL OPERATOR:
RECOMANDARI/REGIM/MEDICATIE
-
DATA INVESTIGATII
11/03/2015 10:28:06 ALT/GPT.:25 U/L; Amilaza:31 U/L; AST/GOT:22 U/L;
Bilirubina totala:0.3 mg/dL; Creatinina.:0.9 mg/dL; Glucoza:128
mg/dL; Ionograma (Na:146.4 mmol/L, K:2.78 mmol/L, Cl:98.7
mmol/L); Urea:33 mg/dL; APTT:24.0 s; Fibrinogen:693 mg/dL; PT-
APP-INR (PT:15.8 s, APP:70 %, INR:1.23 ); Hemograma (WBC:5.7 x
103/uL, RBC:4.27 x 106/uL, HGB:11.0 g/dL, HCT:36.6 %, MCV:85.6
fL, MCH:25.7 pg, MCHC:30.1 g/dL, RDW:15.6 %, PLT:236 x 103/uL,
PCT:0.169 %, MPV:7.2 fL, PDW:16.6 , LY#:0.5 x 103/uL, MO#:0.4 x
103/uL, NE#:3.7 x 103/uL, EO#:1.1 x 103/uL, BA#:0.0 x 103/uL,
LY%:9.0 %, MO%:7.8 %, NE%:64.6 %, EO%:18.5 %, BA%:0.1 %,
Comentariu:Lymphopenia %; Lymphopenia #; Eosinophilia %;
Eosinophilia #; 1+ Anisocytosis; 1+ Hypochromia; 1+ Poikilocytosis;
Small Platelets; ); VSH:18 mm/h; Medic: As.Pr.MARIAN BOBU
09/03/2015 05:19:41 ALT/GPT:12 U/L; Amilaza:21 UI; AST/GOT:16 U/L; Bilirubina
Directa:0.53 mg/dL; Bilirubina indirecta:0.80 ; Bilirubina totala:1.33
mg/dL; Creatinina:0.98 mg/dL; Glucoza:183 mg/dL; Urea:34 mg/dL;
APTT:28.1 s; Fibrinogen:534 mg/dL; PT-APP-INR (PT:19.1 s,
APP:51 %, INR:1.53 ); Hemograma (WBC:8.93 x 103/uL, LY#:0.54 x
103/uL, LY:6.10 %, MO#:0.40 x 103/uL, MO:4.50 %, NE#:7.85 x
103/uL, NE:87.90 %, EO#:0.10 x 103/uL, EO:1.10 %, BA#:0.04 x
103/uL, BA:0.40 %, RBC:5.14 x 106/uL, HGB:13.86 g/dL, HCT:42.05
%, MCV:81.87 fL, MCH:26.98 pg, MCHC:32.95 g/dL, RDW:14.24 %,
PLT:240 x 103/uL, MPV:7.55 fL); Medic: As.Pr. GEORGETA
CORDONEANU
08/03/2015 22:31:14 CULTURA AEROBA LICHID PUNCTIE CU ANTIBIOGRAMA
(COMENTARII:10.03.2015.Nu s-au dezvoltat germeni dupa 48 ore de
incubare;cultura in curs de observatie pana in data de13.03.2015 ,
GERMENI:13.03.2015 Nu s-au dezvoltat germeni dupa 5 zile de
incubare ); Medic: Dr. ELENA DORINA BOTEZ
08/03/2015 15:00:54 Creatinina:1.25 mg/dL; Glucoza:89 mg/dL; Ionograma (Na:137
mmol/L, K:3.79 mmol/L, Cl:86 mmol/L); Urea:59 mg/dL; APTT:22.2
s; Fibrinogen:448 mg/dL; PT-APP-INR (PT:17.8 s, APP:57 %,
INR:1.41 ); Hemograma (WBC:14.65 x 103/uL, LY#:1.13 x 103/uL,
LY:7.70 %, MO#:0.85 x 103/uL, MO:5.80 %, NE#:12.45 x 103/uL,
NE:85.00 %, EO#:0.15 x 103/uL, EO:1.00 %, BA#:0.07 x 103/uL,
BA:0.50 %, RBC:5.13 x 106/uL, HGB:13.55 g/dL, HCT:41.49 %,
MCV:80.81 fL, MCH:26.39 pg, MCHC:32.66 g/dL, RDW:13.79 %,
PLT:346 x 103/uL, MPV:7.68 fL); VSH:20 mm/h; Medic: As.Pr.
DANIELA ALEXANDRU
EPICRIZA
Pacient in varsta de 77 de ani, se prezinta la spital pentru durere abdominala importanta cu
scadere ponderala si oprirea tranzitului intestinal pentru gaze si materii fecale debut de ~10 zile.
Examen clinic - pacient supraponderal, tegument si mucoase palide, TA=105/75mmHg,
SaO2=98% spontan, abdomen meteorizat, dureros difuz spontan si la palpare, cu semne de
iritatie peritoneala; TR- arie perianala de aspect normal, sfincter anal normoton, ampula rectala
cu materii fecale de aspect normal.
Ecografie abdominala - meteorism abdominal intens, nu permite vizualizarea prin abord
abdominal. Intercostal drept: ficat omogen, RS fara dilatatii, fara lichid in sp Morrison.
Intercostal stang splina si RS greu vizualizabil.
Biologic anexat biletului de externare
Consult cardiologic - Dg: BCI. FiA. Tratament cu: Digoxin 1/2f/zi; Carvedilol 6.25g (1+1/2)/zi;
Aspenter 75mg 2cp/zi; Sortis 1/zi.
Se decide si se intervine chirurgical de urgenta. Intraperitoneal - anse intestinale destinse, cadru
colic dilatat; lichid serocitrin minim in cavitatea peritoneala din care se recolteaza pentru examen
bacteriologic. La nivelul rectului superior, formatiune tumorala rectala stenozanta, invadanta in
vezica urinara si vasele iliace bilateral. Se practica rezectie rectosigmoidiana, inchiderea
capatului distal cu fire separate si exteriorizarea capatului proximal in colostoma in flancul stang.
Ficat de aspect normal. Nu se evidentiaza macroscopic determinari secundare. Lavaj si drenaj
peritoneal.
Evolutie postoperatorie lent favorabila, cu reluarea tranzitului intestinal pe colostoma, plaga
postoperatorie supla, in curs de vindecare.
Pacientul se externeaza ameliorat din punct de vedere chirurgical, cu abdomen suplu, nedureros,
tranzit intestinal prezent pe colostoma si toleranta digestiva buna.
PROTOCOL OPERATOR:
RECOMANDARI/REGIM/MEDICATIE
DATA INVESTIGATII
11/03/2015 10:28:06 ALT/GPT.:25 U/L; Amilaza:31 U/L; AST/GOT:22 U/L;
Bilirubina totala:0.3 mg/dL; Creatinina.:0.9 mg/dL; Glucoza:128
mg/dL; Ionograma (Na:146.4 mmol/L, K:2.78 mmol/L, Cl:98.7
mmol/L); Urea:33 mg/dL; APTT:24.0 s; Fibrinogen:693 mg/dL; PT-
APP-INR (PT:15.8 s, APP:70 %, INR:1.23 ); Hemograma (WBC:5.7 x
103/uL, RBC:4.27 x 106/uL, HGB:11.0 g/dL, HCT:36.6 %, MCV:85.6
fL, MCH:25.7 pg, MCHC:30.1 g/dL, RDW:15.6 %, PLT:236 x 103/uL,
PCT:0.169 %, MPV:7.2 fL, PDW:16.6 , LY#:0.5 x 103/uL, MO#:0.4 x
103/uL, NE#:3.7 x 103/uL, EO#:1.1 x 103/uL, BA#:0.0 x 103/uL,
LY%:9.0 %, MO%:7.8 %, NE%:64.6 %, EO%:18.5 %, BA%:0.1 %,
Comentariu:Lymphopenia %; Lymphopenia #; Eosinophilia %;
Eosinophilia #; 1+ Anisocytosis; 1+ Hypochromia; 1+ Poikilocytosis;
Small Platelets; ); VSH:18 mm/h; Medic: As.Pr.MARIAN BOBU
09/03/2015 05:19:41 ALT/GPT:12 U/L; Amilaza:21 UI; AST/GOT:16 U/L; Bilirubina
Directa:0.53 mg/dL; Bilirubina indirecta:0.80 ; Bilirubina totala:1.33
mg/dL; Creatinina:0.98 mg/dL; Glucoza:183 mg/dL; Urea:34 mg/dL;
APTT:28.1 s; Fibrinogen:534 mg/dL; PT-APP-INR (PT:19.1 s,
APP:51 %, INR:1.53 ); Hemograma (WBC:8.93 x 103/uL, LY#:0.54 x
103/uL, LY:6.10 %, MO#:0.40 x 103/uL, MO:4.50 %, NE#:7.85 x
103/uL, NE:87.90 %, EO#:0.10 x 103/uL, EO:1.10 %, BA#:0.04 x
103/uL, BA:0.40 %, RBC:5.14 x 106/uL, HGB:13.86 g/dL, HCT:42.05
%, MCV:81.87 fL, MCH:26.98 pg, MCHC:32.95 g/dL, RDW:14.24 %,
PLT:240 x 103/uL, MPV:7.55 fL); Medic: As.Pr. GEORGETA
CORDONEANU
08/03/2015 22:31:14 CULTURA AEROBA LICHID PUNCTIE CU ANTIBIOGRAMA
(COMENTARII:10.03.2015.Nu s-au dezvoltat germeni dupa 48 ore de
incubare;cultura in curs de observatie pana in data de13.03.2015 ,
GERMENI:13.03.2015 Nu s-au dezvoltat germeni dupa 5 zile de
incubare ); Medic: Dr. ELENA DORINA BOTEZ
08/03/2015 15:00:54 Creatinina:1.25 mg/dL; Glucoza:89 mg/dL; Ionograma (Na:137
mmol/L, K:3.79 mmol/L, Cl:86 mmol/L); Urea:59 mg/dL; APTT:22.2
s; Fibrinogen:448 mg/dL; PT-APP-INR (PT:17.8 s, APP:57 %,
INR:1.41 ); Hemograma (WBC:14.65 x 103/uL, LY#:1.13 x 103/uL,
LY:7.70 %, MO#:0.85 x 103/uL, MO:5.80 %, NE#:12.45 x 103/uL,
NE:85.00 %, EO#:0.15 x 103/uL, EO:1.00 %, BA#:0.07 x 103/uL,
BA:0.50 %, RBC:5.13 x 106/uL, HGB:13.55 g/dL, HCT:41.49 %,
MCV:80.81 fL, MCH:26.39 pg, MCHC:32.66 g/dL, RDW:13.79 %,
PLT:346 x 103/uL, MPV:7.68 fL); VSH:20 mm/h; Medic: As.Pr.
DANIELA ALEXANDRU
EPICRIZA
Pacient in varsta de 59 de ani, diagosticat cu neoplasm anorectal infiltrativ (ADK), pentru care s-
a practicat in data de 18.01.2016,enterectomie segmentara cu rezectie segment ileal, cu
ileoileoanastomoza T-T cu fire separate, amputtie de rect cu mare dificultate din pricina unei
invazii nivel anterior in vezica urinara si prostata, drenaj pelvin, mesaj perineal se prezinta pentru
aparitia a doua formatiuni tumorale la nivel pelvin, una la nivelul fostului canal anal, una la
jumatatea distantei dintre fostul canal anal si scrot.
La internare pacient stabil, afebril, abdomen suplu, mobil cu respiratia, nedureros sponta si la
palapre, fara semene de iritatie peritoneala.
In data de 31.01.2017 se intervine chirurgical si se practica excizia formatiunilcor tumorale.
Examen CT vezi anexat.
Evolutie postoperatorie favorabila.
Pacientul se externeaza cu stare generala buna.
PROTOCOL OPERATOR:
RECOMANDARI/REGIM/MEDICATIE
DATA INVESTIGATII
30/01/2017 13:38:43 TOMOGRAFIA COMPUTERIZATA A ABDOMENULUI SI
PELVISULUI, CU SUBSTANTA DE CONTRAST
INTRAVENOASA (REZULTAT:
CT TORACO-ABDOMINO-PELVIN nativ, contrast i.v.
Ex. CT evidentiaza:
- o leziune situata in fosa ischio-rectala dr. cu dimensiuni de 2,5/3,7 cm.,
avand densitate tisulara si iodofilie marginala, bine delimtiata, venind in
raport (fara interfata de demarcatie) cu prostata si muschiul obturator
intern
- o alta leziune pelvina, avand caracrete similare, situata cranial de
precedenta, pe linia mediana, cu dimensiuni de 3,5/4 cm.
- o alta leziune prezentand caractere similare se evidentiaza subcutantat,
interfesier, cu dimensiuni de 2/4 cm. (aspect sugestiv pentru leziuni
recidivante)
- colostoma stg.
- nodul pulmonar situat in segmentul ant. al lobului superior dr.,
adiacent scizurii orizontale, cu dimensiuni de 12/17 mm., relativ bine
delimitat (se va urmari imagistic)
- bule de emfizem apicale bilateral
Ficat, cai biliare, colecist, pancreas, glande suprarenale, splina, ambii
rinichi, vezica urinara cu aspect CT normal.
Fara adenopatii toraco-abdomino-pelvine.
Sinusuri costo-diafragmatice libere.
Mediastinul prezinta aspect normal.
EPICRIZA
Pacient in varsta de 59 de ani, diagosticat cu neoplasm anorectal infiltrativ (ADK), pentru care s-
a practicat in data de 18.01.2016,enterectomie segmentara cu rezectie segment ileal, cu
ileoileoanastomoza T-T cu fire separate, amputtie de rect cu mare dificultate din pricina unei
invazii nivel anterior in vezica urinara si prostata, drenaj pelvin, mesaj perineal se prezinta pentru
aparitia a doua formatiuni tumorale la nivel pelvin, una la nivelul fostului canal anal, una la
jumatatea distantei dintre fostul canal anal si scrot.
La internare pacient stabil, afebril, abdomen suplu, mobil cu respiratia, nedureros sponta si la
palapre, fara semene de iritatie peritoneala.
In data de 31.01.2017 se intervine chirurgical si se practica excizia formatiunilcor tumorale.
Examen CT vezi anexat.
Evolutie postoperatorie favorabila.
Pacientul se externeaza cu stare generala buna.
PROTOCOL OPERATOR:
RECOMANDARI/REGIM/MEDICATIE
DATA INVESTIGATII
30/01/2017 13:38:43 TOMOGRAFIA COMPUTERIZATA A ABDOMENULUI SI
PELVISULUI, CU SUBSTANTA DE CONTRAST
INTRAVENOASA (REZULTAT:
CT TORACO-ABDOMINO-PELVIN nativ, contrast i.v.
Ex. CT evidentiaza:
- o leziune situata in fosa ischio-rectala dr. cu dimensiuni de 2,5/3,7 cm.,
avand densitate tisulara si iodofilie marginala, bine delimtiata, venind in
raport (fara interfata de demarcatie) cu prostata si muschiul obturator
intern
- o alta leziune pelvina, avand caracrete similare, situata cranial de
precedenta, pe linia mediana, cu dimensiuni de 3,5/4 cm.
- o alta leziune prezentand caractere similare se evidentiaza subcutantat,
interfesier, cu dimensiuni de 2/4 cm. (aspect sugestiv pentru leziuni
recidivante)
- colostoma stg.
- nodul pulmonar situat in segmentul ant. al lobului superior dr.,
adiacent scizurii orizontale, cu dimensiuni de 12/17 mm., relativ bine
delimitat (se va urmari imagistic)
- bule de emfizem apicale bilateral
Ficat, cai biliare, colecist, pancreas, glande suprarenale, splina, ambii
rinichi, vezica urinara cu aspect CT normal.
Fara adenopatii toraco-abdomino-pelvine.
Sinusuri costo-diafragmatice libere.
Mediastinul prezinta aspect normal.
EPICRIZA
Pacient in varsta de 59 de ani, diagosticat cu neoplasm anorectal infiltrativ (ADK), pentru care s-
a practicat in data de 18.01.2016,enterectomie segmentara cu rezectie segment ileal, cu
ileoileoanastomoza T-T cu fire separate, amputatie de rect cu mare dificultate din pricina unei
invazii nivel anterior in vezica urinara si prostata, drenaj pelvin, mesaj perineal se prezinta pentru
aparitia a doua formatiuni tumorale la nivel pelvin, una la nivelul fostului canal anal, una la
jumatatea distantei dintre fostul canal anal si scrot.
La internare pacient stabil, afebril, abdomen suplu, mobil cu respiratia, nedureros sponta si la
palapre, fara semene de iritatie peritoneala.
Examen CT vezi anexat.
Evolutie postoperatorie favorabila.
Pacientul se externeaza cu stare generala buna.
PROTOCOL OPERATOR:
RECOMANDARI/REGIM/MEDICATIE
DATA INVESTIGATII
16/08/2017 14:52:47 TOMOGRAFIA COMPUTERIZATA A ABDOMENULUI SI
PELVISULUI, CU SUBSTANTA DE CONTRAST
INTRAVENOASA (REZULTAT:Pacient operat pentru neoplasm rectal
(fara documentatie medicala in acest sens la momentul examinarii).
Actual AIS.
Proces expansiv tisular, neomogen , iodofil se evidentiaza la nivelul
canalului anal, ce invadeaza muschiul ridicator anal bilateral si se
extinde spre dr, la nivelul fosei ischiorectale de aceasta parte ,
invadand inclusiv muschiului obturator intern dr. Anterior, nu se mai
vizualizeaza interfata de demarcatie fata de conturul posterior al
prostatei -invazie. Aceeasi situatie in cazul raportului cu vezicula
seminala dr. In sens caudal, modificarile descend pana la nivelul
sfincterului anal.
Aspect densificat, infiltrat al grasimii la nivelyul fosei ischiorectale
bilateral.
Adenopatii se remarca inghinal dr cu diametru max ax scurt 10 mm,
hilar hepatic diametru max 8 mm.
Nu se constata determinari secundare la nivel hepatic, splenic,
pancreatic, renal.
Aspect hiperplazic la nivelul glandei suprarenale stg si bratului medial al
glandei suprarenale dr. De urmarit.
VU prezinta amprenta prostatica simetrica la nivelul planseului.
Prostata: neomogena, invadata la nivelul aspectului posterior de
formatiunea descrisa mai sus.
Fara fluid peritoneal.
Fara determinari secundare osoasa la nivelul segmentelor osoase
examinate.
Concluzie: Pacient operat pentru neo rectal. Recidiva tumorala la
nivelul canalului anal cu invazie locala. , ASISTENT:Tane Adela; );
Medic: LAURA ROMASCANU
16/08/2017 12:13:48 Bilirubina totala:0.86 mg/dL;
Glucoza:67 mg/dL; Ionograma:LIPSA REACTIV :ALT / AST /ACP /
ALP / FE / HDL -COL /AMI / D BIL / CREAT. / GGT / MG /
ELECTROLITI /ACID URIC . ; Proteine totale:7.35 g/dL;
Trigliceride:66 mg/dL; Urea:17 mg/dL; APTT:25.5 s; Fibrinogen:693
mg/dL; PT-APP-INR (PT:12.8 s, APP:111 %, INR:0.94 );
Hemograma (WBC:6.85 x 103/uL, LYM#:1.69 x 103/uL, LYM:24.70
%, MON#:0.60 x 103/uL, MON:8.70 %, NEU#:4.39 x 103/uL,
NEU:64.10 %, EOS#:0.14 x 103/uL, EOS:2.10 %, BAS#:0.03 x 103/uL,
BAS:0.40 %, RBC:4.40 x 106/uL, HGB:14.81 g/dL, HCT:43.68 %,
MCV:99.29 fL, MCH:33.67 pg, MCHC:33.91 g/dL, RDW:11.53 %,
PLT:195.21 x 103/uL, MPV:7.81 fL); VSH:62 mm/h; Medic: As.Pr.
CRISTINA FLIPACHE
16/08/2017 11:29:29 RADIOGRAFIA TORACO-PULMONARA -FATA:1.06
Dozamedie/organ; RADIOGRAFIA ABDOMENULUI (D(Gray x
Cm2):14.38 µGym2, Asistent:Balan Mariana; Voicu Oana; ); Medic:
MARIA CRISTINA TOLBARU
EPICRIZA
Pacient in varsta de 59 de ani, diagosticat cu neoplasm anorectal infiltrativ (ADK), pentru care s-
a practicat in data de 18.01.2016,enterectomie segmentara cu rezectie segment ileal, cu
ileoileoanastomoza T-T cu fire separate, amputatie de rect cu mare dificultate din pricina unei
invazii nivel anterior in vezica urinara si prostata, drenaj pelvin, mesaj perineal se prezinta pentru
aparitia a doua formatiuni tumorale la nivel pelvin, una la nivelul fostului canal anal, una la
jumatatea distantei dintre fostul canal anal si scrot.
La internare pacient stabil, afebril, abdomen suplu, mobil cu respiratia, nedureros sponta si la
palapre, fara semene de iritatie peritoneala.
Examen CT vezi anexat.
Evolutie postoperatorie favorabila.
Pacientul se externeaza cu stare generala buna.
PROTOCOL OPERATOR:
RECOMANDARI/REGIM/MEDICATIE
DATA INVESTIGATII
05/12/2017 17:19:31 TOMOGRAFIA COMPUTERIZATA A ABDOMENULUI SI
PELVISULUI, CU SUBSTANTA DE CONTRAST
INTRAVENOASA (REZULTAT:Revine cu documentatia anterioara
(incluziv imagistica) pentru interpretare. , CTDI (doza medie
efectiva):2218.7 mGy x CM); Medic: FLOAREA FIRICEL
04/12/2017 11:10:28 ALT/GPT:26 U/L; Amilaza:119 U/L; AST/GOT:56 U/L; Bilirubina
Directa:0.2 mg/dL; Bilirubina indirecta:0.6 ; Bilirubina totala:0.8
mg/dL; Creatinina:1.22 mg/dL; Glucoza:109 mg/dL; Ionograma
(Na:142 mmol/L, K:4.91 mmol/L, Cl:105 mmol/L); APTT.:26.300 s;
Fibrinogen.:860.489 mg/dL; PT-APP-INR. (PT:13.500 s, INR:1.000 ,
APP:105.245 %); Hemograma (WBC:9.07 x 103/uL, LYM#:1.72 x
103/uL, LYM:19.00 %, MON#:0.44 x 103/uL, MON:4.80 %, NEU#:6.64
x 103/uL, NEU:73.20 %, EOS#:0.24 x 103/uL, EOS:2.70 %, BAS#:0.03
x 103/uL, BAS:0.30 %, RBC:4.19 x 106/uL, HGB:12.96 g/dL,
HCT:39.95 %, MCV:95.44 fL, MCH:30.96 pg, MCHC:32.44 g/dL,
RDW:12.57 %, PLT:370.99 x 103/uL, MPV:6.66 fL); Medic: B.Pr.
IRINA CIUREL
04/12/2017 11:09:48 RADIOGRAFIA TORACO-PULMONARA -FATA (µGray x
m2:1.44 Dozamedie/organ, Asistent:Balan Mariana; );
RADIOGRAFIA ABDOMENULUI:7.65 µGym2; Medic: FLOAREA
FIRICEL
EPICRIZA
Pacient in varsta de 59 de ani, diagosticat in urma cu 4 luni cu neoplasm anorectal infiltrativ
(ADK), practicandu-se la momentul respectiv biopsie tumorala si colostomie terminala la nivel
sigmoidului, ce a urmat ulterior chimioterapie si radioterapie tintita, se prezinta la acest moment
in vederea continuarii tratamentului chirurgical.
Ecografie abdominala: in limite normale, fara determinari secundare intraabdominal decelabile
imagistic.
CT abdominal: vezi anexat.
Biologic: vezi anexat.
Se intervine chirurgical in data de 18.01.2016, decelandu-se important sindrom aderential pelvin,
cu invazie tumorala la nivelul unei anse ileale situate la 120 de cm de valvula ileocecala, prinse
in proceseul inflamator pelvin. Se practica enterectomie segmentara cu rezectie acestui segment
ileal, cu ileoileoanastomoza T-T cu fire separate. Se practica amputtie de rect cu mare dificultate
din pricina unei invazii nivel anterior in vezica urinara si prostata, drenaj pelvin, mesaj perineal.
Rezultat anatomopatologic - anexat biletului de externare.
Postoperator, pacientul prezinta o evolutie lent favorabila, cu suprimarea mesei perineale,
reluandu-si tranzitul intestinal pe la nivelul colostomei.
Pacientul dezvolta la aprox. 2 saptamani postoperator o supuratie profunda, cu exteriorizare de
lichid tulbure, purulent, cenusiu, atat pe la nivelul drenajului situat pelvin, cat si pe la nivel plagii
perienale de unde se suprima un fir de la nivelul polului anterior al acesteia pentru o mai buna
evacuare. Se practica toaleta si pansament zilnic, cu scaderea treptata a drenajului purulent,
suprimandu-se in cele din urma drenajul pelvin.
Se externeaza in data de 12.02.2016 cu stare generala buna, afebril, echilibrat hemodinamic si
respirator, TI pe colostoma, minima evacuare de lichid purulent pe la nivelul plagii perineale.
PROTOCOL OPERATOR:
RECOMANDARI/REGIM/MEDICATIE
EPICRIZA
Pacient in varsta de 52 ani, fara patologie chirurgicala anterioara importanta, se prezinta pentru
dureri la nivelul abdomenului inferior cu tulburari de tranzit intestinal insotite de greata ,
inapetenta, acutizate in ultimele ore si cu distensie abdominala importanta. Se interneaza
pentru reevaluare clinico-biologica.
Biologic : anexate biletului de externare.
Colonoscopie - la 10-12 cm de orificiul anal formatiune tumorala circumferentiala,
partial stenozanta, sangeranda. Nu se poate continua investigatia.
Se decide interventia chirurgicala si seevidentiaza formatiune tumorala de
maridimensiuni situata la nivelul rectului superiorce invadeaza planul posterior pana la nivelul
coloaneisacrate si anterior vezica urinara. Se practica rezectia partiala a formatiunii tumorale, cu
colostoma stanga terminala.
Evolutie postoperatorie favorabila, cu tranzit intestinal reluat pentru gaze si materii
fecale pe colostoma.
PROTOCOL OPERATOR:
RECOMANDARI/REGIM/MEDICATIE
DATA INVESTIGATII
04/06/2013 09:27:37 Albumina:2.8 g/dL; ALT/GPT.:30 U/L; Amilaza:65 U/L;
AST/GOT:40 U/L; Creatinina.:0.8 mg/dL; Glucoza:98 mg/dL;
Ionograma (Na:138 mmol/L, K:3.61 mmol/L, Cl:101 mmol/L);
Urea:16 mg/dL; APTT:28.5 s; Fibrinogen:816 mg/dL; PT-APP-INR
(PT:15.1 s, APP:82 %, INR:1.12 ); Hemograma (WBC:14.4 x 103/uL,
RBC:4.50 x 106/uL, HGB:12.5 g/dL, HCT:36.8 %, MCV:81.9 fL,
MCH:27.8 pg, MCHC:33.9 g/dL, RDW:13.8 %, PLT:278 x 103/uL,
PCT:0.217 %, MPV:7.8 fL, PDW:16.0 , LY#:0.9 x 103/uL, MO#:0.6 x
103/uL, NE#:12.9 x 103/uL, EO#:0.0 x 103/uL, BA#:0.0 x 103/uL,
LY%:6.5 %, MO%:3.9 %, NE%:89.5 %, EO%:0.1 %, BA%:0.0 %,
Comentariu:Leukocytosis; Neutrophilia %; Neutrophilia #;
Lymphopenia %; Lymphopenia #; ); Medic: Ch.Pr. CARMEN
BAJENARU
02/06/2013 18:23:00 Albumina:3.8 g/dL; ALT/GPT:8 U/L; Amilaza:93 UI; AST/GOT:19
U/L; Bilirubina Directa:0.09 mg/dL; Bilirubina indirecta:0.42 ;
Bilirubina totala:0.51 mg/dL; Creatinina:0.93 mg/dL; GGT:19 U/L;
Glucoza:94 mg/dL; Ionograma (Na:134 mmol/L, K:4.69 mmol/L,
Cl:100 mmol/L); Urea:19 mg/dL; APTT:27.4 s; Fibrinogen:585
mg/dL; PT-APP-INR (PT:13.6 s, APP:98 %, INR:1.01 ); Hemograma
(WBC:9.44 x 103/uL, LY#:2.97 x 103/uL, LY:31.50 %, MO#:0.75 x
103/uL, MO:7.90 %, NE#:5.01 x 103/uL, NE:53.10 %, EO#:0.65 x
103/uL, EO:6.90 %, BA#:0.06 x 103/uL, BA:0.60 %, RBC:4.84 x
106/uL, HGB:12.70 g/dL, HCT:39.19 %, MCV:81.06 fL, MCH:26.27
pg, MCHC:32.41 g/dL, RDW:13.39 %, PLT:325 x 103/uL, MPV:7.81
fL); Medic: As.Pr. GEORGETA CORDONEANU
EPICRIZA
Pacient in varsta de 76 de ani cunoscut cu neoplasm rectal operat in 07.2011 (colectomie
segmentara cu anus iliac stang), se prezinta pentru durere in etajul abdominal inferior cu iradiere
lombara bilateral si in regiunea genitala, aparuta de aprox 6 luni.
Ex local: abdomen suplu, mobil cu respiratia, sensibil in etajul inferior, fara iritatie peritoneala,
formatiune pseudotumorala de mari dimensiuni, la nivelul cicatricii postoperatorii mediane pubo
suprambilicale, supuratie parietala cronica - multiple granuloame de fir ; TI prezent pe
colostoma; TR - arie perianala de aspect normal, nu se poate palpa bontul rectal, secretie de
consistenta usor crescuta, negricioasa.
Biologic vezi anexat.
Markeri tumorali CA 19-9, CEA - anexat.
CT abdomen vezi anexat.
Pacientul se transfera in Spitalul de Boli Cronice Sf Luca Sectia Oncologie cu aviz Dna Dr
Ciuhu, cu stare generala buna, afebril, abdomen suplu, sensibil in etajul inferior, fara iritatie
peritoneala, TI prezent pe colostoma.
PROTOCOL OPERATOR:
RECOMANDARI/REGIM/MEDICATIE
DATA INVESTIGATII
15/01/2013 10:34:34 Albumina:3.5 g/dL; ALT/GPT.:27 U/L; Amilaza:76 U/L;
AST/GOT:17 U/L; Creatinina.:0.9 mg/dL; Glucoza:112 mg/dL;
Ionograma (Na:139 mmol/L, K:4.76 mmol/L, Cl:99 mmol/L); Proteine
totale:6.7 g/dL; Urea:29 mg/dL; APTT:30.1 s; Fibrinogen:590 mg/dL;
PT-APP-INR (PT:12.9 s, APP:103 %, INR:0.98 ); Hemograma
(WBC:6.9 x 103/uL, RBC:3.43 x 106/uL, HGB:9.1 g/dL, HCT:26.8 %,
MCV:78.2 fL, MCH:26.6 pg, MCHC:34.0 g/dL, RDW:16.1 %, PLT:355
x 103/uL, PCT:0.302 %, MPV:8.5 fL, PDW:16.2 , LY#:1.1 x 103/uL,
MO#:0.7 x 103/uL, NE#:4.9 x 103/uL, EO#:0.2 x 103/uL, BA#:0.0 x
103/uL, LY%:15.3 %, MO%:9.7 %, NE%:72.0 %, EO%:3.0 %,
BA%:0.0 %, Comentariu:Neutrophilia %; Neutrophilia #; Lymphopenia
%; Lymphopenia #; Eosinophilia %; Anemia; 1+ Anisocytosis; 1+
Microcytosis; 1+ Hypochromia; 1+ Poikilocytosis; ); VSH:80 mm/h;
Medic: As.Pr. SILVIA CONSTANTIN
EPICRIZA
Pacienta in varsta 56 de ani, operata de neoplasm de col uterin chimio si radio tratata, se
interneaza in clinica pentru rectoragii si dureri la defecatie.
Examen local – arie perianala de aspect normal, sfincter anal normoton, ampula rectala
cu materii fecale si o formatiune tumorala circumferentiala nestenozanta.
Biologic - anexat biletului de externare.
Ecografie abdominal : ficat omogen, fara cai biliare intrahepatice destinse, pancreas de
dimensiuni normale, omogen, colecist fara calculi, rinichi bilateral de aspect normal. Fara lichid
in peritoneu.
Se decide interventia chirurgicala. Intraoperator- la nivelul anselor intestinale subtiri si
organelor parenchimatoase nu se deceleaza macroscopic leziuni patologice. La nivelul rectului
inferior formatiune tumorala invadanta in vezica urinara si vagin, de 6/4 cm ; partial stenozanta,
circumferentiala, dura la palpare. Se decide si se practica amputatie de rect pe cale abdomino-
pelvina, lavaj si drenaj peritoneal.
Postoperator imediat evolutia pacientei este favorabila. Toleranta digestiva buna, tranzit
prezent pentru gaze si materii fecale pe colostoma.
La 10 zile de la interventia chirurgicala pe tubul de dren perineal se evacueaza continut
bilio-digestiv.
In data de 4.09.2013 se reintervine chirurgical si se evidentiaza anse intestinale dilatate,
cu perete gros, blocate in spatiul retrovezical restant in urma amputatiei de rect, masa viscerala
intim aderenta la nivelul sacrului si pachetului vascular iliac drept. Se evidentiaza la acest nivel
continut intestinal, dar fara posibilitatea obiectivarii fistulei digestive. Manevrele de mobilizare a
blocului visceral in tentativa de a evidentia traiectul fistulos se soldeaza cu sangerare abundenta.
Se decide si se practica derivatie entero-cecala de excludere latero-laterala in dublu strat. Se
repozitioneaza drenajul perineal si al spatiului retro- vezical. Anse intestinale dilatate - nu se
poate inchide peretele abdominal - se monteaza plasa de substitutie si drenaj subtegumentar.
Evolutie postoperatorie trenanta, cu drenaj perineal (de la nivel perineal) in scadere,
afebrila, tranzit prezent pe colostoma pentru gaze si materii fecale.
In data de 14.10.2013 se externeaza cu drenajul perineal montat prin care se
exteriorizeaza ~ 250 ml aspect bilio-digestiv.
PROTOCOL OPERATOR:
RECOMANDARI/REGIM/MEDICATIE
DATA INVESTIGATII
07/10/2013 03:20:18 Albumina:2.6 g/dL; ALT/GPT.:52 U/L; Amilaza:40 U/L;
AST/GOT:23 U/L; Bilirubina Directa:0.1 mg/dL; Bilirubina
indirecta:1.00 mg/dL; Bilirubina totala:1.1 mg/dL; Creatinina.:0.7
mg/dL; GGT:122 U/L; Glucoza:113 mg/dL; Ionograma (Na:141
mmol/L, K:4.99 mmol/L, Cl:98 mmol/L); Proteine totale:6.3 g/dL;
Urea:23 mg/dL; APTT:27.6 s; Fibrinogen:587 mg/dL; PT-APP-INR
(PT:14.1 s, APP:89 %, INR:1.06 ); Hemograma (WBC:7.40 x 103/uL,
LY#:2.58 x 103/uL, LY:34.90 %, MO#:0.80 x 103/uL, MO:10.80 %,
NE#:3.76 x 103/uL, NE:50.80 %, EO#:0.20 x 103/uL, EO:2.70 %,
BA#:0.06 x 103/uL, BA:0.80 %, RBC:4.57 x 106/uL, HGB:12.59 g/dL,
HCT:40.14 %, MCV:87.91 fL, MCH:27.56 pg, MCHC:31.35 g/dL,
RDW:16.03 %, PLT:351 x 103/uL, MPV:9.60 fL); VSH:120 mm/h;
Medic: As.Pr. SILVIA CONSTANTIN
EPICRIZA
Pacienta in varsta 56 de ani, operata de neoplasm de col uterin chimio si radio tratata, se
interneaza in clinica pentru rectoragii si dureri la defecatie.
Examen local – arie perianala de aspect normal, sfincter anal normoton, ampula rectala
cu materii fecale si o formatiune tumorala circumferentiala nestenozanta.
Biologic - anexat biletului de externare.
Ecografie abdominal : ficat omogen, fara cai biliare intrahepatice destinse, pancreas de
dimensiuni normale, omogen, colecist fara calculi, rinichi bilateral de aspect normal. Fara lichid
in peritoneu.
Se decide interventia chirurgicala. Intraoperator- la nivelul anselor intestinale subtiri si
organelor parenchimatoase nu se deceleaza macroscopic leziuni patologice. La nivelul rectului
inferior formatiune tumorala invadanta in vezica urinara si vagin, de 6/4 cm ; partial stenozanta,
circumferentiala, dura la palpare. Se decide si se practica amputatie de rect pe cale abdomino-
pelvina, lavaj si drenaj peritoneal.
Postoperator imediat evolutia pacientei este favorabila. Toleranta digestiva buna, tranzit
prezent pentru gaze si materii fecale pe colostoma.
La 10 zile de la interventia chirurgicala pe tubul de dren perineal se evacueaza continut
bilio-digestiv.
In data de 4.09.2013 se reintervine chirurgical si se evidentiaza anse intestinale dilatate,
cu perete gros, blocate in spatiul retrovezical restant in urma amputatiei de rect, masa viscerala
intim aderenta la nivelul sacrului si pachetului vascular iliac drept. Se evidentiaza la acest nivel
continut intestinal, dar fara posibilitatea obiectivarii fistulei digestive. Manevrele de mobilizare a
blocului visceral in tentativa de a evidentia traiectul fistulos se soldeaza cu sangerare abundenta.
Se decide si se practica derivatie entero-cecala de excludere latero-laterala in dublu strat. Se
repozitioneaza drenajul perineal si al spatiului retro- vezical. Anse intestinale dilatate - nu se
poate inchide peretele abdominal - se monteaza plasa de substitutie si drenaj subtegumentar.
Evolutie postoperatorie trenanta, cu drenaj perineal (de la nivel perineal) in scadere,
afebrila, tranzit prezent pe colostoma pentru gaze si materii fecale.
In data de 14.10.2013 se externeaza cu drenajul perineal montat prin care se
exteriorizeaza ~ 250 ml aspect bilio-digestiv.
PROTOCOL OPERATOR:
RECOMANDARI/REGIM/MEDICATIE
DATA INVESTIGATII
07/10/2013 03:20:18 Albumina:2.6 g/dL; ALT/GPT.:52 U/L; Amilaza:40 U/L;
AST/GOT:23 U/L; Bilirubina Directa:0.1 mg/dL; Bilirubina
indirecta:1.00 mg/dL; Bilirubina totala:1.1 mg/dL; Creatinina.:0.7
mg/dL; GGT:122 U/L; Glucoza:113 mg/dL; Ionograma (Na:141
mmol/L, K:4.99 mmol/L, Cl:98 mmol/L); Proteine totale:6.3 g/dL;
Urea:23 mg/dL; APTT:27.6 s; Fibrinogen:587 mg/dL; PT-APP-INR
(PT:14.1 s, APP:89 %, INR:1.06 ); Hemograma (WBC:7.40 x 103/uL,
LY#:2.58 x 103/uL, LY:34.90 %, MO#:0.80 x 103/uL, MO:10.80 %,
NE#:3.76 x 103/uL, NE:50.80 %, EO#:0.20 x 103/uL, EO:2.70 %,
BA#:0.06 x 103/uL, BA:0.80 %, RBC:4.57 x 106/uL, HGB:12.59 g/dL,
HCT:40.14 %, MCV:87.91 fL, MCH:27.56 pg, MCHC:31.35 g/dL,
RDW:16.03 %, PLT:351 x 103/uL, MPV:9.60 fL); VSH:120 mm/h;
Medic: As.Pr. SILVIA CONSTANTIN
PROTOCOL OPERATOR:
RECOMANDARI/REGIM/MEDICATIE
DATA INVESTIGATII
12/02/2013 17:07:49 Acid uric:8.59 mg/dL; Albumina:1.6 g/dL; ALT/GPT:427 U/L;
Amilaza:229 UI; AST/GOT:repeta recoltarea ; Bilirubina Directa:7.1
mg/dL; Bilirubina indirecta:1.76 ; Bilirubina totala (Bilirubina
totala:8.86 mg/dL, COMENTARII:ser icteric ); Colesterol:89 mg/dL;
Glucoza:repeta recoltarea ;
Ionograma (Na:141 mmol/L, K:5.45 mmol/L, Cl:107 mmol/L,
Comentarii:SER INTENS ICTERIC );
Proteine totale:4.11 g/dL; Trigliceride:42 mg/dL; Urea:137 mg/dL;
APTT:46.6 s; Fibrinogen:231 mg/dL; PT-APP-INR (PT:76.5 s,
APP:10 %, INR:6.90 ); Hemograma (WBC:7.69 x 103/uL, LY#:1.38 x
103/uL, LY:18.00 %, MO#:1.72 x 103/uL, MO:22.40 %, NE#:4.47 x
103/uL, NE:58.20 %, EO#:0.05 x 103/uL, EO:0.70 %, BA#:0.05 x
103/uL, BA:0.70 %, RBC:4.06 x 106/uL, HGB:10.31 g/dL, HCT:33.07
%, MCV:81.46 fL, MCH:25.41 pg, MCHC:31.19 g/dL, RDW:17.97 %,
PLT:45 x 103/uL, MPV:8.32 fL, Comentarii:microcoaguli prezenti );
Medic: As.Pr. NICOLETA PREDA
11/02/2013 10:13:33 ALT/GPT:SER HEMOLIZAT.REPETA RECOLTAREA PENTRU
RESTUL ANALIZELOR NELUCRATE. ;
Creatinina.:1.5 mg/dL; Glucoza:95 mg/dL;
Urea:119 mg/dL; APTT:35.1 s; Fibrinogen:287 mg/dL; PT-APP-INR
(PT:44.1 s, APP:18 %, INR:3.94 , Comentarii:PLASMA SLAB
HEMOLIZATA SI INTENS ICTERICA ); Hemograma (WBC:16.8 x
103/uL, RBC:4.65 x 106/uL, HGB:12.0 g/dL, HCT:37.6 %, MCV:80.8
fL, MCH:25.7 pg, MCHC:31.8 g/dL, RDW:21.9 %, PLT:85 x 103/uL,
PCT:0.084 %, MPV:9.9 fL, PDW:16.6 , LY#:0.7 x 103/uL, MO#:0.8 x
103/uL, NE#:15.2 x 103/uL, EO#:0.1 x 103/uL, BA#:0.0 x 103/uL,
LY%:3.9 %, MO%:4.6 %, NE%:91.2 %, EO%:0.3 %, BA%:0.0 %,
Comentariu:Leukocytosis; Neutrophilia %; Neutrophilia #;
Lymphopenia %; Lymphopenia #; 3+ Anisocytosis; 1+ Hypochromia;
1+ Poikilocytosis; Thrombocytopenia; ); Medic: Ch.Pr. CARMEN
BAJENARU
08/02/2013 07:53:13 ALT/GPT.:89 U/L; Amilaza:71 U/L; AST/GOT:255 U/L; Bilirubina
Directa.:APARATUL DA EROARE DE CITIRE DIN CAUZA
ICTERIEI MARI. REPETA. ;
Bilirubina totala (Bilirubina totala:2.5 mg/dL, Comentarii:SER
INTENS ICTERIC. ); CK:292 U/L; CK-MB:368 U/L; Colesterol:95
mg/dL; Creatinina.:1.0 mg/dL; Glucoza:91 mg/dL; Trigliceride:81
mg/dL; Urea:43 mg/dL; APTT:27.8 s; Fibrinogen:358 mg/dL; PT-
APP-INR (PT:19.8 s, APP:51 %, INR:1.59 , Comentarii:PLASMA
ICTERICA ); Hemograma (WBC:7.8 x 103/uL, RBC:3.64 x 106/uL,
HGB:10.3 g/dL, HCT:29.1 %, MCV:79.8 fL, MCH:28.2 pg,
MCHC:35.3 g/dL, RDW:21.1 %, PLT:70 x 103/uL, PCT:0.061 %,
MPV:8.7 fL, PDW:16.7 , LY#:0.7 x 103/uL, MO#:0.2 x 103/uL, NE#:6.9
x 103/uL, EO#:0.0 x 103/uL, BA#:0.0 x 103/uL, LY%:8.7 %, MO%:2.1
%, NE%:88.6 %, EO%:0.5 %, BA%:0.1 %, Comentariu:Neutrophilia %;
Neutrophilia #; Lymphopenia %; Lymphopenia #; Anemia; 2+
Anisocytosis; 1+ Microcytosis; Thrombocytopenia; ); VSH:incorect
recoltat ; Medic: As.Pr. GEORGETA CORDONEANU
08/02/2013 03:24:58 VSH:12 mm/h; Medic: As.Pr.MARIAN BOBU
08/02/2013 02:51:53 ALT/GPT.:103 U/L; Amilaza:88 U/L; AST/GOT:256 U/L;
Bilirubina totala (Bilirubina totala:3.4 mg/dL, Comentarii:ser icteric );
Creatinina.:1.2 mg/dL; Glucoza:77 mg/dL; Ionograma (Na:132
mmol/L, K:4.2 mmol/L, Cl:87 mmol/L); Urea:45 mg/dL; APTT:24.9 s;
Fibrinogen:492 mg/dL; PT-APP-INR (PT:21.1 s, APP:49 %, INR:1.61
); Hemograma (WBC:8.41 x 103/uL, LY#:0.89 x 103/uL, LY:10.60 %,
MO#:1.12 x 103/uL, MO:13.30 %, NE#:6.29 x 103/uL, NE:74.80 %,
EO#:0.07 x 103/uL, EO:0.80 %, BA#:0.04 x 103/uL, BA:0.50 %,
RBC:4.65 x 106/uL, HGB:12.10 g/dL, HCT:40.07 %, MCV:86.12 fL,
MCH:25.99 pg, MCHC:30.18 g/dL, RDW:19.72 %, PLT:180 x 103/uL,
MPV:8.96 fL); Medic: As.Pr.MARIAN BOBU
EPICRIZA
Pacienta in varsta de 56 de ani, diagnosticata in urma cu 5 luni cu neoplasm rectal, pentru care s-
a practicat colostomie terminala maturata primar la nivelul sigmoidului in data de 18.07.2019,
urmand tratament oncologic (chimioterapie), se prezinta pentru reevaluare clinico-biologica si
imagistica, la indicatiile medicului oncolog.
Clinic la momentul consultului: Abdomen suplu, mobil cu miscarile respiratorii, sensibil la
palpare la nivelul hipogastrului, fara semne de iritatie peritoneala; colostoma functionala; TR-
formatiune tumorala rectala ulcerovegetanta, sangeranda la atingere.
Biologic:anexat
Rx abdominal: anexat
Rx pulmonar: anexat
Rectoscopie: tumora rectala ulcerovegetanta la nivelul a 2/3 inferioare ale rectului din care se
preleveaza biopsie.
Pacienta se externeaza in data de 06.12.2019 cu stare generala buna, abdomen suplu, mobil cu
respiratia, nedureros spontan si la palpare fara semne de iritatie peritoneala, tranzit intestinal
prezent pe colostoma, urmand a se prezenta pentru reevaluare oncologica.
PROTOCOL OPERATOR:
RECOMANDARI/REGIM/MEDICATIE
DATA INVESTIGATII
04/12/2019 11:32:35 ALT/GPT:18 U/L; Amilaza:80 U/L;
AST/GOT:15 U/L; Bilirubina Directa:0.1 mg/dL; Bilirubina
indirecta:0.4 mg/dL; Bilirubina totala:0.5 mg/dL; Creatinina:0.98
mg/dL; Glucoza:213 mg/dL; Urea:44 mg/dL; APTT:24.1 s;
Fibrinogen:442 mg/dL; PT-APP-INR (PT:13.8 s, APP:106 %,
INR:0.96 ); Hemograma (WBC:7.70 x 103/uL, LYM#:2.53 x 103/uL,
LYM:32.90 %, MON#:0.52 x 103/uL, MON:6.70 %, NEU#:4.46 x
103/uL, NEU:57.90 %, EOS#:0.15 x 103/uL, EOS:2.00 %, BAS#:0.04 x
103/uL, BAS:0.50 %, RBC:3.58 x 106/uL, HGB:12.22 g/dL, HCT:36.81
%, MCV:102.81 fL, MCH:34.13 pg, MCHC:33.19 g/dL, RDW:15.36 %,
PLT:248.23 x 103/uL, MPV:7.55 fL); VSH:20 mm/h; Medic: As.Pr.
ADRIANA NEDELCU
04/12/2019 11:30:33 RADIOGRAFIA TORACO-PULMONARA -FATA
(REZULTAT:Hiperinflatie pulmonara.
Cord normal radiologic.
, µGray x m2:19.1 Dozamedie/organ, Asistent:Sirbu Elena Dumitra;
Tacu Mariana; ); RADIOGRAFIA ABDOMENULUI (REZULTAT:
Nivele hidroaerice in fosa iliaca dr.
Fara pneumoperitoneu.
EPICRIZA
Pacient in varsta de 57 de ani, se prezinta cu rectoragii. Pacient diagnosticat in alt serviciu de
specialitate cu adenocarcinom rectal inferior - formatiune tumorala ulcero-vegetanta la 10 cm de
orificiul anal, sangeranda spontan si la palpare.
Biologic - anexate biletului de externare.
Examen CT toraco-abdominal - anexat biletului de externare.
Consult oncologic - Sp Sf. Luca - se recomanda radioterapie, ulterior interventie chirurgicala.
PROTOCOL OPERATOR:
RECOMANDARI/REGIM/MEDICATIE
DATA INVESTIGATII
19/11/2013 09:14:20 ALT/GPT.:52 U/L; Amilaza:57 U/L; AST/GOT:29 U/L; Bilirubina
Directa:0.2 mg/dL;
Bilirubina totala:0.5 mg/dL; Colesterol:296 mg/dL; Creatinina.:1.0
mg/dL; Glucoza:110 mg/dL; Ionograma (Na:140 mmol/L, K:4.06
mmol/L, Cl:103 mmol/L); Trigliceride:183 mg/dL; Urea:38 mg/dL;
APTT:27.1 s; Fibrinogen:355 mg/dL; PT-APP-INR (PT:12.0 s,
APP:135 %, INR:0.88 ); Hemograma (WBC:6.1 x 103/uL, RBC:5.07 x
106/uL, HGB:16.0 g/dL, HCT:43.2 %, MCV:85.3 fL, MCH:31.5 pg,
MCHC:37.0 g/dL, RDW:11.9 %, PLT:207 x 103/uL, PCT:0.166 %,
MPV:8.0 fL, PDW:16.9 , LY#:2.0 x 103/uL, MO#:0.6 x 103/uL, NE#:3.4
x 103/uL, EO#:0.1 x 103/uL, BA#:0.0 x 103/uL, LY%:33.6 %,
MO%:10.3 %, NE%:54.9 %, EO%:1.2 %, BA%:0.0 %); VSH:8 mm/h;
Medic: As.Pr. ELENA CAMELIA CALITA
EPICRIZA
PROTOCOL OPERATOR:
RECOMANDARI/REGIM/MEDICATIE
INVESTIGATII PARACLINICE IN CURSUL INTERNARII
DATA INVESTIGATII
15/08/2019 07:05:20 ALT/GPT:10 U/L; Amilaza: U/L; AST/GOT:56 U/L; Bilirubina
Directa:6.5 mg/dL; Bilirubina indirecta:1.3 mg/dL; Bilirubina totala
(Bilirubina totala:7.8 mg/dL, Comentarii:SER INTENS ICTERIC );
CK:68 U/L; CK-MB:12 U/L; Colesterol:25 mg/dL; Creatinina:2.20
mg/dL; Glucoza:62 mg/dL; Ionograma (Na:144 mmol/L, K:2.60
mmol/L, Cl:111 mmol/L);
Proteine totale:4.4 g/dL; Trigliceride:88 mg/dL; Urea:44 mg/dL;
APTT:not coag. s; Fibrinogen:FIBRINOGENUL DERIVAT NU
POATE FI CALCULAT DE APARAT ; PT-APP-INR
(Comentarii:PLASMA ICTERICA , Comentarii:ANALIZORUL
AFISAZA EROARE DE COAGULARE LA DETERMINARI
REPETATE ); Hemograma (WBC:17.72 x 103/uL, LYM#:1.97 x
103/uL, LYM:11.10 %, MON#:1.49 x 103/uL, MON:8.40 %,
NEU#:13.88 x 103/uL, NEU:78.30 %, EOS#:0.30 x 103/uL, EOS:1.70
%, BAS#:0.09 x 103/uL, BAS:0.50 %, RBC:2.60 x 106/uL, HGB:8.15
g/dL, HCT:24.42 %, MCV:93.89 fL, MCH:31.34 pg, MCHC:33.38
g/dL, RDW:16.10 %, PLT:43.60 x 103/uL, MPV:10.62 fL); Medic:
As.Pr. CRISTINA PETROVICI
14/08/2019 11:24:09 RADIOGRAFIA TORACO-PULMONARA -FATA (µGray x
m2:21.3 Dozamedie/organ, Asistent:Pascu Florentina; ,
REZULTAT:Revarsat lichidian pleural bilateral etalat posterior, in
cantitate mare in dreapta si medie in stanga.
Infiltrat pulmonar mixt, predominant interstitial bilateral.Sonda IOT cu
capatul distal in 1/3 inf a traheei.
CVC cu capat distal la nivelul ariei de proiectie a trunchiului venos
brahiocefalic dr, traiect orizontal. ); Medic: Mihaela-Aurelia Gheorghiu
14/08/2019 11:03:45 ALT/GPT:10 mg/dL; Amilaza:3 U/L; AST/GOT:78 U/L; Bilirubina
Directa:6.8 mg/dL;
Bilirubina totala (Bilirubina totala:8.2 mg/dL, Comentarii:SER
ICTERIC. ); CK:101 U/L; CK-MB:34 U/L; Creatinina:2.35 mg/dL;
GGT:276 U/L; Glucoza:193 mg/dL; Ionograma:APARAT DEFECT ;
Proteine totale:5.0 g/dL; Urea:48 mg/dL; APTT.:52.600 s;
PT-APP-INR. (PT:38.900 s, INR:3.449 , APP:22.421 %,
5:FIBRINOGENUL DERIVAT NU POATE FI CALCULAT DE
APARAT AUTOMATIC); Hemograma (WBC:15.4 x 103/uL,
UWBC:15.4 x 103/uL, RBC:2.71 x 106/uL, HGB:8.4 g/dL, HCT:25.3 %,
MCV:93.6 fL, MCH:30.9 pg, MCHC:33.0 g/dL, RDW:22.4 %, RDW-
SD:70.9 , PLT:51 x 103/uL, MPV:9.7 fL, PCT:0.049 %, PDW:19.6 ,
NE%:86.3 %, LY%:7.3 %, MO%:5.5 %, EO%:0.4 %, BA%:0.5 %,
NE#:13.3 x 103/uL, LY#:1.1 x 103/uL, MO#:0.9 x 103/uL, EO#:0.1 x
103/uL, BA#:0.1 x 103/uL, NRBC:0.1 ); Medic: As.Pr. ADRIANA
NEDELCU
13/08/2019 14:15:50 ALT/GPT:9 U/L; Amilaza:2 U/L; AST/GOT:62 U/L; Bilirubina
Directa:6.1 mg/dL;
Bilirubina totala:7.5 mg/dL; Creatinina:1.75 mg/dL; Glucoza:57
mg/dL; Ionograma (Na:140 mmol/L, K:3 mmol/L, Cl:108 mmol/L);
Urea:41 mg/dL; APTT:56.7 s; Fibrinogen:442 mg/dL; PT-APP-INR
(PT:35.8 s, APP:27 %, INR:2.94 ); Hemograma (WBC:9.60 x 103/uL,
LYM#:1.38 x 103/uL, LYM:14.40 %, MON#:0.73 x 103/uL, MON:7.60
%, NEU#:7.26 x 103/uL, NEU:75.60 %, EOS#:0.19 x 103/uL, EOS:2.00
%, BAS#:0.04 x 103/uL, BAS:0.40 %, RBC:2.71 x 106/uL, HGB:8.45
g/dL, HCT:25.65 %, MCV:94.75 fL, MCH:31.20 pg, MCHC:32.93
g/dL, RDW:17.44 %, PLT:30.84 x 103/uL, MPV:..... fL); VSH:20
mm/h; Medic: As.Pr.MARIAN BOBU
04/08/2019 15:40:36 APTT:55.2 s; Fibrinogen:392 mg/dL; PT-APP-INR (PT:34.2 s,
APP:29 %, INR:2.78 ); Medic: Dr. ELENA DORINA BOTEZ
04/08/2019 11:46:35 Albumina:1.8 g/dL; ALT/GPT:9 U/L; Amilaza:3 U/L; AST/GOT:57
U/L; Bilirubina Directa:3.8 mg/dL; Bilirubina indirecta:0.9 mg/dL;
Bilirubina totala (Bilirubina totala:4.7 mg/dL, Comentarii:SER
ICTERIC. ); CK:19 U/L; CK-MB:7 U/L; Creatinina:1.35 mg/dL;
Fier:58 µg/dL; Glucoza:200 mg/dL;
Proteine totale:5.0 g/dL; Urea:16 mg/dL; APTT:La determinari
repetate ,aparatul afiseaza''eroare de coagulare'' ; Fibrinogen:La
determinari repetate ,aparatul afiseaza''eroare de coagulare'' ; PT-APP-
INR:La determinari repetate ,aparatul afiseaza''eroare de coagulare'' ;
Hemograma (WBC:8.74 x 103/uL, LYM#:0.64 x 103/uL, LYM:7.30 %,
MON#:0.27 x 103/uL, MON:3.10 %, NEU#:7.68 x 103/uL, NEU:87.80
%, EOS#:0.14 x 103/uL, EOS:1.60 %, BAS#:0.02 x 103/uL, BAS:0.20
%, RBC:2.93 x 106/uL, HGB:8.90 g/dL, HCT:26.43 %, MCV:90.26 fL,
MCH:30.38 pg, MCHC:33.65 g/dL, RDW:15.63 %, PLT:36.93 x
103/uL, MPV:10.75 fL); Medic: As.Pr. ADRIANA NEDELCU
03/08/2019 14:39:34 Glucoza:163 mg/dL; Hemograma (WBC:9.48 x 103/uL, LYM#:1.05 x
103/uL, LYM:11.10 %, MON#:0.42 x 103/uL, MON:4.40 %, NEU#:7.71
x 103/uL, NEU:81.30 %, EOS#:0.27 x 103/uL, EOS:2.80 %, BAS#:0.04
x 103/uL, BAS:0.40 %, RBC:3.23 x 106/uL, HGB:9.58 g/dL, HCT:29.17
%, MCV:90.38 fL, MCH:29.69 pg, MCHC:32.85 g/dL, RDW:16.11 %,
PLT:63.05 x 103/uL, MPV:10.62 fL); Medic: As.Pr.MARIAN BOBU
02/08/2019 16:47:08 RADIOGRAFIA TORACO-PULMONARA -FATA
(Asistent:Bataiosu Geta; , µGray x m2:29 Dozamedie/organ);
02/08/2019 10:37:41 Albumina:2.3 g/dL; ALT/GPT:12 mg/dL; Amilaza:7 U/L;
AST/GOT:49 U/L; Bilirubina Directa:3.4 mg/dL; Bilirubina
indirecta:0.9 mg/dL; Bilirubina totala (Bilirubina totala:4.3 mg/dL,
Comentarii:SER INTENS ICTERIC ); CK:26 U/L; CK-MB:17 U/L;
Creatinina:1.23 mg/dL; Glucoza:82 mg/dL; Ionograma (Na:144
mmol/L, K:3.16 mmol/L, Cl:104 mmol/L); LDH:197 U/L;
Proteine totale:5.8 g/dL; Urea:18 mg/dL; APTT:41.8 s;
Fibrinogen:401 mg/dL; PT-APP-INR (PT:33.6 s, APP:29 %, INR:2.72
); Hemograma (WBC:9.52 x 103/uL, LYM#:1.35 x 103/uL, LYM:14.20
%, MON#:0.70 x 103/uL, MON:7.30 %, NEU#:7.08 x 103/uL,
NEU:74.30 %, EOS#:0.36 x 103/uL, EOS:3.80 %, BAS#:0.04 x 103/uL,
BAS:0.40 %, RBC:3.05 x 106/uL, HGB:9.24 g/dL, HCT:27.36 %,
MCV:89.60 fL, MCH:30.24 pg, MCHC:33.75 g/dL, RDW:15.66 %,
PLT:51.24 x 103/uL, MPV:10.24 fL, Comentarii: MICROCOAGULI
PREZENTI! ); Medic: As.Pr. ILEANA DOBRE
30/07/2019 11:31:07 APTT:31.0 s; Fibrinogen:488 mg/dL; PT-APP-INR (PT:34.8 s,
APP:28 %, INR:2.84 ); Medic: B.Pr. IRINA CIUREL
30/07/2019 07:24:50 UROCULTURA CU ANTIBIOGRAMA
(UROCULTURA:NEGATIVA , COMENTARII:t2 ); Medic: Dr.
ELENA DORINA BOTEZ
30/07/2019 05:30:53 Albumina:2.2 g/dL; ALP:101 U/L; ALT/GPT:11 U/L; Amilaza:6 U/L;
AST/GOT:38 U/L; Bilirubina totala:3.2 mg/dL; Calciu:7.3 mg/dL;
CK:15 U/L; CK-MB:8 U/L; Colesterol:58 mg/dL; Creatinina:0.97
mg/dL; Fier:72 µg/dL; Glucoza:89 mg/dL; Ionograma (Na:149
mmol/L, K:2.72 mmol/L, Cl:107 mmol/L); Lipide Totale:277.5 mg/dL;
Magneziu:0.6 mg/dL; Proteine totale:5.5 g/dL;
Trigliceride:57 mg/dL; Urea:12 mg/dL; APTT:35.4 s;
Fibrinogen:FIBRINOGENUL DERIVAT NU POATE FI CALCULAT
DE APARAT ; PT-APP-INR:ANALIZORUL AFISAZA EROARE DE
COAGULARE LA DETERMINARI REPETATE ; Hemograma
(WBC:8.95 x 103/uL, LYM#:1.51 x 103/uL, LYM:16.90 %, MON#:1.01
x 103/uL, MON:11.30 %, NEU#:5.93 x 103/uL, NEU:66.20 %,
EOS#:0.46 x 103/uL, EOS:5.10 %, BAS#:0.04 x 103/uL, BAS:0.50 %,
RBC:3.37 x 106/uL, HGB:10.20 g/dL, HCT:29.84 %, MCV:88.57 fL,
MCH:30.28 pg, MCHC:34.18 g/dL, RDW:16.22 %, PLT:93.32 x
103/uL, MPV:9.60 fL); Medic: As.Pr. DANIELA ALEXANDRU
28/07/2019 16:31:10 RADIOGRAFIA TORACO-PULMONARA -FATA (µGray x
m2:19.2 Dozamedie/organ, Asistent:Sorici Cristian; ); Medic:
RUXANDRA ANCA NACEV
28/07/2019 12:05:31 ALT/GPT:14 U/L; Amilaza:4 U/L; AST/GOT:43 U/L; Bilirubina
Directa:1.9 mg/dL; Bilirubina indirecta:1.6 mg/dL; Bilirubina
totala:2.5 mg/dL; CK-MB:22 U/L; Creatinina:1.12 mg/dL; GGT:106
U/L; Glucoza:72 mg/dL; Ionograma (Na:140 mmol/L, K:3.61 mmol/L,
Cl:105 mmol/L); Proteine totale:5.5 g/dL; Urea:17 mg/dL; APTT:not
coag. s; Fibrinogen:531 mg/dL; PT-APP-INR (PT:38.1 s, APP:25 %,
INR:3.15 ); Hemograma (WBC:12.89 x 103/uL, LYM#:1.83 x 103/uL,
LYM:14.20 %, MON#:1.80 x 103/uL, MON:14.00 %, NEU#:8.75 x
103/uL, NEU:67.90 %, EOS#:0.44 x 103/uL, EOS:3.40 %, BAS#:0.06 x
103/uL, BAS:0.50 %, RBC:3.61 x 106/uL, HGB:10.89 g/dL, HCT:31.86
%, MCV:88.32 fL, MCH:30.18 pg, MCHC:34.17 g/dL, RDW:15.45 %,
PLT:169.56 x 103/uL, MPV:8.83 fL); Medic: As.Pr. ILEANA DOBRE
26/07/2019 11:20:52 Albumina:1.8 g/dL; ALT/GPT:15 U/L; Amilaza:6 U/L; AST/GOT:34
U/L; Bilirubina Directa:1.4 mg/dL; Bilirubina indirecta:0.60 mg/dL;
Bilirubina totala:2.0 mg/dL; CK:21 U/L; CK-MB:13 U/L;
Creatinina:1.02 mg/dL; Glucoza:118 mg/dL; Ionograma (Na:146
mmol/L, K:3.32 mmol/L, Cl:107 mmol/L); Proteine totale:5.5 g/dL;
Urea:47 mg/dL; APTT:not coag. s; Fibrinogen:615 mg/dL; PT-APP-
INR (PT:31.4 s, APP:32 %, INR:2.51 ); Hemograma (WBC:11.9 x
103/uL, UWBC:11.9 x 103/uL, RBC:3.55 x 106/uL, HGB:10.3 g/dL,
HCT:31.5 %, MCV:88.5 fL, MCH:29.0 pg, MCHC:32.7 g/dL,
RDW:21.3 %, RDW-SD:65.6 , PLT:180 x 103/uL, MPV:8.9 fL,
PCT:0.161 %, PDW:18.7 , NE%:69.2 %, LY%:12.1 %, MO%:13.7 %,
EO%:4.1 %, BA%:0.9 %, NE#:8.2 x 103/uL, LY#:1.4 x 103/uL,
MO#:1.6 x 103/uL, EO#:0.5 x 103/uL, BA#:0.1 x 103/uL, NRBC:0.1 );
Medic: As.Pr. CRISTINA PETROVICI
25/07/2019 10:50:13 RADIOGRAFIA TORACO-PULMONARA -FATA
(REZULTAT:Incidenta DD mult rotat.
CVC in VCS.
Revarsat lichidian pleural bilateral, etalat posterior, in cantitate medie in
dr, si mica in stg.
Mediastin neinterpretabil in DD. , Asistent:Parpalea Aurelia; ); Medic:
Mihaela-Aurelia Gheorghiu
24/07/2019 14:19:29 Albumina:1.8 g/dL; ALT/GPT:11 U/L; Amilaza:5 U/L; AST/GOT:27
U/L; Bilirubina Directa:1.7 mg/dL; Bilirubina indirecta:0.6 mg/dL;
Bilirubina totala:2.3 mg/dL; CK:20 U/L; CK-MB:12 U/L;
Creatinina:0.69 mg/dL; Glucoza:74 mg/dL; Ionograma (Na:143
mmol/L, K:3.80 mmol/L, Cl:110 mmol/L); LDH:162 U/L; Proteine
totale:5.1 g/dL; Urea:17 mg/dL; APTT:''eroare de coagulare'' la
determinari repetate ; Fibrinogen:682 mg/dL; PT-APP-INR (PT:28.6 s,
APP:30 %, INR:2.25 ); Hemograma (WBC:18.83 x 103/uL,
LYM#:2.03 x 103/uL, LYM:10.80 %, MON#:1.07 x 103/uL, MON:5.70
%, NEU#:14.94 x 103/uL, NEU:79.30 %, EOS#:0.70 x 103/uL,
EOS:3.70 %, BAS#:0.09 x 103/uL, BAS:0.50 %, RBC:3.60 x 106/uL,
HGB:10.66 g/dL, HCT:31.57 %, MCV:87.62 fL, MCH:29.60 pg,
MCHC:33.78 g/dL, RDW:15.15 %, PLT:174.41 x 103/uL, MPV:8.83
fL); Medic: As.Pr. CRISTINA FLIPACHE
23/07/2019 13:13:39 APTT:not coag. s; Fibrinogen:733 mg/dL; PT-APP-INR (PT:28.2 s,
APP:30 %, INR:2.21 ); Medic: Ch.Pr. CARMEN BAJENARU
23/07/2019 08:04:23 UROCULTURA CU ANTIBIOGRAMA:NEGATIVA ; Medic: Dr.
ELENA DORINA BOTEZ
22/07/2019 13:12:28 Acid uric:7.6 mg/dL; Albumina:1.7 g/dL; ALT/GPT:10 U/L;
Amilaza:6 U/L; AST/GOT:30 U/L; Bilirubina totala:1.2 mg/dL;
CK:30 U/L; CK-MB:22 U/L; Creatinina:0.74 mg/dL; Fier:53 µg/dL;
Glucoza:100 mg/dL; Ionograma (Na:143 mmol/L, K:2.72 mmol/L,
Cl:107 mmol/L);
Proteine totale:4.9 g/dL; Urea:16 mg/dL; APTT:not coag. s;
Fibrinogen:615 mg/dL; PT-APP-INR (PT:26.7 s, APP:33 %, INR:2.08
); Hemograma (WBC:11.29 x 103/uL, LYM#:1.64 x 103/uL,
LYM:14.50 %, MON#:0.51 x 103/uL, MON:4.50 %, NEU#:8.61 x
103/uL, NEU:76.30 %, EOS#:0.49 x 103/uL, EOS:4.30 %, BAS#:0.05 x
103/uL, BAS:0.40 %, RBC:3.33 x 106/uL, HGB:9.89 g/dL, HCT:28.94
%, MCV:86.98 fL, MCH:29.73 pg, MCHC:34.18 g/dL, RDW:14.91 %,
PLT:75.48 x 103/uL, MPV:9.22 fL); Medic: As.Pr. DANIELA
ALEXANDRU
21/07/2019 15:39:53 ALT/GPT:11 U/L; AST/GOT:28 U/L; Bilirubina Directa:0.5 mg/dL;
Bilirubina totala:0.8 mg/dL; CK:23 U/L; CK-MB:14 U/L;
Creatinina:0.75 mg/dL; Glucoza:124 mg/dL; Ionograma (Na:144
mmol/L, K:2.83 mmol/L, Cl:109 mmol/L); Urea:22 mg/dL; APTT
(APTT:not coag. s, COMENTARII:nu coaguleaza ); Fibrinogen:650
mg/dL; PT-APP-INR (PT:27.6 s, APP:31 %, INR:2.16 ); Hemograma
(WBC:14.34 x 103/uL, LYM#:1.92 x 103/uL, LYM:13.40 %,
MON#:0.85 x 103/uL, MON:5.90 %, NEU#:11.02 x 103/uL, NEU:76.80
%, EOS#:0.49 x 103/uL, EOS:3.40 %, BAS#:0.07 x 103/uL, BAS:0.50
%, RBC:3.26 x 106/uL, HGB:9.53 g/dL, HCT:28.16 %, MCV:86.50 fL,
MCH:29.28 pg, MCHC:33.85 g/dL, RDW:14.78 %, PLT:171.37 x
103/uL, MPV:8.58 fL); Medic: As.Pr. CRISTINA PETROVICI
20/07/2019 08:10:01 Albumina:1.5 g/dL; ALT/GPT:9 U/L; Amilaza:6 U/L; AST/GOT:24
U/L; Bilirubina Directa:0.4 mg/dL;
Bilirubina totala:0.6 mg/dL; CK:21 U/L; CK-MB:16 U/L;
Colesterol:57 mg/dL; Creatinina:0.99 mg/dL; GGT:176 U/L;
Glucoza:120 mg/dL; Ionograma (Na:145 mmol/L, K:2.79 mmol/L,
Cl:111 mmol/L); LDH:164 U/L; Proteine totale:4.6 g/dL; Urea:28
mg/dL; APTT:not coag. s; Fibrinogen:592 mg/dL; PT-APP-INR
(PT:29.1 s, APP:29 %, INR:2.28 ); Hemograma (WBC:7.31 x 103/uL,
LYM#:1.18 x 103/uL, LYM:16.10 %, MON#:0.57 x 103/uL, MON:7.80
%, NEU#:5.31 x 103/uL, NEU:72.60 %, EOS#:0.24 x 103/uL, EOS:3.30
%, BAS#:0.01 x 103/uL, BAS:0.20 %, RBC:2.81 x 106/uL, HGB:8.25
g/dL, HCT:24.64 %, MCV:87.75 fL, MCH:29.40 pg, MCHC:33.51
g/dL, RDW:14.62 %, PLT:91.29 x 103/uL, MPV:8.83 fL); Medic: As.Pr.
ADRIANA NEDELCU
18/07/2019 09:20:08 RADIOGRAFIA TORACO-PULMONARA -FATA (Asistent:Sirbu
Elena Dumitra; , REZULTAT:CVC in VCS.
Revarsat lichidian pleural bilateral, etalat posterior, dr > stg.
Infiltrat pulmonar mixt, peri si parahilar bilateral. ); Medic: Mihaela-
Aurelia Gheorghiu
18/07/2019 07:33:16 Acid uric:7.3 mg/dL; Albumina:1.8 g/dL; ALP:81 U/L; ALT/GPT:9
mg/dL; Amilaza:13 U/L; AST/GOT:17 U/L; Bilirubina Directa:0.8
mg/dL; Bilirubina indirecta:0.4 mg/dL; Bilirubina totala:1.2 mg/dL;
Calciu:8.7 mg/dL; Calciu Ionic:4.6 mg/dL; CK:15 U/L; CK-
MB:LIPSA REACTIV ; Creatinina:1.48 mg/dL; Fier:46 µg/dL;
GGT:131 U/L; Glucoza:87 mg/dL; Ionograma (Na:146 mmol/L,
K:3.45 mmol/L, Cl:112 mmol/L); Magneziu:1.0 mg/dL; Proteine
totale:4.8 g/dL; Urea:57 mg/dL; APTT.:38.400 s; Fibrinogen.:687.146
mg/dL; PT-APP-INR. (PT:27.900 s, INR:2.338 , APP:33.672 %);
Hemograma (WBC:4.8 x 103/uL, UWBC:4.8 x 103/uL, RBC:2.78 x
106/uL, HGB:8.1 g/dL, HCT:24.0 %, MCV:86.1 fL, MCH:29.0 pg,
MCHC:33.7 g/dL, RDW:18.5 %, RDW-SD:55.1 , PLT:145 x 103/uL,
MPV:8.5 fL, PCT:0.123 %, PDW:18.3 , NE%:85.8 %, LY%:8.9 %,
MO%:3.1 %, EO%:1.7 %, BA%:0.5 %, NE#:4.1 x 103/uL, LY#:0.4 x
103/uL, MO#:0.1 x 103/uL, EO#:0.1 x 103/uL, BA#:0.0 x 103/uL,
NRBC:0.2 ); Medic: B.Pr. IRINA CIUREL
17/07/2019 11:27:45 TOMOGRAFIA COMPUTERIZATA A ABDOMENULUI SI
PELVISULUI, CU SUBSTANTA DE CONTRAST
INTRAVENOASA (REZULTAT:Creatinina 0.84 mg/DL pe
10.07.2019, creatinina 1.75 mg/DL pe 17.07.2019- examinare nativa.
Status postoperator, tumora colon sigmoid.
Revarsat lichidian pleural cu dimensiuni de 38 mm de partea dr. si 29
mm de partea stg.
Atelectazie bazala bilateral.
Lama lichidiana de 10 mm perihepatica. Anterior de lobul stg. hepatic,
densitate aerica cu grosime de 7 mm (pneumoperitoneu?).
Ficat, splina, pancreas, glande suprarenale- fara modificari notabile CT
nativ.
Rinichi cu forma si dimensiuni normale, cu dilatatie pielocaliceala
bilateral.Vezica urinara destinsa, pereti ingrosati, fara imagini de calculi.
Adenopatie inghinala dr., rorunda, cu dimensiuni de 10 mm.
Fara modificari de structura osoasa.
Se regaseste colectia de la nivelul muschiului obturator intern stg.
Sonda urinara corest pozitionata.
, CTDI (doza medie efectiva):719.6 mGy x CM, ASISTENT:Paslariu
Elena Sorina; ); Medic: FLORIN PETCU
17/07/2019 10:42:28 Acid uric:5.9 mg/dL; Albumina:2.4 g/dL; ALP:101 U/L;
ALT/GPT:12 mg/dL; Amilaza:16 U/L; AST/GOT:20 U/L; Bilirubina
Directa:0.9 mg/dL; Bilirubina totala:1.4 mg/dL; Calciu:8.9 mg/dL;
CK:27 U/L; CK-MB.:LIPSA REACTIV ; Colesterol:67 mg/dL;
Creatinina:1.75 mg/dL; Glucoza:117 mg/dL; HDL-Colesterol:LIPSA
REACTIV ; Ionograma (Na:149 mmol/L, K:3.97 mmol/L, Cl:117
mmol/L);
Proteine totale:5.6 g/dL; Urea:66 mg/dL; APTT:ANALIZORUL
AFISAZA EROARE DE COAGULARE LA DETERMINARI
REPETATE. ; Fibrinogen:798 mg/dL; PT-APP-INR (PT:25.4 s,
APP:35 %, INR:1.97 ); Hemograma (WBC:20.1 x 103/uL, UWBC:20.1
x 103/uL, RBC:3.39 x 106/uL, HGB:9.7 g/dL, HCT:29.3 %, MCV:86.4
fL, MCH:28.6 pg, MCHC:33.1 g/dL, RDW:18.9 %, RDW-SD:56.4 ,
PLT:229 x 103/uL, MPV:8.1 fL, PCT:0.186 %, PDW:17.8 , NE%:87.7
%, LY%:4.4 %, MO%:7.3 %, EO%:0.3 %, BA%:0.3 %, NE#:17.6 x
103/uL, LY#:0.9 x 103/uL, MO#:1.5 x 103/uL, EO#:0.1 x 103/uL,
BA#:0.1 x 103/uL, NRBC:0.0 ); Medic: As.Pr. ILEANA DOBRE
16/07/2019 07:50:05 UROCULTURA CU ANTIBIOGRAMA
(UROCULTURA:NEGATIVA , COMENTARII:t2 ); Medic: Dr.
ELENA DORINA BOTEZ
16/07/2019 05:22:32 Albumina:1.9 g/dL; ALT/GPT:9 mg/dL; Amilaza:18 U/L;
AST/GOT:13 U/L; Bilirubina Directa:0.5 mg/dL; Bilirubina
indirecta:0.2 mg/dL; Bilirubina totala:0.7 mg/dL; CK:10 U/L; CK-
MB:LIPSA REACTIV ; Creatinina:1.04 mg/dL; Glucoza:92 mg/dL;
Ionograma (Na:147 mmol/L, K:3.53 mmol/L, Cl:115 mmol/L);
Proteine totale:4.8 g/dL; Urea:49 mg/dL; APTT:42.9 s;
Fibrinogen:Fibrinogenul derivat nu poate fi calculat de aparat ; PT-
APP-INR (PT:24.6 s, APP:37 %, INR:1.86 ); Hemograma
(WBC:12.38 x 103/uL, LYM#:1.03 x 103/uL, LYM:8.30 %, MON#:0.85
x 103/uL, MON:6.90 %, NEU#:10.31 x 103/uL, NEU:83.30 %,
EOS#:0.15 x 103/uL, EOS:1.20 %, BAS#:0.04 x 103/uL, BAS:0.30 %,
RBC:3.11 x 106/uL, HGB:9.20 g/dL, HCT:27.63 %, MCV:88.93 fL,
MCH:29.62 pg, MCHC:33.31 g/dL, RDW:14.62 %, PLT:127.25 x
103/uL, MPV:8.06 fL); Medic: As.Pr. ILEANA DOBRE
14/07/2019 10:45:57 ALT/GPT:11 U/L; AST/GOT:11 U/L; Creatinina:0.77 mg/dL;
Glucoza:83 mg/dL; Ionograma (Na:141 mmol/L, K:3.37 mmol/L,
Cl:112 mmol/L); Urea:36 mg/dL; APTT:32.3 s;
Fibrinogen:FIBRINOGENUL DERIVAT NU POATE FI CALCULAT
DE APARAT. ; PT-APP-INR (PT:24.4 s, APP:38 %, INR:1.85 );
Hemograma (WBC:15.70 x 103/uL, LYM#:0.85 x 103/uL, LYM:5.40
%, MON#:0.69 x 103/uL, MON:4.40 %, NEU#:13.93 x 103/uL,
NEU:88.70 %, EOS#:0.19 x 103/uL, EOS:1.20 %, BAS#:0.05 x 103/uL,
BAS:0.30 %, RBC:2.94 x 106/uL, HGB:8.91 g/dL, HCT:26.31 %,
MCV:89.47 fL, MCH:30.30 pg, MCHC:33.87 g/dL, RDW:13.95 %,
PLT:129.35 x 103/uL, MPV:7.94 fL); Medic: As.Pr. CRISTINA
FLIPACHE
13/07/2019 15:06:43 Hemograma (WBC:12.49 x 103/uL, LYM#:0.91 x 103/uL, LYM:7.30
%, MON#:0.66 x 103/uL, MON:5.30 %, NEU#:10.74 x 103/uL,
NEU:86.00 %, EOS#:0.15 x 103/uL, EOS:1.20 %, BAS#:0.02 x 103/uL,
BAS:0.20 %, RBC:2.74 x 106/uL, HGB:8.25 g/dL, HCT:24.36 %,
MCV:88.95 fL, MCH:30.12 pg, MCHC:33.86 g/dL, RDW:13.31 %,
PLT:107.03 x 103/uL, MPV:7.81 fL); Medic: As.Pr. ILEANA DOBRE
12/07/2019 09:09:58 Albumina:1.5 g/dL; ALP:38 U/L; ALT/GPT:10 mg/dL; Amilaza:11
U/L; AST/GOT:14 U/L; Bilirubina Directa:0.8 mg/dL; Bilirubina
indirecta:0.3 mg/dL; Bilirubina totala:1.1 mg/dL; Calciu:7.6 mg/dL;
CK:20 U/L; CK-MB:LIPSA REACTIV ; Creatinina:0.88 mg/dL;
Fier:7 µg/dL; Glucoza:128 mg/dL; Ionograma (Na:142 mmol/L,
K:4.07 mmol/L, Cl:116 mmol/L); LDH:102 U/L; Proteine totale:3.6
g/dL; Urea:31 mg/dL; APTT:35.8 s; Fibrinogen:508 mg/dL; PT-APP-
INR (PT:24.1 s, APP:38 %, INR:1.86 ); Hemograma (WBC:13.5 x
103/uL, UWBC:13.5 x 103/uL, RBC:2.96 x 106/uL, HGB:8.5 g/dL,
HCT:25.2 %, MCV:85.0 fL, MCH:28.8 pg, MCHC:33.9 g/dL,
RDW:16.2 %, RDW-SD:47.3 , PLT:148 x 103/uL, MPV:8.0 fL,
PCT:0.118 %, PDW:17.1 , NE%:91.1 %, LY%:4.6 %, MO%:4.1 %,
EO%:0.0 %, BA%:0.2 %, NE#:12.3 x 103/uL, LY#:0.6 x 103/uL,
MO#:0.5 x 103/uL, EO#:0.0 x 103/uL, BA#:0.0 x 103/uL, NRBC:0.0 );
Medic: As.Pr.MARIAN BOBU
11/07/2019 19:26:53 Acid uric:3.5 mg/dL; Albumina:1.7 g/dL; ALP:46 U/L; ALT/GPT:11
U/L; Amilaza:11 U/L; AST/GOT:20 U/L; Bilirubina Directa:1.1
mg/dL; Bilirubina indirecta:0.5 mg/dL; Bilirubina totala:1.6 mg/dL;
Calciu:6.8 mg/dL; Calciu Ionic:4.22 mg/dL; CK:33 U/L; CK-MB:25
U/L; Creatinina:0.56 mg/dL; Fier:53 µg/dL; GGT:93 U/L;
Glucoza:122 mg/dL; Ionograma (Na:141 mmol/L, K:3.49 mmol/L,
Cl:114 mmol/L); Magneziu:0.7 mg/dL; Proteine totale:3.4 g/dL;
Urea:20 mg/dL; APTT.:29.100 s; Fibrinogen.:396.699 mg/dL; PT-
APP-INR. (PT:25.000 s, INR:2.056 , APP:39.135 %); Hemograma
(WBC:24.23 x 103/uL, LYM#:1.33 x 103/uL, LYM:5.50 %, MON#:0.90
x 103/uL, MON:3.70 %, NEU#:21.61 x 103/uL, NEU:89.20 %,
EOS#:0.27 x 103/uL, EOS:1.10 %, BAS#:0.12 x 103/uL, BAS:0.50 %,
RBC:3.40 x 106/uL, HGB:9.92 g/dL, HCT:29.73 %, MCV:87.52 fL,
MCH:29.22 pg, MCHC:33.38 g/dL, RDW:13.16 %, PLT:248.58 x
103/uL, MPV:7.55 fL); Medic: As.Pr. CRISTINA FLIPACHE
11/07/2019 18:40:40 UROCULTURA CU ANTIBIOGRAMA:12.07.2019Absenti germeni
cu risc epidemiologic dupa 24 ore de incubare-T1 ; CULTURA
ASPIRAT BRONSIC CU ANTIBIOGRAMA:12.07.2019Absenti
germeni cu risc epidemiologic dupa 24 ore de incubare-T1 ; CULTURA
EXUDAT NAZAL CU ANTIBIOGRAMA:12.07.2019Absenti
germeni cu risc epidemiologic dupa 24 ore de incubare-T1 ; Medic:
As.Pr. SIMONA OPREA
11/07/2019 05:49:49 Hemograma (WBC:9.03 x 103/uL, LYM#:1.13 x 103/uL, LYM:12.50
%, MON#:0.68 x 103/uL, MON:7.50 %, NEU#:7.06 x 103/uL,
NEU:78.10 %, EOS#:0.13 x 103/uL, EOS:1.40 %, BAS#:0.05 x 103/uL,
BAS:0.50 %, RBC:2.81 x 106/uL, HGB:7.91 g/dL, HCT:24.02 %,
MCV:85.56 fL, MCH:28.18 pg, MCHC:32.94 g/dL, RDW:14.08 %,
PLT:177.81 x 103/uL, MPV:7.55 fL); Medic: As.Pr. ILEANA DOBRE
10/07/2019 10:45:50 Albumina:2.2 g/dL; Proteine totale:5.2 g/dL; Medic: B.Pr. IRINA
CIUREL
10/07/2019 08:45:36 ALT/GPT:20 mg/dL; Amilaza:32 U/L; AST/GOT:33 U/L; Bilirubina
Directa:0.1 mg/dL; Bilirubina indirecta:0.10 mg/dL; Bilirubina
totala:0.2 mg/dL; Creatinina:0.84 mg/dL; Glucoza:88 mg/dL;
Ionograma (Na:146 mmol/L, K:4.14 mmol/L, Cl:115 mmol/L);
Urea:39 mg/dL; APTT:27.3 s; Fibrinogen:626 mg/dL; PT-APP-INR
(PT:18.9 s, APP:55 %, INR:1.43 ); Hemograma (WBC:9.4 x 103/uL,
UWBC:9.4 x 103/uL, RBC:3.02 x 106/uL, HGB:8.3 g/dL, HCT:25.3 %,
MCV:83.8 fL, MCH:27.4 pg, MCHC:32.7 g/dL, RDW:17.8 %, RDW-
SD:51.2 , PLT:240 x 103/uL, MPV:7.7 fL, PCT:0.184 %, PDW:16.9 ,
NE%:75.8 %, LY%:13.9 %, MO%:9.2 %, EO%:0.6 %, BA%:0.5 %,
NE#:7.1 x 103/uL, LY#:1.3 x 103/uL, MO#:0.9 x 103/uL, EO#:0.1 x
103/uL, BA#:0.0 x 103/uL, NRBC:0.1 ); VSH:46 mm/h; Medic: As.Pr.
NICOLETA PREDA
08/07/2019 16:31:13 RADIOGRAFIA TORACO-PULMONARA -FATA (µGray x
m2:13.1 Dozamedie/organ, Asistent:Gavrilas Mihaela; Parpalea Aurelia;
, REZULTAT:Fara leziuni pleuro-pulmonare cu caracter activ decelabile
rg.
Fracturi vechi, vicios consolidate la nivelul arcurilor costale
anterolateral V si VI dr.
CVC cu ebord la nivelul v jugulare dr, pozitionat cu extremitatea int in
et. spatiului intercostal ant II-III dr.
); Medic: LAURA ROMASCANU
06/07/2019 11:13:37 Hemograma (WBC:8.71 x 103/uL, LYM#:1.36 x 103/uL, LYM:15.60
%, MON#:0.49 x 103/uL, MON:5.60 %, NEU#:6.75 x 103/uL,
NEU:77.50 %, EOS#:0.09 x 103/uL, EOS:1.00 %, BAS#:0.03 x 103/uL,
BAS:0.30 %, RBC:3.41 x 106/uL, HGB:9.41 g/dL, HCT:28.86 %,
MCV:84.69 fL, MCH:27.61 pg, MCHC:32.60 g/dL, RDW:13.98 %,
PLT:251.88 x 103/uL, MPV:7.30 fL); Medic: As.Pr. CRISTINA
FLIPACHE
04/07/2019 11:36:10 TOMOGRAFIA COMPUTERIZATA A ABDOMENULUI SI
PELVISULUI, CU SUBSTANTA DE CONTRAST
INTRAVENOASA (REZULTAT:CT abdomino-pelvin nativ + contrast
iv:
La nivelul flancului drept, subhepatic se pune in evidenta- colectie
polilobata ce pare sa inflitreze colonul transvers si ansele ileale,
neexistand limita de demarcatie cu acestea, cu diametrul de 10/11/13 cm
( transvers/cranio-caudal/ antero-posterior), ce inflitraza tesuturile moi
de la nivelul peretelui abdominal.
Imagini nodulara cu aspect conopidiform situata retrovezical, densitate
parafluida, iodofilie periferica, cu diametrul de 3,3/4 cm in plan axial.
Ficat, splina, pancreas, rinichi stang, glande suprarenale- cu aspect CT in
limite normale.
Rinichi drept- cu dialtatie pielo-caliceala gr. II.
V.U.- perete anterior usor ingrosat, grosime ~ 8 mm.
Colectie la nivelul muschiului abturator stang, cu densitate parafluida,
iodofilie periferica, cu diametrul de 2,0/3,1 cm in plan axial, ce pare sa
nu prezinte limita de demarcatie cu prostata ( perete lateral stang).
Adenopatii abdominale perigastrice ( curbura mica), celiace
mezenterice, iliace comune drepte cu diametrul maxim 16 mm.
Fara lichid intraperitoneal.
Fara modificari de structura osoasa cu caracter osteolitice/
osteocondensant. , CTDI (doza medie efectiva):1780 mGy x CM);
Medic: SIMONA BELAUS
04/07/2019 11:29:57 CULTURA COLECTIE PURULENTA INCHISA CU
ANTIBIOGRAMA(Aerobioza) (GERMENI:Escherichia coli; ESBL
pozitiv,germen multidrogrezistent , ANTIBIOTICE
REZISTENT:Ampicillin--Rezistent; Augumentin (Amoxacillin /
Clav.acid)--Rezistent; Cefazolin--Rezistent; Cefepime--Rezistent;
Cefotaxime--Rezistent; Ceftazidime--Rezistent; Cefuroxime--Rezistent;
Ciprofloxacin--Rezistent; Fosfamycin--Rezistent; Gentamicin--
Rezistent; Levofloxacin--Rezistent; Mezlicillin--Rezistent;
MOXIFLOXACIN--Rezistent; Piperaciliin--Rezistent; Tetracycline--
Rezistent; Tigecyclin--Rezistent; Tobramycin--Rezistent; Trimethoprim
/ Sulphametoxazol--Rezistent; , ANTIBIOTICE SENSIBIL:Amikacin--
Sensibil; Cefoxitin--Sensibil; Meropenem--Sensibil; Piperacillin /
tazobactam--Sensibil; ); CULTURA COLECTIE PURULENTA
INCHISA CU ANTIBIOGRAMA(Anaerobioza) :Nu s-au dezvoltat
germeni anaerobi dupa 24 ore de incubare ; Medic: Dr. MIRELA
CONSTANTIN
04/07/2019 11:26:56 ALT/GPT:22 mg/dL; Amilaza:9 U/L; AST/GOT:21 U/L; Bilirubina
Directa:0.2 mg/dL; Bilirubina indirecta:0.2 mg/dL; Bilirubina
totala:0.4 mg/dL; Creatinina:1.38 mg/dL; Glucoza:95 mg/dL;
Ionograma (Na:130 mmol/L, K:4.20 mmol/L, Cl:97 mmol/L); Urea:49
mg/dL; APTT:25.6 s; Fibrinogen:815 mg/dL; PT-APP-INR (PT:21.0
s, APP:46 %, INR:1.60 ); Hemograma (WBC:14.47 x 103/uL,
LYM#:1.45 x 103/uL, LYM:10.00 %, MON#:1.72 x 103/uL,
MON:11.90 %, NEU#:11.10 x 103/uL, NEU:76.70 %, EOS#:0.14 x
103/uL, EOS:1.00 %, BAS#:0.06 x 103/uL, BAS:0.40 %, RBC:2.93 x
106/uL, HGB:7.65 g/dL, HCT:24.38 %, MCV:83.32 fL, MCH:26.16 pg,
MCHC:31.39 g/dL, RDW:13.85 %, PLT:319.04 x 103/uL, MPV:7.30
fL); VSH:110 mm/h; Medic: As.Pr. NICOLETA PREDA
EPICRIZA
PROTOCOL OPERATOR:
RECOMANDARI/REGIM/MEDICATIE
DATA INVESTIGATII
03/12/2014 09:03:01 Acid uric:4.7 mg/dL; Albumina:1.8 g/dL; Creatinina.:1.6 mg/dL;
Glucoza:162 mg/dL; Ionograma (Na:159 mmol/L, K:2.78 mmol/L,
Cl:132 mmol/L, Comentarii:LUCRAT DE DOUA ORI. ); Proteine
totale:5.3 g/dL; Urea:100 mg/dL; APTT:24.6 s; Fibrinogen:334
mg/dL; PT-APP-INR (PT:14.3 s, APP:87 %, INR:1.08 ); Hemograma
(WBC:8.5 x 103/uL, RBC:3.43 x 106/uL, HGB:10.5 g/dL, HCT:29.5 %,
MCV:85.9 fL, MCH:30.7 pg, MCHC:35.7 g/dL, RDW:15.7 %, PLT:216
x 103/uL, PCT:0.175 %, MPV:8.1 fL, PDW:17.2 , LY#:0.9 x 103/uL,
MO#:0.2 x 103/uL, NE#:7.3 x 103/uL, EO#:0.1 x 103/uL, BA#:0.0 x
103/uL, LY%:10.5 %, MO%:2.1 %, NE%:86.8 %, EO%:0.6 %,
BA%:0.0 %, Comentariu:Neutrophilia %; Neutrophilia #; Lymphopenia
%; Lymphopenia #; Anemia; 1+ Anisocytosis; ); VSH:28 mm/h; Medic:
As.Pr. CONSTANTINA PREDESCU
26/11/2014 16:26:06 HEMOCULTURA CU ANTIBIOGRAMA
(COMENTARII:28.11.2014.Nu s-au dezvoltat germeni dupa 48 ore de
incubare;cultura in curs de observatie pana in data de 3.12.2014 ,
GERMENI:Stafilococi coagulazo-negativi (SCN); , ANTIBIOTICE
REZISTENT:Ciprofloxacin; Erythromycin; MOXIFLOXACIN;
Oxacillin; Trimethoprim / Sulphametoxazol; Vancomycin; ); Medic: Dr.
MIRELA CONSTANTIN
25/11/2014 12:52:58 HEMOCULTURA CU ANTIBIOGRAMA
(COMENTARII:27.11.2014.Nu s-au dezvoltat germeni dupa 48 ore de
incubare;cultura in curs de observatie pana in data de 2.12.2014 ,
GERMENI:2.12.2014.Nu s-au dezvoltat germeni dupa 7 zile de incubare
); Medic: Dr. MIRELA CONSTANTIN
24/11/2014 07:12:59 Albumina:1.2 g/dL; ALT/GPT.:20 U/L; Amilaza:14 U/L;
AST/GOT:30 U/L; Bilirubina Directa:0.1 mg/dL;
Bilirubina totala:0.2 mg/dL; Colesterol:110 mg/dL; Creatinina.:1.2
mg/dL; Ionograma:LIPSA REACTIV ; Proteine totale:4.6 g/dL;
Urea:40 mg/dL; APTT:25.6 s; Fibrinogen:655 mg/dL; PT-APP-INR
(PT:13.9 s, APP:95 %, INR:1.03 ); Hemograma (WBC:7.7 x 103/uL,
RBC:2.81 x 106/uL, HGB:8.8 g/dL, HCT:25.3 %, MCV:90.3 fL,
MCH:31.3 pg, MCHC:34.7 g/dL, RDW:13.4 %, PLT:343 x 103/uL,
PCT:0.215 %, MPV:6.3 fL, PDW:16.8 , LY#:0.5 x 103/uL, MO#:0.5 x
103/uL, NE#:6.6 x 103/uL, EO#:0.1 x 103/uL, BA#:0.0 x 103/uL,
LY%:6.8 %, MO%:6.8 %, NE%:85.7 %, EO%:0.7 %, BA%:0.0 %,
Comentariu:Neutrophilia %; Neutrophilia #; Lymphopenia %;
Lymphopenia #; Anemia; Small Platelets; ); VSH:70 mm/h; Medic:
As.Pr.MARIAN BOBU
20/11/2014 15:04:15 UROCULTURA CU ANTIBIOGRAMA:NEGATIVA ; SUMAR DE
URINA (Densitate:1030 , pH:6 , Glucoza:Negativ ,
Urobilinogen:Normal , Proteine:3+(300 mg/dl) , Bilirubina:Negativ ,
Nitriti:Negativ , Leucocite:25 Leu/µL , Corpi Cetonici:Negativ mg/dL,
Epitelii plate:Foarte rare , Leucocite:Relativ frecvente ,
Altele:NUMEROASE LEVURI ); Medic: Ch.Pr. CARMEN
BAJENARU
17/11/2014 08:57:46 Acid uric:3.6 mg/dL; Albumina:1.6 g/dL; ALT/GPT.:22 U/L;
Amilaza:19 U/L; AST/GOT:24 U/L; Bilirubina Directa:0.1 mg/dL;
Bilirubina totala:0.3 mg/dL; Colesterol:98 mg/dL; Creatinina.:1.2
mg/dL; Fosfataza alcalina.:73 U/L; Glucoza:174 mg/dL; Ionograma
(K:2.68 mmol/L, Cl:111 mmol/L, Comentarii:NA=ELECTROD
DEFECT ); Proteine totale:4.9 g/dL; Trigliceride:109 mg/dL; Urea:66
mg/dL; APTT:23.5 s; Fibrinogen:599 mg/dL; PT-APP-INR (PT:13.4
s, APP:101 %, INR:1.00 ); Hemograma (WBC:17.6 x 103/uL,
RBC:3.13 x 106/uL, HGB:9.9 g/dL, HCT:29.6 %, MCV:94.5 fL,
MCH:31.7 pg, MCHC:33.5 g/dL, RDW:12.6 %, PLT:313 x 103/uL,
PCT:0.242 %, MPV:7.7 fL, PDW:17.4 , LY#:0.6 x 103/uL, MO#:0.6 x
103/uL, NE#:16.4 x 103/uL, EO#:0.0 x 103/uL, BA#:0.0 x 103/uL,
LY%:3.2 %, MO%:3.2 %, NE%:93.4 %, EO%:0.2 %, BA%:0.0 %,
Comentariu:Leukocytosis; Neutrophilia %; Neutrophilia #;
Lymphopenia %; Lymphopenia #; Anemia; ); VSH:38 mm/h; Medic:
As.Pr. ELENA CAMELIA CALITA
13/11/2014 13:52:15 Hemograma (WBC:15.46 x 103/uL, LY#:1.38 x 103/uL, LY:8.90 %,
MO#:1.44 x 103/uL, MO:9.30 %, NE#:12.40 x 103/uL, NE:80.20 %,
EO#:0.14 x 103/uL, EO:0.90 %, BA#:0.11 x 103/uL, BA:0.70 %,
RBC:3.52 x 106/uL, HGB:11.37 g/dL, HCT:32.87 %, MCV:93.41 fL,
MCH:32.32 pg, MCHC:34.60 g/dL, RDW:10.87 %, PLT:400 x 103/uL,
MPV:7.68 fL); Medic: As.Pr. ADRIANA NEDELCU
04/11/2014 09:54:21 Timp de Coagulare pe lama:6.30 Minut; Timp de Sangerare:2.15
Minut; Medic: As.Pr. CONSTANTINA PREDESCU
03/11/2014 10:29:38 ALT/GPT:LIPSA REACTIV ; Amilaza:LIPSA REACTIV ;
AST/GOT:21 U/L; Creatinina.:1.2 mg/dL; Glucoza:154 mg/dL;
Ionograma (Na:137 mmol/L, K:4.75 mmol/L, Cl:108 mmol/L);
APTT:23.4 s;
PT-APP-INR:LIPSA REACTIV ; Hemograma (WBC:11.0 x 103/uL,
RBC:3.74 x 106/uL, HGB:12.2 g/dL, HCT:35.7 %, MCV:95.3 fL,
MCH:32.5 pg, MCHC:34.1 g/dL, RDW:12.0 %, PLT:307 x 103/uL,
PCT:0.235 %, MPV:7.7 fL, PDW:16.8 , LY#:1.3 x 103/uL, MO#:0.5 x
103/uL, NE#:8.9 x 103/uL, EO#:0.1 x 103/uL, BA#:0.2 x 103/uL,
LY%:11.8 %, MO%:4.6 %, NE%:81.1 %, EO%:0.9 %, BA%:1.6 %,
Comentariu:Leukocytosis; Neutrophilia %; Neutrophilia #;
Lymphopenia %; Basophilia %; Basophilia #; Anemia; ); Medic: B.Pr.
IRINA CIUREL